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1 
FLUORESCENT CONJUGATED POLYMERS 
WITH A BODIPY-BASED BACKBONE AND 
USES THEREOF 
2 
wherein each-AR- is independently selected from arylene or 
heteroarylene; 
wherein each R3 is independently selected from R, alkyl, 
aryl or heteroaryl 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
5 wherein each R2 and R4 are independently selected from 
alkyl or H; 
This is a divisional of U.S. patent application Ser. No. 
13/141,158, filed on Sep. 14, 2011, which is a U.S. national 
stage entry of International Patent Application No. PCT/ 10 
US2009/069415, filed on Dec. 23, 2009, which claims 
priority to U.S. Provisional Patent Application No. 61/140, 
529, filed on Dec. 23, 2008, the entire contents of all of 
which are fully incorporated herein by reference. 15 
STATEMENT OF GOVERNMENT SUPPORT 
wherein each R1 and R5 are independently selected from 
hydrogen, alkyl, or 
--=-AR; 
wherein each R0 is -F, --OR, -R, aryl, heteroaryl, 
-----R, -----Ary!, 
This invention was made with United States government 
support from the National Institutes of Health, Grant No. 20 or 
1R43CA134039-01 and from USDA Cooperative State 
Research, Education, and Extension Service-Nanoscale 
Science and Engineering for Agriculture and Food Systems, 
National Research Initiative Grant no. 2007-35603-17740. 
-----====--Heteroaryl; 
The United States government has certain rights in this 25 
invention. 
BACKGROUND 
4-Difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) 30 
derivatives are becoming increasingly popular for promising 
applications in biological probes, suproamolecular fluores-
cent gels, solar cells and sensors because BODIPY dyes 
possess elevated chemical and photostability, relatively high 
absorption coefficients and fluorescence quantum yields, and 35 
show narrow absorption and emission bands with high peak 
intensities. 
SUMMARY 
wherein each R is independently selected from -H, 
-(CH2)mR10, -(CH2)mCOO(CH2)pCH3, (CH2)mS03Na, 
-(CH2)mP03Na, -(CH2)mN(CH3)3 +Br-, -(CH2)mCOH 
(CH2)pCH3, -(CH2)mOR10, -(CH2)mORg, ----CH2CH2 
(OCH2CH2)mOR10, ----CH2CHiOCH2CH2)mORg, 
----CH2CHiOCH2CH2)mSR8 , or 
nnn 
----c_O O O OCH3 
0 0 0 OCH3; \_J\_J\_J 
Among other things, the present invention provides a 
40 
and 
polymer according to formula (I): 
f 
~N......_ /N 
B 
/\ 
Ro Ro 
A 
Rs 
wherein each -A- is independently selected from 
-AR-, 
or 
--=-AR-=--, 
-----===~-AR-..==c===--, or 
--------AR--------
(I) 
wherein each R8 is independently selected from a carbohy-
drate residue; 
and wherein each R10 is independently selected from hydro-
gen, alkyl, heteroalkyl, hydroxy, amino, ammonic acid, 
45 thiol, carboxylic acid, nitrile, azide, ethynylene, halo, and 
tosylate; 
50 
55 
60 
65 
wherein m is from O to 100; 
wherein n is from 2 to 300 and 
wherein p is from O to 20. 
The invention further provides a polymer according to 
formula (II): 
(II) 
-{A Ak-
US 9,623,123 B2 
3 
wherein each -A- is independently selected from 
-AR-, 
or 
--=-AR-=--, 
----'==~-AR-=~-, or 
--------AR--------
wherein each-AR- is independently selected from arylene or 
heteroarylene; 
wherein each R3 is independently selected from R, alkyl, 
10 
s 
4 
~N, /N 
B 
/\ 
R0 Ro 
s 
15 
wherein each -A- is independently selected from 
-AR-, 
(III) 
aryl or heteroaryl 20 
wherein each R2 and R4 are independently selected from 
alkyl or H; 
wherein each R6 is independently selected from H or alkyl; 
wherein each R0 is -F, --OR, -R, aryl, heteroaryl, 
---==-R, --==-Ary!, 
or 
---==-Heteroaryl; 
wherein each R is independently selected from -H, 
-(CH2)mR10, -(CH2)mCOO(CH2)pCH3, -(CH2)m 
or 
25 --=-AR-=--, 
----AR----, or 
--====----,===--AR--====---===--
30 wherein each-AR- is independently selected from arylene or 
heteroarylene; 
wherein each R3 is independently selected from R, alkyl, 
aryl or heteroaryl 
35 wherein each R2 and R4 are independently selected from 
alkyl or H; 
wherein each R6 is independently selected from H or alkyl; 
wherein each R0 is -F, --OR, -R, aryl, heteroaryl, 
S03Na, -(CH2)mP03Na, -(CH2)mN(CH3)3 +Br-, 40 
-(CH2)mCOH(CH2)pCH3, -(CH2)mOR10, -(CH2)mORs, ----R, ----Ary!, 
-CH2CH2(0CB2CH2)mOR1o, ----CH2CH2(0CH2CH2)m 
ORs, -CH2CHiOCH2CH2)mSRs, or 
nnn 
---(__O O O OCH3 
0 0 0 OCH3; 
LJLJLJ 
and 
wherein each Rs is independently selected from a carbohy-
drate residue; 
or 
45 
---==-Heteroaryl; 
wherein each R is independently selected from -H, 
50 
-(CH2)mR10, -(CH2)mCOO(CH2)pCH3, (CH2)mS03Na, 
-(CH2)mP03Na, -(CH2)mN(CH3)3 +Br-, -(CH2)mCOH 
(CH2)pCH3, -(CH2)mOR10, -(CH2)mORs, ----CH2CH2 
(OCH2CH2)mOR10, ----CH2CHiOCH2CH2)mORs, 
----CH2CHiOCH2CH2)mSRs, or 55 
and wherein each R10 is independently selected from hydro-
gen, alkyl, heteroalkyl, hydroxy, amino, ammonic acid, 
thiol, carboxylic acid, nitrile, azide, ethynylene, halo, and 
60 
tosylate; 
nnn 
---(__O O O OCH3 
wherein m is from O to 100; 
wherein n is from 2 to 300 and 
wherein p is from O to 20. 
In addition, the invention provides a polymer according to 
formula (III): 
0 0 0 OCH3; 
LJLJLJ 
65 and 
wherein each Rs is independently selected from a carbohy-
drate residue; 
US 9,623,123 B2 
5 6 
and wherein each R10 is independently selected from hydro- or 
gen, alkyl, heteroalkyl, hydroxy, amino, ammonic acid, 
thiol, carboxylic acid, nitrile, azide, ethynylene, halo, and 
tosylate; --=~-Heteroaryl; 
wherein m is from O to 100; 5 
wherein n is from 2 to 300 and 
wherein p is from O to 20. 
The invention also provides a polymer according to 
formula (IV): 
R2 
R3 
Ri 
~ 
R,; R,; 
~N, /N 
B 
/\ ~ Ro Ro 
A 
R6 
wherein each -A- is independently selected from 
-AR-, 
or 
--=-AR-=--, 
-----AR-----, or 
wherein each-AR- is independently selected from arylene or 
heteroarylene; 
wherein each R3 is independently selected from R, alkyl, 
aryl or heteroaryl 
wherein each R2 and R4 are independently selected from 
alkyl or H; 
wherein each R6 is independently selected from H or alkyl; 
wherein each R0 is -F, --OR, -R, aryl, heteroaryl, 
--=~-R, -----Ary!, 
wherein each R is independently selected from -H, 
-(CH2)mR10, -(CH2)mCOO(CH2)pCH3, (CH2)mS03Na, 
-(CH2)mP03Na, -(CH2)mN(CH3)3 +Br-, -(CH2)mCOH 
(IV) 
Ro Ro 
\/ 
-= 
B 
-.:::::N/ '-N 
R6 
~ 
R2 R3 Ri 
40 (CH2)pCH3, -(CH2)mOR10, -(CH2)mORg, ----CH2CH2 
(OCH2CH2)mOR10, ----CH2CHiOCH2CH2)mORg, 
----CH2CHiOCH2CH2)mSR8 , or 
45 /\/\/\ 
---(__O O O OCH3 
0 0 0 OC~; 
\_J\_J\_J 50 
and 
wherein each R8 is independently selected from a carbohy-
55 drate residue; 
and wherein each R10 is independently selected from hydro-
gen, alkyl, heteroalkyl, hydroxy, amino, ammonic acid, 
thiol, carboxylic acid, nitrile, azide, ethynylene, halo, and 
tosylate; 
60 wherein m is from O to 100; 
wherein n is from 2 to 300 and 
wherein p is from O to 20. 
The invention further provides methods of using the 
above polymers including a method of enhancing medical 
65 imaging comprising administering an effective amount of a 
polymer to a subject in need of medical imaging and 
obtaining an image, wherein the amount of the polymer is 
US 9,623,123 B2 
7 
sufficient to enhance an image compared to an image 
obtained in absence of the polymer. 
Also, the invention provides a method of detecting the 
presence of a target in a sample comprising contacting the 
sample with a polymer which binds to the target and 5 
detecting fluorescence of the polymer. 
In addition, the invention provides a method of monitor-
ing drug delivery comprising administering a polymer to a 
subject and detecting fluorescence of the polymer in the 
subject, wherein the polymer is further functionalized with 10 
an active agent. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 shows various carbohydrate residues. 
FIG. 2A and FIG. 28 show various aryl groups. 
FIG. 3 shows a synthetic route to conjugated polymers 
with BODIPY backbone. 
15 
FIG. 4 shows UV-visible absorption and emission spectra 20 
of BODIPY derivatives and polymer II. 
FIG. 5 shows a synthetic route to fluorescent BODIPY-
based conjugated copolymers. 
FIG. 6 shows normalized UV-Visible absorption and 
fluorescent spectra of compounds 9 and 10, and polymer III 25 
in methylene chloride solution. 
FIG. 7 shows an ORTEP representation of the molecular 
structure of compound 18. The non-H atoms are represented 
by thermal ellipsoids displayed at the 50% probability level 
and the H-atoms are indicated by circles of arbitrary radii. 30 
FIG. 8 shows normalized UV-Visible absorption and 
fluorescent spectra of compounds 9 and 10, and polymer III 
in DMF solution. 
FIG. 9 shows normalized UV-Visible absorption and 
fluorescent spectra of compounds 14 and 15, and polymer IV 35 
in methylene chloride solution. 
FIG. 10 shows normalized UV-Visible absorption and 
fluorescent spectra of compounds 14 and 15, and polymer IV 
in DMF solution. 
FIG. 11 shows normalized UV-Visible absorption and 40 
fluorescent spectra of compounds 18 and 19, and polymer V 
in methylene chloride solution. 
8 
FIG. 25 shows chemical structures ofBODIPY polymeric 
and copolymeric dyes. 
FIG. 26 shows a synthetic route to BODIPY dyes. 
FIG. 27 shows a synthetic route to BODIPY copolymeric 
dyes. 
FIG. 28 shows a synthetic route to BODIPY copolymeric 
dyes. 
FIG. 29 shows a synthetic route to BODIPY copolymeric 
dyes. 
FIG. 30 shows absorption spectra of BODIPY dyes and 
polymeric dyes. 
FIG. 31 shows fluorescence spectra ofBODIPY dyes and 
polymeric dyes. 
FIG. 32 shows absorption and fluorescence spectra of 
BODIPY copolymeric dyes. 
FIG. 33 shows TGA curves for BODIPY based polymers. 
FIG. 34 shows chemical structures of conjugated poly-
mers with BODIPY backbone. 
FIG. 35 shows a synthetic route to a BODIPY based 
polymer. 
FIG. 36 shows a synthetic route to a BODIPY based 
polymer. 
FIG. 37 shows synthetic route to a BODIPY based poly-
mer. 
FIG. 38 shows absorption and fluorescence spectra for 
BODIPY dyes and polymers. 
FIG. 39 shows absorption and fluorescence spectra for 
BODIPY dyes and polymers. 
FIG. 40 shows absorption and fluorescence spectra for 
BODIPY dyes and polymers. 
FIG. 41 shows TGA curves for BODIPY based polymers. 
FIG. 42 shows chemical structures of conjugated poly-
mers with BODIPY backbone 
FIG. 43 shows a synthetic route to a BODIPY based 
polymer. 
FIG. 44 shows a synthetic route to a BODIPY based 
polymer. 
FIG. 45 shows absorption spectra for BODIPY dyes and 
polymers. 
FIG. 46 shows fluorescence spectra for BODIPY dyes and 
polymers. 
FIG. 12 shows normalized UV-Visible absorption and 
fluorescent spectra of compounds 18 and 19, and polymer V 
in DMF solution. 
FIG. 47 shows UV-visible absorption (left) and fluores-
cent spectra (right) of polymer XXIV in the absence and 
45 presence of E.coli bacteria ofORNl 78 strain (lxl08 cells). 
FIG. 13 shows chemical structures of BODIPY-based 
conjugated glycopolymers. 
FIG. 14 shows chemical Structures of BODIPY-based 
conjugated glycol-copolymers. 
Excitation wavelength is 370 nm. 
DETAILED DESCRIPTION 
FIG. 15 shows a synthetic route to fluorescent conjugated 50 
glyopolymers XIX and XX. 
Before any embodiments of the present application are 
explained in detail, it is to be understood that the invention 
is not limited in its application to the details of construction 
and the arrangement of components set forth in the follow-
ing description or illustrated in the following drawings. The 
invention is capable of other embodiments and of being 
practiced or of being carried out in various ways. 
FIG. 16 shows a synthetic route to fluorescent conjugated 
glycopolythiophenes. 
FIG. 17 shows a synthetic route to highly water-soluble 
fluorene-based ~-glucose-bearing and a-marmose bearing 55 
conjugated glycopolymers with poly(ethylene glycol) teth-
ered spacers (polymers XXIII and XXIV, respectively). The present application provides fluorescent conjugated 
polymers with a BODIPY-based backbone. In one embodi-
ment, the present invention provides different BODIPY 
FIG. 18 shows a synthetic route to bromide-bearing 
poly(BODIPY-ethylene )(polymer I) and ester-bearing poly 
(BODIPY-ethynylene)s (Polymers XXVI and XXVII). 
FIG. 19 shows a synthetic route to BODIPY-based copo-
lymers (polymers XXVIII and XXIX). 
FIG. 20 shows a synthetic route to BODIPY dyes. 
FIG. 21 shows a synthetic route to BODIPY dyes. 
FIG. 22 shows a synthetic route to BODIPY dyes. 
FIG. 23 shows a synthetic route to BODIPY dyes. 
FIG. 24 shows a synthetic route to BODIPY dyes. 
60 monomers incorporated into a polyfluorene backbone 
through the 2,6-positions of BODIPY cores. Suitably, these 
polymers have emission into the orange region. The absorp-
tion and fluorescent maxima of certain of the copolymers are 
significantly red-shifted up to 48 nm and 74 nm relative to 
65 those of the starting BODIPY dyes due to the extended 
it-conjugation of the conjugated polymers in methylene 
chloride solution. In addition, in certain embodiments, these 
US 9,623,123 B2 
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polymers are highly fluorescent with quantum yields ranging 
from about 55.6% to about 84.8% in methylene chloride 
solution. 
In one embodiment, the invention provides a polymer 
5 
according to formula (I): 
(I) 
R2 
R3 ~ 10 
f ~ ~ j A 
~N......_ /N 
B 
/\ 15 R1 Ro Ro Rs 
10 
/\/\/\ 
---(__O O O OCH3 
0 0 0 OC~; 
\_J\_J\_J 
and 
wherein each R8 is independently selected from a carbohy-
drate residue; 
and wherein each R10 is independently selected from hydro-
gen, alkyl, heteroalkyl, hydroxy, amino, ammonic acid, 
thiol, carboxylic acid, nitrile, azide, ethynylene, halo, and 
tosylate; 
wherein m is from O to 100; 
wherein n is from 2 to 300 and 
wherein p is from O to 20. 
wherein each -A- is independently selected from In another embodiment, the invention provides a polymer 
20 according to formula (II): 
-AR-, (II) 
25 
or 
--=-AR-=--, 
30 
-{A Ak-
wherein each-AR- is independently selected from arylene or 35 wherein each -A- is independently selected from 
heteroarylene; 
wherein each R3 is independently selected from R, alkyl, 
aryl or heteroaryl 
wherein each R2 and R4 are independently selected from 40 
alkyl or H; 
wherein each R1 and R5 are independently selected from 
hydrogen, alkyl, or 
--=-AR; 
45 
or 
-AR-, 
--<===~-AR--===>---
----'=c==c~-AR-...=c=cc==c--, or 
--------AR--------
wherein each R0 is -F, --OR, -R, aryl, heteroaryl, 
50 
wherein each-AR- is independently selected from arylene or 
heteroarylene; 
-----R, -----Ary!, wherein each R3 is independently selected from R, alkyl, 
aryl or heteroaryl 
wherein each R2 and R4 are independently selected from 
55 alkyl or H; 
or 
-----Heteroaryl; 
60 
wherein each R is independently selected from -H, 
-(CH2)mR10, -(CH2)mCOO(CH2)pCH3, (CH2)mS03Na, 
-(CH2)mP03Na, -(CH2)mN(CH3)3 +Br-, -(CH2)mCOH 
(CH2)pCH3, -(CH2)mOR10, -(CH2)mORg, ----CH2CH2 65 
(OCH2CH2)mOR10, ----CH2CHiOCH2CH2)mORg, 
-CH2CHiOCH2CH2)mSR8 , or 
wherein each R6 is independently selected from H or alkyl; 
wherein each R0 is -F, --OR, -R, aryl, heteroaryl, 
-----"c==c~-R, ----'==~-Ary!, 
or 
-----Heteroaryl; 
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11 
wherein each R is independently selected from -H, 
-(CH2)mR10, -(CH2)mCOO(CH2)pCH3, (CH2)mS03Na, 
-(CH2)mP03Na, -(CH2)mN(CH3)3 +Br-, -(CH2)mCOH 
(CH2)pCH3, -(CH2)mOR10, -(CH2)mORs, ----CH2CH2 
(OCH2CH2)mOR10, ----CH2CHiOCH2CH2)mORs, 5 
-CH2CHiOCH2CH2)mSRs, or 
10 
/\/\/\ 
12 
--=-AR-=--, 
----AR----, or 
wherein each-AR- is independently selected from arylene or 
heteroarylene; 
wherein each R3 is independently selected from R, alkyl, 
aryl or heteroaryl 
---(__O O O OCH3 
wherein each R2 and R4 are independently selected from 
15 alkyl or H; 
0 0 0 OC~; 
\__J \__J \__J 
20 
and 
wherein each Rs is independently selected from a carbohy- 25 
drate residue; 
and wherein each R10 is independently selected from hydro-
gen, alkyl, heteroalkyl, hydroxy, amino, ammonic acid, 
thiol, carboxylic acid, nitrile, azide, ethynylene, halo, and 
tosylate; 
wherein m is from O to 100; 
wherein n is from 2 to 300 and 
wherein p is from O to 20. 
30 
In yet another embodiment, the invention provides a 35 
polymer according to formula (III): 
s 
..-::::.N..__ /N 
B 
/\ 
Ro Ro 
s 
wherein each -A- is independently selected from 
40 
(III) 
45 
50 
Ah-
n 55 
60 
wherein each R6 is independently selected from H or alkyl; 
wherein each R0 is -F, --OR, -R, aryl, heteroaryl, 
_---==cc===c-R, _---==cc===c-Ary), 
or 
----Heteroaryl; 
wherein each R is independently selected from -H, 
-(CH2)mR10, -(CH2)mCOO(CH2)pCH3, (CH2)mS03Na, 
-(CH2)mP03Na, -(CH2)mN(CH3)3 +Br-, -(CH2)mCOH 
(CH2)pCH3, -(CH2)mOR10, -(CH2)mORs, ----CH2CH2 
(OCH2CH2)mOR10, ----CH2CHiOCH2CH2)mORs, 
----CH2CHiOCH2CH2)mSRs, or 
/\/\/\ 
---(__O O O OCH3 
0 0 0 OC~; 
\__J \__J \__J 
and 
wherein each Rs is independently selected from a carbohy-
drate residue; 
and wherein each R10 is independently selected from hydro-
gen, alkyl, heteroalkyl, hydroxy, amino, ammonic acid, 
thiol, carboxylic acid, nitrile, azide, ethynylene, halo, and 
tosylate; 
-AR-, 
wherein m is from O to 100; 
wherein n is from 2 to 300 and 
65 wherein p is from O to 20. 
or 
In a further embodiment, the invention provides a poly-
mer according to formula (IV): 
US 9,623,123 B2 
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.--,::.N.....,_ /N 
B 
/\ 
Ro Ro 
A 
wherein each -A- is independently selected from 
-AR-, 
or 
--=-AR-=--, 
----==c=-AR--===c~- , or 
wherein each-AR- is independently selected from arylene or 
14 
(IV) 
(OCH2CH2)mOR10, ----CH2CHiOCH2CH2)mORg, 
30 
----CH2CHiOCH2CH2)mSR8 , or 
35 /\/\/\ 
---(__O O O OCH3 
0 0 0 OC~; 
\__/ \__/ \__/ 40 
and 
heteroarylene; 45 wherein each R8 is independently selected from a carbohy-
drate residue; wherein each R3 is independently selected from R, alkyl, 
aryl or heteroaryl 
wherein each R2 and R4 are independently selected from 
alkyl or H; 
wherein each R6 is independently selected from H or alkyl; 
wherein each R0 is -F, --OR, -R, aryl, heteroaryl, 
----R, ----==c=-Aryl, 
or 
----Heteroaryl; 
and wherein each R10 is independently selected from hydro-
gen, alkyl, heteroalkyl, hydroxy, amino, ammonic acid, 
50 thiol, carboxylic acid, nitrile, azide, ethynylene, halo, and 
tosylate; 
wherein m is from O to 100; 
wherein n is from 2 to 300 and 
55 wherein p is from O to 20. 
60 
In certain embodiments, -AR- is selected from the fol-
lowing: 
wherein each R is independently selected from -H, 
-(CH2)mR10, -(CH2)mCOO(CH2)pCH3, (CH2)mS03Na, 65 
-(CH2)mP03Na, -(CH2)mN(CH3)3 +Br-, -(CH2)mCOH 
(CH2)pCH3, -(CH2)mOR10, -(CH2)mORg, ----CH2CH2 
15 
-continued 
RK 
Ro RL 
RF 
X 
I 
Ro Rn Re 
R 
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R 
10 
15 
Rs 
20 
R 
Rn Re 
25 
30 
RO 
NC 
35 X 
~ b 
16 
-continued 
R 
R 
N /N 
'M2 
(bpy)i 
Rn 
OR 
Rs 
Re 
RO 
OR 
R 
Rs 
Rn Re 
OR 
X 
CN 
40 
---0-i)--0---
NC CN 
45 
~ 
50 
OR 
R R 
55 
60 
-0-N N-0-, 
65 Rs Rs 
US 9,623,123 B2 
17 
-continued 
X 
or 
X 
R 
10 
wherein each RA, RB, Re and RD is independently selected 
from R, OR, hydrogen, alkyl, heteroalkyl, hydroxy, amino, 
thiol, carboxylic acid, nitrile, azide, halo or RA and RB may 15 
together form an aromatic ring, or Re and RD may together 
form an aromatic ring or both RA and RB and Re and RD may 
together form an aromatic ring; 
wherein each RD RF and RG is independently selected from 
R, OR, hydrogen, alkyl, heteroalkyl, aryl, heteroaryl, 20 
hydroxy, amino, thiol, carboxylic acid, nitrile, azide, halo, or 
RE and RF may together form a ring; 
wherein each RH, RI, RJ, RK, Rv RM, RN, and R0 is 
independently selected from R, OR, hydrogen, alkyl, het-
eroalkyl, hydroxy, amino, thiol, carboxylic acid, nitrile, 25 
azide, halo, or RI and RJ may together form a ring, or RN, 
and RN may together form a ring; 
wherein each RP and RQ is independently selected from 
hydrogen or together form an aromatic ring; 
wherein each Rs is independently selected from hydrogen or 30 
OR; 
wherein each X is independently a carbon atom or a het-
eroatom; 
wherein q is an integer from 1 to 3; 
wherein M is selected from Zn, Cu, Fe, and Pt; 
wherein M2 is selected from Ru or Ir; and 
wherein bpy is 
0-0; N N 
and 
wherein each R is independently selected from -H, 
-(CH2)mR10, -(CH2)mCOO(CH2)pCH3, (CH2)mS03Na, 
-(CH2)mP03Na, -(CH2)mN(CH3)3 +Br-, -(CH2)mCOH 
(CH2)pCH3, -(CH2)mOR10, -(CH2)mORg, ----CH2CH2 
35 
40 
45 
(OCH2CH2)mOR10, ----CH2CHiOCH2CH2)mORg, 50 
-CH2CHiOCH2CH2)mSR8 , or 
/\/\/\ 
---(__O O O OCH3 
0 0 0 OC~; 
\_J\_J\_J 
55 
60 
and 
wherein each R8 is independently selected from a carbohy-
drate residue; 
and wherein each R10 is independently selected from hydro-
gen, alkyl, heteroalkyl, hydroxy, amino, ammonic acid, 65 
thiol, carboxylic acid, nitrile, azide, ethynylene, halo, and 
tosylate. 
18 
Alternatively, -AR- may be 
f 
_,:;;N'- /N 
B 
/\ 
Ro Ro 
R R 
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20 
wherein bpy is 
0-0; N N 
wherein each R is independently selected from -H, 
-(CH2)mR10, -(CH2)mCOO(CH2)pCH3, (CH2)mS03Na, 
-(CH2)mP03Na, -(CH2)mN(CH3)3 +Br-, -(CH2)mCOH 
(CH2)pCH3, -(CH2)mOR10, -(CH2)mORg, ----CH2CH2 
(OCH2CH2)mOR10, ----CH2CHiOCH2CH2)mORg, 
15 ----CH2CHiOCH2CH2)mSR8 , or 
20 
R R 
25 
!\!\!\ 
---(__O O O OCH3 
0 0 0 OC~; 
\_J\_J\_J 
and 
wherein each R8 is independently selected from a carbohy-
drate residue; 
R R 
Rp 
30 
and wherein each R10 is independently selected from hydro-
gen, alkyl, heteroalkyl, hydroxy, amino, ammonic acid, 
thiol, carboxylic acid, nitrile, azide, ethynylene, halo, and 
tosylate. 
For example, -AR- may be those moieties shown in FIG. 
35 2. 
N......._ ,......N 
M2 
(bpy)i 
wherein each RA, RB, Re and RD is independently selected 40 
from R, OR, hydrogen, alkyl, heteroalkyl, hydroxy, amino, 
thiol, carboxylic acid, nitrile, azide, halo or RA and RB may 
together form an aromatic ring, or Re and RD may together 
form an aromatic ring or both RA and RB and Re and RD may 45 
together form an aromatic ring; 
wherein each RD RF and RG is independently selected from 
R, OR, hydrogen, alkyl, heteroalkyl, aryl, heteroaryl, 
hydroxy, amino, thiol, carboxylic acid, nitrile, azide, halo, or 
RE and RF may together form a ring; 50 
wherein each RH, RI, RJ, RK, Rv RM, RN, and R0 is 
independently selected from R, OR, hydrogen, alkyl, het-
eroalkyl, hydroxy, amino, thiol, carboxylic acid, nitrile, 
azide, halo, or RI and RJmay together form a ring, or RM and 55 
RN may together form a ring; 
wherein each Rp and RQ is independently selected from 
hydrogen or together form an aromatic ring; 
wherein each Rs is independently selected from hydrogen or 
60 OR; 
wherein each X is independently a carbon atom or a het-
eroatom; 
wherein q is an integer from 1 to 3; 
wherein M is selected from Zn, Cu, Fe, or Pt; 
wherein M2 is selected from Ru or Ir; and 
65 
In certain embodiments, R3 may be 
Ry 
--OOR, ~, )--J 
Ry 
R R 
or 
where R is as defined above. 
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In other embodiments, R3 may be 
R R 
-(;r-OR 
R 
R p or 
wherein each RF is independently selected from R, OR, 
hydrogen, alkyl, heteroalkyl, aryl, heteroaryl, hydroxy, 
amino, thiol, carboxylic acid, nitrile, azide or halo; and 
wherein each R is independently selected from -H, 
-(CH2)mR10, -(CH2)mCOO(CH2)pCH3, (CH2)mS03Na, 
-(CH2)mP03Na, -(CH2)mN(CH3)3 +Br-, -(CH2)mCOH 
22 
where R is as defined above. 
In some embodiments, R0 may be 
10 
OR 
X - ~ 
~R, 
15 
or 
20 
R R 
(CH2)pCH3, -(CH2)mOR10, -(CH2)mORg, ----CH2CH2 
(OCH2CH2)mOR10, ----CH2CHiOCH2CH2)mORg, 25 
wherein each R is as defined above. 
-CH2CHiOCH2CH2)mSR8 , or 
;\;\;\ 
----c_O O O OCH3 
0 0 0 OC~; 
\__J \__J \__J 
and 
wherein each R8 is independently selected from a carbohy-
drate residue; 
and wherein each R10 is independently selected from hydro-
gen, alkyl, heteroalkyl, hydroxy, amino, ammonic acid, 
thiol, carboxylic acid, nitrile, azide, ethynylene, halo, and 
tosylate. 
In certain embodiments, R1 or R5 may be 
R R 
In some embodiments, m is from O to 50 or from O to 30 
or from O to 20. In some embodiments, n is from 2 to 200 
or 2 to 150. In some embodiments, p is from 1 to 10 or 3 to 
30 15. 
As used herein, "alky I" refers to a saturated or unsaturated 
hydrocarbon chain having 1 to 12 carbon atoms ( e.g. methyl, 
ethyl, propyl, butyl). Alkyl groups may be straight or 
branched. In some embodiments, branched alkyl groups 
35 have one or two branches. Unsaturated alkyl groups have 
one or more double bonds and/or one or more triple bonds. 
Suitably, unsaturated alkyl groups have one or two double 
bonds or one triple bond. Alkyl chains may be unsubstituted 
40 or substituted with from 1 to about 4 substituents unless 
otherwise specified. Suitably, alkyl groups are mono-, di-, or 
tri-substituted. Suitable alkyl substituents include, but are 
not limited to, cyano, oxo, halo, hydroxy, aryl ( e.g., phenyl, 
tolyl, alkyloxphenyl, alkyloxycarbonylphenyl, halophenyl), 
45 heterocyclyl, and heteroaryl. "Lower alkyl" refers to alkyl 
chains having from 1 to 4 carbon atoms. 
"Ary!" refers to an aromatic carbocyclic group. "Ary!" 
may be exemplified by phenyl. The aryl group may be 
substituted or unsubstituted. More than one substituent may 
50 be present. Substituents may also be themselves substituted. 
55 
When substituted, the substituent group is preferably but not 
limited to heteroaryl; acyl, carboxyl, carbonylamino, nitro, 
amino, cyano, halogen, or hydroxyl. "Arylene" refers to a 
divalent aryl group. 
"Aromatic ring" refers to a mono, bicyclic, or polycyclic 
ring structure which is conjugated and has a much greater 
stability due to electron delocalization than the hypothetical 
localized structure. The aromatic ring optionally contains 
one or more heteroatoms independently selected from nitro-
60 gen, oxygen, selenium, or sulfur. Suitable aromatic rings 
include, for example: anthracenyl, bipyridyl, fluorenonyl, 
furanyl, naphthyl, phenanthryl, phenyl, pyrazinyl, pyrenyl, 
pyridinyl, pyrrolyl, selenopheyl, thiazolyl, thienyl. Aromatic 
rings may be unsubstituted or substituted with from 1 to 
65 about 4 substituents. Suitable aromatic ring substitutents 
may include, for example: aryl, alkyl, alkenyl, alkynyl, halo, 
heteroalkyl, heterocyclyl, and heteroaryl. 
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"Halo" refers to fluoro, chloro, bromo or iodo. 
"Heteroalkyl" refers to a saturated or unsaturated chain 
containing carbon and at least one heteroatom, wherein no 
two heteroatoms are adjacent. Heteroalkyl groups contain 
from 1 to 12 member atoms ( carbon and heteroatoms) in the 5 
chain. Heteroalkyl groups may be straight or branched. 
Suitably, the branched heteroalkyl may have one or two 
branches. Unsaturated heteroalkyl have one or more double 
bonds and/or one or more triple bonds. Heteroalkyl groups 
may be unsubstituted or substituted with from 1 to about 4 10 
substituents unless otherwise specified. Suitable heteroalkyl 
substituents include halo, aryl (e.g., phenyl, tolyl, alkyloxy-
phenyl, alkyloxycarbonylphenyl, halophenyl), heterocyclyl, 
heteroaryl. For example, alkyl chains substituted with the 15 
following substituents are heteroalkyl: alkoxy (e.g., 
methoxy, ethoxy, propoxy, butoxy, pentoxy), aryloxy (e.g., 
phenoxy, chlorophenoxy, tolyloxy, methoxyphenoxy, ben-
zyloxy, alkyloxycarbonylphenoxy, acyloxyphenoxy), acy-
loxy (e.g., propionyloxy, benzoyloxy, acetoxy), carbamoy- 20 
loxy, carboxy, mercapto, alkylthio, acylthio, arylthio (e.g., 
phenylthio, chlorophenylthio, alkylphenylthio, alkoxyphe-
nylthio, benzylthio, alkyloxycarbonylphenylthio ), amino 
(e.g., amino, mono- and di-Cl-C3 alkanylamino, methyl-
phenylamino, methylbenzylamino, Cl-C3 alkanylamido, 25 
carbamamido, ureido, guanidino ). "Lower heteroalkyl" 
refers to heteroalkyl chains having 1 to 4 member atoms. 
"Heteroaryl" refers to a monocyclic or bicyclic aromatic 
carbocyclic radical having one or more heteroatoms in the 
carbocyclic ring. Heteroaryl may be substituted or unsub- 30 
stituted. More than one substituent may be present. When 
substituted, the substituents may themselves be substituted. 
Preferred but non limiting substituents are aryl, C1 -C4 
alkylaryl, amino, halogen, hydroxy, cyano, nitro, carboxyl, 35 
carbonylamino, or C1 -C4 alkyl. Preferred heteroaromatic 
groups include tetrazoyl, triazolyl, thienyl, thiazolyl, puri-
nyl, pyrimidyl, pyridyl, and furanyl. More preferred het-
eroaromatic groups include benzothiofuranyl; thienyl, fura-
nyl, tetrazoyl, triazolyl, and pyridyl. "Heteroarylene" refers 40 
to a divalent heteroaryl group. 
"Heteroatom" refers to a nitrogen, sulfur, selenium or 
oxygen atom. Groups containing more than one heteroatom 
may contain different heteroatoms. As used herein, halogens 
are not heteroatoms. 45 
"Member atom" refers to a polyvalent atom ( e.g., C, 0, N, 
or S atom) in a chain or ring system that continues the chain 
or ring system. For example, in benzene the six carbon 
atoms are member atoms and the six hydrogen atoms are not 
member atoms. 
"Ring" refers to a cycloalkyl, heterocycloalkyl, or an 
aromatic ring. The ring has from 5 to 7 members. A ring may 
50 
be unsubstituted or substituted with from 1 to about 4 
substituents. Suitable ring substitutents may include, for 
example: aryl, alkyl, alkenyl, alkynyl, halo, heteroalkyl, 55 
heterocyclyl, or heteroaryl. 
As used herein, 
OR y 60 
65 
24 
refers to any of the following: 
OR ¢ 
OR OR OR A (YoR (YoR 
H;CYCH; RO~OR y 
OR OR 
I~ I~ ~ *
OR 
OR RO # OR RO # 
OR OR OR A ¢cOR ROWOR ROYOR I ,? OR Y'OR 
As used herein, 
refers to any of the following: 
~ s -or-R ---Q-R 
R R 
---p 1):-R --p-R 
R R R R 
As used herein, 
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refers to any of the following: 
'9 'frR 10 
R R 
The polymers of the present invention may display sig-
nificant red shifts of both UV-absorption and emission 15 
maxima compared with their BODIPY counterparts due to 
significantly extended it-conjugation. Commonly, polyfluo-
rene homopolymers possess a large band gap and emit blue 
light. A variety of narrow-band-gap monomer units such as 
2,1,3-benzoselenadiazole, 2,1,3-naphthoselenadiazole and 20 
4,7-dithiophen-2'-yl-2,1,3-benzothiazole can be incorpo-
rated into the polyfluorene backbone to tune the polymer 
emission wavelengths from orange to red or even to the 
near-infrared region. Use of a long, flexible and highly 
hydrophilic oligo(ethylene glycol) linker at the mesa posi- 25 
tion facilitates, inter alia, water-solubility of conjugated 
glycopolymers, prevention of nonspecific interactions with 
other proteins, and reduction of steric binding hindrance of 
the polymeric carbohydrates to carbohydrate-binding pro-
teins at bacterial and viral surfaces. In one embodiment, the 30 
BODIPY-based polymers are soluble in aqueous solution or 
organic solvents such as chloroform, methylene chloride, 
acetone, dimethylformamide, dimethyl sulfoxide and tetra-
hydrofuran. Suitably, aromatic groups can be introduced at 
the mesa-position to enhance solubility. 35 
In some embodiments, the BODIPY-based polymer may 
be further functionalized with a moiety selected from the 
group consisting of an active agent, DNA, RNA, PNA 
aptamers, antibodies, carbohydrates, a saccaride (such as 
monosaccharides, disaccharides, trisaccharides, and oli- 40 
go saccharides), polypeptides, peptides, cancer-homing pep-
tides, and lipids. These additional groups may be added 
through any one of a variety of reactions known to one of 
ordinary skill in the art, such as click chemistry, amidation 
reactions and thioether formations. The functionalization 45 
suitably takes place at the mesa position. 
meso 
50 
26 
POLYMER! 
0 
POLYMER II 
0 
Synthesis of BODIPY-Based Polymers 
The BODIPY-based polymers may be synthesized using a 
palladium catalyzed Suzuki polymerization of boronic acid 
substituted monomers and diiodo-substituted BODIPY-
monomers, by employing a palladium catalyzed Sono-
gashira polymerization of diiodo-substituted BODIPY 
! 
~ 2\-k,-_.AJ6 
3 ;\ 5 
4' 4 
The use of poly( ethylene glycol) linkers between carbo-
hydrates and polymer backbone makes fluorene-based con-
jugated glycopolymers highly soluble in aqueous solution 
and enables sensitive detection of a few cells of E. coli 
bacteria. 
55 monomers with diethynyl-substituted BODIPY monomers 
or aryl monomers, by polymerizing diethynyl-substituted 
BODIPY monomers with CuCl, or by utilizing a palladium 
catalyzed Heck polymerization of diiodo-substituted 
BODIPY-monomers with divinyl-functionalized BODIPY 
In one embodiment, the present invention provides fluo-
rescent conjugated polymers with BODIPY backbone bear-
ing ethyl phenoxybutanoate groups at the mesa-position 
(polymers I and II). 
60 monomers or aryl monomers. Various polymers and their 
syntheses are described in Color Tuning of Polyfluorene 
Emission with BODIPY Monomers. Ge Meng, Singaravelu 
Velayudham, Adrian Smith, Rudy Luck, and Haiying Liu, 
65 Macromolecules, 42 (2009) 1995-2001, which is incorpo-
rated by reference herein; Synthesis and Optical Properties 
of Red and Deep-Red Emissive Polymeric and Copolymeric 
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-continued 
POLYMER V 
BODIPY Dyes, Venkat R. Donuru, Giri K. Vegesna, Singa-
ravelu Velayudham, Sarah Green, and Haiying Liu, Chem-
istry of Materials, 21(10) (2009) 2130-2138, which is incor-
porated by reference herein; and Deep-Red Emissive 
5 
Conjugated Poly(2,6-BODIPY-Ethynylene)s Bearing Alkyl 
Side Chains, Venkat R. Donuru, Giri K. Vegesna, Singara-
velu Velayudham, Ge Meng, Haiying Liu, Journal of Poly-
mer Science, Part A: Polymer Chemistry, 47(20) (2009) 
5354-5366, which is incorporated by reference herein. 
For example, 9,9-dihexylfluorene-2, 7-diboronic acid may 
be coupled with each one of three different 2,6-diiodo-
substituted BODIPY monomers, affording polymers III, IV 
and V. 
POLYMER III 
POLYMER IV 
10 
15 
20 
Use in Medical Imaging and for Detection of Cells, Bacteria 
and Viruses. 
Carbohydrates play important roles in key recognition 
events with a variety of receptor proteins such as hormones, 
25 enzymes, toxins, lectins, antibodies, viruses, and bacteria. 
They are also involved in numerous biological processes 
such as cell growth, recognition and differentiation, cancer 
metastasis, inflammation, bacterial and viral infection. Indi-
vidual carbohydrate-protein interactions are generally weak, 
but should be able to be amplified by the glycoside clusters 
30 expressed on the cell surface. The overall binding capacity 
with protein receptors, commonly with multiple binding 
sites, may be enhanced over the affinity of individual mon-
ovalent ligands through cooperative multiple interactions. 
Fluorescent conjugated glycopolymers, such as those 
35 according to the present invention, which combine fluores-
cent scaffolding and carbohydrate reporting functions into 
one package, provide techniques to study carbohydrate-
protein interactions for bioimaging applications because of 
their intrinsic fluorescence and multivalent display of car-
bohydrates. The fluorescent conjugated glycopolymers 
40 described herein have utility as bioimaging materials with 
high fluorescent quantum yields for sensitive detection of 
cells, bacteria and influenza virus. The deep-red and near-
infrared emissions of the polymers help to circumvent the 
problem of residual blue fluorescence (blue haze) that tends 
45 to emanate from biological fluids because the deep-red and 
near infrared polymeric dyes have low background absorp-
tion, low scattering and cheap illumination sources. In 
addition, fluorescent conjugated glycopolymers, such as 
those described herein, with near-infrared emissions will 
have a potential in vivo application in deep-tissue bioimag-
50 ing detection since the near-infrared emission propagates 
through two or more centimeters of tissue and may enable 
deep tissue imaging. They may also be used for cancer 
imaging by attaching cancer-homing peptides to conjugated 
polymers. 
55 Each of the polymers according to the present invention 
may be further functionalized with a moiety selected from 
the group consisting of an active agent, DNA, RNA, PNA 
aptamers, antibodies, carbohydrates, saccharides (such as 
monosaccharides, disaccharides, trisaccharides, and oli-
60 gosaccharides ), polypeptides, peptides, cancer-homing pep-
tides, and lipids. Suitably, these moieties are attached at the 
mesa-position through a tethered linker, e.g. an oligo(ethy-
elene glycol). Alternatively, the moiety may be attached to 
the aryl monomer. 
65 Suitable carbohydrates include, but are not limited to, 
mannose, sialic acid and galactose as is shown below in 
Table 1. 
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TABLE 1 
Chemical Structures of a few carbohydrates in BODIPY-based conjugated 
glycopolymers and their interactive bacteria or virus. 
Carbohydrate 
Residue (R) 
a-Mannose 
tto_: -\:: 
Ho~<fo~ 
OH MHAc 
13-Lactosamine 
OH HO 
HO~ o loaf (o: ~ \o_: 
~cHN~o~c(o~ 
HO HO OH 
a2,3-Sialic acid 
OH 
HO~ ]OOH 
AcHN~oh _n ~\
0
_: 
HO HO~c(o~ 
OH OH 
Bacteria or Escherichia coli 
virus 
Clostridium 
perfringens 
a2,6-Sialic acid 
Avian influenza 
virus 
Suitably, the BODIPY-based polymers fluoresce in the 
near-infrared region, e.g. about 700 to about 1400 nanome-
ters, or the deep red region, e.g. about 630 to about 699 
nanometers. 
35 
Human influenza 
virus 
polymer is detected. In some embodiments, the fluorescence 
may be quantified. In some embodiments, the fluorescence 
is compared with a control. 
In yet another embodiment, the BODIPY-based polymers 
In another embodiment, the BODIPY-based polymers of 
the present invention may be used to detect the presence of 
a target, such as a tumor, a cancer cell, a bacteria or viruses, 
in a sample. The sample may be in vitro or the sample may 
be in a subject. The desired target is contacted with a 
BODIPY-based polymer and the fluorescence of the 
BODIPY-based polymer is detected. In some embodiments, 
the fluorescence may be quantified. The desired target may 
be, among other things, a cell, a tumor, a cancer cell, a 
bacteria, or a virus. In some embodiments, the fluorescence 
40 may be used to monitor drug delivery. Again, the BODIPY-
based polymer is administered to a subject and the fluores-
cence of the BODIPY-based polymer is detected. In some 
embodiments, the fluorescence may be quantified. In some 
embodiments, the fluorescence is compared with a control. 
45 The BODIPY-based polymer may be further functionalized 
with an active agent, suitably the one which is to be 
monitored. 
is compared with a control. In yet another embodiment, the 50 
BODIPY-based polymer targets the area which is to be 
imaged. The BODIPY-based polymer may be designed to 
target the area by attaching an additional moiety to the 
polymer, e.g. a cancer-homing peptide, antibodies, carbo-
hydrates, monosaccharides, disaccharides, trisaccharides, 55 
oligosaccharides (and others discussed herein). 
In one embodiment, the BODIPY-based polymers of the 
present invention may be used as fluorescent agents to 
enhance biomedical imaging, such as imaging of DNA, 
proteins, peptides, tumors and cancer cells. The BODIPY- 60 
based polymer may be designed to target the area by 
attaching an additional moiety to the polymer, e.g. a cancer-
homing peptide (such as such as RGD, NGR, GFE, F3, and 
LyP-1 ), antibodies, carbohydrates, mono saccharides, disac-
charides, trisaccharides, oligosaccharides ( and others dis- 65 
cussed herein). The BODIPY-based polymer is administered 
to the subject and the fluorescence of the BODIPY-based 
The term "contacting" is used to mean contacting in vitro, 
in vivo (i.e., in a subject, such as a mammal, including 
humans, rabbits, cats and dogs) or ex vivo. In some embodi-
ments, the contact may occur as a result of administration of 
a BODIPY-based polymer to a subject. The term "adminis-
tration" contemplates any route known to one of ordinary 
skill in the art, including, but not limited to, oral, topical, 
parenteral, injection, inhalation, implants, buccal and rectal. 
An effective amount of a BODIPY-based polymer accord-
ing to the present invention will vary with the particular 
target, the age and physical condition of the subject, the 
route of administration, the particular pharmaceutically-
acceptable carrier utilized, and like factors within the knowl-
edge and expertise of one of ordinary skill in the art. 
It is to be understood that the invention is not limited in 
its application to the details of construction and the arrange-
ment of components set forth in the following description or 
illustrated in the following drawings. The invention is 
capable of other embodiments and of being practiced or of 
being carried out in various ways. Also, it is to be understood 
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that the phraseology and terminology used herein is for the 
purpose of description and should not be regarded as lim-
iting. The use of"including," "comprising," or "having" and 
variations thereof herein is meant to encompass the items 
listed thereafter and equivalents thereof as well as additional 5 
items. 
EXAMPLES 
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of the mesa-phenyl compounds (3a, 4a, 5a and 6a) are a little 
less than the corresponding more substituted analogues (3b, 
4b, 5b and 6b ). 
Compound lb: 
1HNMR (400MHz, CDC13 ) ll 9.80 (s, lH), 7.42-7.37 (m, 
2H), 6.94 (d, 1=8.0 Hz, lH), 4.15-4.06 (m, SH), 2.54-2.49 
(m, 4H), 2.17-2.12 (m, 4H), 1.23 (t, 1=7.2 Hz, 6H); 13C 
NMR (100 MHz, CDC13 ) Ii 191.0, 173.2, 154.4, 149.3, 
130.3, 126.9, 112.2, 111.5, 68.1, 68.0, 60.6, 30.8, 30.6, 24.6, 
Characterization ofBODIPY-Based Monomers and Func-
tional Conjugated Polymers 
10 24.5, 14.4. 
Compound 3b: 
1H NMR (400 MHz, CDC13 ) Ii 6.95 (d, 1=8.4 Hz, lH), 
6.78-6.76 (m, 2H), 5.95 (s, lH), 4.17-4.05 (m, 6H), 3.98 (t, 
1=6.0 Hz, 2H) 2.56-2.48 (m, !OH), 2.18-2.08 (m, 4H), 1.44 
15 (s, 6H), 1.26-1.20 (m, 6H); 13C NMR (100 MHz, CDC13 ) Ii 
173.3, 173.2, 155.5, 149.7, 143.3, 141.7, 131.8, 127.7, 
121.3, 121.1, 114.3, 113.9, 68.5, 68.2, 60.6, 30.8, 24.8, 14.7, 
14.6, 14.4. ESI-MS calculated for M+584.4. found 607.3 
All intermediates, carbohydrates, BODIPY dyes and con-
jugated polymers and glycopolymers will be fully charac-
terized by 1 H, 13C and 11 B NMR spectroscopy, mass spec-
trometry, FI-IR and elemental analysis. Spectrophotometer 
and spectrofluometer will be used to study optical absorp-
tion, bandgap, Stoke's shift, fluorescence quantum yield and 
vibrational structures of fluorescent conjugated glycopoly-
mers. The molecular weights of the glycopolymers can be 
manipulated by controlling polymerization time for conju- 20 
gated polymers. Gel permeation chromatography ("GPC") 
will be used to determine molecular weight of the conju-
gated polymers. Matrix-assisted laser desorption/ionization 
time of flight mass spectrometer will also be used to deter-
mine molecular weights, repeated units, and capping end 
groups of conjugated polymers. 
(M+Na). 
Compound 4b: 
1H NMR (400 MHz, CDC13 ) Ii 6.97 (d, 1=8.4 Hz, lH), 
6.75-6.71 (m, 2H), 4.17-4.09 (m, 6H), 3.97 (t, 1=6.0 Hz, 
2H), 2.61 (s, 6H) 2.57-2.48 (m, 4H), 2.18-2.08 (m, 4H), 1.45 
(s, 6H), 1.27-1.20 (m, 6H); 13C NMR (100 MHz, CDC13 ) Ii 
Example 1 
25 173.3, 173.1, 156.8, 150.0, 149.9, 145.5, 141.4, 131.8, 
127.2, 120.9, 114.3, 113.6, 85.7, 68.6, 68.2, 60.6, 30.8, 24.8, 
17.3, 16.2, 14.4. ESI-MS calculated for M+836.2. found 
859.4 (M+Na). 
Synthesis of Meso-Aryl-Substituted BODIPY-Based 
Polymers 
30 
Meso-aryl-substituted BODIPY derivatives (3a and 3b) 
were prepared through the reaction of the formyl benzene 
derivatives (la and lb) with a large excess of 2,4-dimeth- 35 
ylpyrrole under acid catalysis, and followed by oxidization 
with 2,3-dichloro-5,6-dicyano-l ,4-benzoquinone (DDQ) 
and treatment with BF3 etherate in the presence of N,N-
diisopropylethylamine (DIEA) (FIG. 3). Further iodination 
of BODIPY derivatives (3a and 3b) afforded 2,6-diiodo- 40 
tetramethyl BODIPY derivatives (4a and 4b). 2,6-Diethynyl 
BODIPY derivatives (6a and 6b) were prepared by palla-
dium-catalyzed Sonogashira reaction of compounds 4a and 
4b with ethynyltrimethylsilane, affording compounds 5a and 
5b, respectively, and followed by hydrolysis of compounds 45 
5a and 5b in the presence of tetrabutylammonium fluoride. 
Diethynylation of compound 4a causes peaks at 1.4 ppm 
corresponding to methyl group of compound 4a at 2 position 
to shift to lower field at 1.5 ppm and result in an additional 
peak at 3.3 ppm corresponding to diethynyl groups of 50 
monomer 6a. BODIPY polymers (I and II) were synthesized 
by palladium-catayzed Sonogashira polymerization of 
diiodo-functionalized BODIPY monomers ( 4a and 4b) with 
diethynyl-functionalized BODIPY monomers (6a and 6b) 
(FIG. 3). 1H NMR peaks of polymer I became a little 55 
broader than those of its monomer counterparts. Polymers I 
and II exhibit solubility similar to that of their BODIPY 
monomers and are soluble in common organic solvents such 
chloroform, methylene chloride and THF. 
Arylation at the mesa position has no significant effect on 60 
the absorption and emission maxima since the arylated 
moiety is not coplanar with the BODIPY core due to the 
steric hindrance although the substitution position is struc-
turally unique. As a result, polymers I and II and their 
monomer counterparts have only 1 nm difference in their 65 
absorption and emission maxima as conjugated polymers do 
not amplify the tiny difference. However, the quantum yields 
Compound 5b: 
1H NMR (400 MHz, CDC13 ) Ii 6.96 (d, 1=8.4 Hz, lH), 
6.74-6.71 (m, 2H), 4.15-4.07 (m, 6H), 3.97 (t, 1=6.0 Hz, 
2H), 2.60 (s, 6H) 2.57-2.48 (m, 4H), 2.18-2.09 (m, 4H), 1.52 
(5, 6H), 1.27-1.20 (m, 6H), 0.19 (5, 18H); 13C NMR (100 
MHz, CDC1 3 ) Ii 173.3, 173.1, 158.8, 149.9, 149.8, 145.0, 
142.7, 131.4, 127.0, 120.9, 116.4, 114.3, 113.6, 101.9, 97.3, 
68.6, 68.2, 60.6, 30.8, 24.8, 14.4, 13.7, 13.6, 0.28; ESI-MS 
calculated for M+ 776.8. found 776.9. 
Compound 6b: 
1H NMR (400 MHz, CDC1 3 ) Ii 6.97 (d, 1=8.4 Hz, lH), 
6.76-6.71 (m, 2H), 4.15-4.07 (m, 6H), 3.96 (t, 1=6.0 Hz, 
2H), 3.30 (s, 2H), 2.60 (s, 6H) 2.57-2.48 (m, 4H), 2.18-2.09 
(m, 4H), 1.54 (s, 6H), 1.27-1.20 (m, 6H); 13C NMR (100 
MHz, CDC13) Ii 173.3, 173.1, 158.9, 150.0, 149.9, 143.2, 
131.4, 126.8, 120.9, 115.2, 114.3, 113.6, 84.6, 76.1, 68.6, 
68.2, 60.6, 30.8, 24.8, 14.4, 13.7, 13.6; ESI-MS calculated 
for M+ 632.5. found 656.9 (M+Na). 
Polymer II: 
1H NMR (400 MHz, CDC1 3 ) Ii 6.97 (d, 1=8.4 Hz, lH), 
6.76-6.71 (m, 2H), 4.15-4.07 (m, 6H), 3.97 (t, 1=6.0 Hz, 
2H), 2.60 (5, 6H) 2.57-2.48 (m, 4H), 2.18-2.09 (m, 4H), 1.54 
(s, 6H), 1.27-1.20 (m, 6H); 13C NMR (100 MHz, CDCb) 
0173.3, 173.1, 158.2, 150.0, 149.8, 143.3, 142.3, 131.7, 
126.9, 120.9, 116.5, 114.2, 113.6, 89.0, 76.1, 68.6, 68.2, 
60.6, 30.8, 24.8, 14.4, 13.8, 13.7. 
Example 2 
Preparation and Characterization of BODIPY-Based 
Polyfluorene Derivatives 
Instrumentation. 
1 H NMR and 13C NMR spectra were taken on a 400 MHz 
Varian Unity Inova spectrophotometer instrument. 1 H and 
13C NMR spectra were recorded in CDC13 , chemical shifts 
(Ii) are given in ppm relative to solvent peaks (lH: Ii 7.26; 
13C: Ii 77.3) as internal standard. UV spectra were taken on 
a Hewlett Packard 8452A Diode Array UV-visible spectra-
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photometer. Fluorescence spectra were recorded on a Spex 
Fluorolog 1681 0.22 m steady-state fluorometer. Fluores-
cence quantum yields of BODIPY dyes and polymers were 
measured in methylene chloride and DMF, and calculated by 
using fluorescein excited at 490 nm in 0.1 N NaOH as the 5 
reference absolute quantum efficiency ( cjm=85% ). Molecular 
weights of the polymers were determined by gel permeation 
chromatography ("GPC") by using a Waters Associates 
Model 6000A liquid chromatograph. Three American Poly-
mer Standards Corp. Ultrastyragel columns in series with 10 
porosity indices of103, 104 , and 105 A were used and housed 
2xCH3); 2.51 (s, 6H, 2xCH3), 3.79 (s, 6H, 2xOCH3-3,5), 
3.88 (s, 3H, OCH3-4), 5.97 (s, 2H, Pyr-H), 6.49 (d, 2H, 
Ph-CH) ppm; 13C NMR (100 MHz, CDC13): Ii 14.40 (Py-
CH3), 14.73 (Py-CH3), 56.57 (OCH3), 61.50 (OCH3), 
105.40, 121.40, 130.28, 131.52, 138.90, 141.54, 143.24, 
154.41, 155.81 ppm; IR (KBr) 3117, 3007, 2954, 2837, 
1739, 1578, 1462, 1408, 1384, 1248, 1186 cm-1. MS (EI+): 
C22H25BF2N20y m/z. calcd. 414.2 (M). found. 414 (M+). 
4,4-Difluoro-8-(3,4,5-trimethoxyphenyl)-2,6-diiodo- l ,3, 
5, 7-tetramethyl-4-bora-3a,4a-diaza-s-indacene (10) 
Iodic acid (176 mg, 1 mmol) dissolved in a minimal 
amount of water was added drop-wise over 20 min to a 
solution of compound 9 (207 mg, 0.5 mmol) and iodine (158 
mg, 1.25 mmol) in EtOH (40 ml). This mixture was stirred 
at 60° C. for 30 min. After cooling, the mixture was 
evaporated under vacuum. The crude product was purified 
in an oven thermostated at 30° C. Mobile phase was HPLC 
grade THF which was filtered and degassed by vacuum 
filtration through a 0.5 µm fluoropore filter prior to use. The 
polymers were detected by a Waters Model 440 ultraviolet 15 
absorbance detector at a wavelength of 254 nm and a Waters 
Model 2410 refractive index detector. Molecular weights 
were measured relative to polystyrene standards. An Enraf by silica gel column chromatography from ethyl acetate and 
n-hexane to afford a golden compound as pure 10 (287 mg, 
430 mmol, yield 86%). 1H NMR (400 MHz, CDC13): ll 1.55 
(s, 6H, 2xCH3), 2.64 (s, 6H, 2xCH3), 3.83 (s, 6H, 2xOCH3-
N onius CAD-4 X-Ray diffractometer was used in the crystal 
structure determination. The windows program WinGX was 20 
used as the interface for the solution and refinement of the 
model. The data were first reduced and corrected for absorp-
tion using the psi-scans, and then solved using the program 
SIR2004. The model was refined using SHELXL97. 
Materials. 
3,5), 3.93 (s, 3H, OCH3-4), 6.48 (s, 2H) ppm. 13C NMR (100 
MHz, CDC13): ll 16.22, 17.09, 56.63, 61.61, 85.40, 105.15, 
129.91, 131.43, 139.32, 141.17, 145.47, 154.68, 157.11 
25 ppm. IR (KBr) 2927, 2845, 2279, 1742, 1575, 1525, 1505, 
1489, 1464, 1450, 1405, 1384, 1369, 1342, 1324, 1306, 
1230, 1165, 1117, 1093, 1075, 1043 cm-1. MS (EI+): 
Unless otherwise indicated, all reagents and solvents were 
obtained from commercial suppliers (Aldrich, Sigma, Fluka, 
Acros Organics, Fisher Scientific, Lancaster), and were used 
without further purification. Air- and moisture-sensitive 
reactions were conducted in oven-dried glassware using 30 
standard Schlenk line or dry box techniques under an inert 
atmosphere of dry nitrogen. 
C22H23BF2I2N20 3. m/z. calcd. 666.0 (M). found. 666 (M+). 
Polymer III: 
To a mixture of compound 10 (50 mg, 0.075 mmol, 1 
equiv), Pd(PPh3)4 (tetrakis(triphenylphosphine )palladium) 
(2.6 mg, 0.005 mmol, 0.6%), and 9,9-dihexylfluorene-2,7-
diboronic acid 11 (35 mg, 0.083 mmol, 1.1 equiv) was added The synthetic scheme for polymers III, IV and Vis shown in FIG. 5 and detailed below. 
4,4-Difluoro-8-(3,4,5-trimethoxyphenyl)-1,3,5, 7-tetram-
ethyl-4-bora-3a,4a-diaza-s-indacene (9) 
3,4,5-Trimethoxylbenzaldehyde 7 (1.65 g, 8.4 mmol) and 
2,4-dimethylpyrrole (1.6 g, 16.8 mmol) were dissolved in 
dry CH2Cl2 (800 mL) under a nitrogen atmosphere. Nine 
drops of trifluoroacetic acid ("TFA") (about 0.5 mL) were 
added, and the mixture was stirred at room temperature 
overnight. After TLC monitoring showed complete disap-
pearance of the aldehyde, a solution of 2,3-dichloro-5,6-
dicyano-l ,4-benzoquinone ("DDQ") (1.9 g, 8.4 mmol) in 
anhydrous CH2Cl2 (200 mL) was added. This mixture was 
further stirred for 3 hours, washed with water three times, 
dried over anhydrous NaS04 , filtered, and concentrated to 
dryness. The resulting compound was roughly purified by 
using aluminum oxide column chromatography to give a 
brown powder as the crude compound 8 (about 1.0 g, 2.7 
mmol, yield of the first step is 32%). This product 8 was used 
without further purification in the next step. The brown 
powder (1.0 g, 2.7 mmol) and N,N-diisopropylethylamine 
("DIEA'') (16 mL, 168 mmol) were dissolved in anhydrous 
CH2Cl2 ( 500 mL) under a nitrogen atmosphere. The solution 
was stirred at room temperature for 30 minutes and BF3-
0Et2 (164 mL, 100 mmol) was subsequently added. This 
mixture was stirred for 3 hours whereupon the complexation 
was found to be completed by TLC monitoring. The mixture 
was washed thoroughly with water and brine, dried over 
anhydrous Na2S04 , filtered, and evaporated under vacuum. 
The crude compound was purified by silica gel column 
chromatography ( eluent: petroleum ether/ethyl acetate: from 
first 10: 1 to final 5: 1, increasing the polarity of the solvent) 
to give a shiny green powder as the pure compound 9 (600 
mg, 1.45 mmol, yield of the second step is 53%, yield 
overall 17% ). 1 H NMR ( 400 MHz, CDC13): Ii 1.50 (s, 6H, 
35 a degassed mixture of toluene (10 mL), EtOH (4 mL) and 
H20 (4 mL) containing Na2C03 (80 mg, 10 equiv) under a 
nitrogen atmosphere. The mixture was vigorously stirred at 
85° C. for 72 hours and then the solvent was evaporated 
under vacuum. The residue was dissolved in 100 mL of ethyl 
40 acetate and washed with water three times. The organic layer 
was collected, dried over anhydrous Na2S04 and filtered. 
The filtrate was concentrated and added to ethanol to pre-
cipitate the polymer. A red powder was obtained by filtra-
tion, further washed with ethanol and then dried under 
45 vacuum for 24 hours to afford polymer III in a yield of 69%. 
1H NMR (400 MHz, CDC13): Ii 0.72 (t, 6H, 2xCH3), 1.04 
(m, 16H, 8xCH2), 1.52 (s, 6H, 2xCH3), 1.95 (br, 2H, 
2xCH2), 2.58 (br, 6H, 2xCH3), 3.86 (br, 6H, 2xOCH3), 3.88 
(br, 3H, OCH3), 6.63 (2H, Bodipy-Ph-H), 7.15 (4H, Ph-H), 
50 7.72 (d, 2H, Ph-H,) ppm; 13C NMR (100 MHz, CDC13): Ii 
12.87 (10, Pyr-CH3), 13.69, 14.13, 22.61, 24.01, 29.75, 
31.66, 36.68, 40.58, 55.34, 56.66, 61.53, 105.53, 119.76, 
124.91, 129.05, 131.50, 132.46, 134.53, 139.06, 140.02, 
141.77, 151.16, 154.59, 154.73, 162.76 ppm; IR (KBr) 
55 2928, 2855, 2051, 1677, 1578, 1456, 1387, 1228, 1176 
cm- 1 . 
4,4-Difluoro-8-( 4-methoxyphenyl)-1, 3, 5, 7-tetramethyl-
4-bora-3a,4a-diaza-s-indacene (14) 
Compound 14 was prepared from 4-methoxybenzalde-
60 hyde 12 in 28% yield according to the method for compound 
9. 1H NMR (400 MHz, CDC13): ll 1.43 (s, 6H, 2xCH3); 2.55 
(s, 6H, 2xCH3), 3.87 (s, 3H, 2xOCH3-4), 5.97 (s, 2H, 
Pyr-H), 7.01 (d, 2H, Ph-CH, J=8.4), 7.17 (d, 2H, Ph-CH, 
J=8.4) ppm; 13C NMR (100 MHz, CDC13): Ii 14.75, 55.50, 
65 94.62, 114.73, 121.29, 127.26, 129.41, 132.07, 142.07, 
143.36, 155.47, 160.35 ppm. IR (KBr) 3038, 2967, 2932, 
2841, 1609, 1573, 1538, 1505, 1463, 1441, 1407, 1368, 
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1303, 1289, 1246, 1184, 1155, 1109, 1075, 1050, 1022cm-1. 
MS (EI+): C20H21BF2N20y m/z. calcd. 354.2 (M). found. 
354 (M+).19 
36 
broad, 4H, 2xCH2), 2.19 (t, 6H, 2xCH3), 2.52 (d, 6H, 
2xCH3), 7.09 (broad, 6H, Ph-H), 7.65 (2H, Bodipy-Ph-H) 
ppm; 13C NMR (100 MHz, CDC13): ll 10.06 (IC, Pyr-CH3), 
11.82, 13.75, 14.15, 19.94, 20.11, 22.64, 24.01, 29.76, 4,4-Difluoro-8-( 4-methoxyphenyl )-2, 6-diiodo- l, 3, 5, 
7-tetramethyl-4-bora-3a, 4a-diaza-s-indacene (15) 5 31.67, 40.49, 55.35, 119.67, 124.92, 128.47, 129.09, 130.52, 
132.51, 134.18, 135.51, 138.21, 139.93, 151.10, 154.36, 
215.64 ppm. IR (KBr) 2925, 2855, 1598, 1535, 1457, 1392, 
1225, 1176, 1073 cm-1. 
Compound 15 was prepared from 4,4-difluoro-8-( 4-
methoxyphenyl)-1,3,5, 7-tetramethyl-4-bora-3a,4a-diaza-s-
indacene 14 in 88% yield according to the method for 
compound 10. 1H NMR (400 MHz, CDC13): ll 1.43 (s, 6H, 
2xCH3), 2.62 (s, 6H, 2xCH3), 3.87 (s, 3H, OCH3-4), 7.02 (d, 10 
2H, Ph-H, J=8.4), 7.12 (d, 2H, Ph-H, J=8.4) ppm. 13C NMR 
(100 MHz, CDC13): Ii 16.21, 17.38, 55.61, 85.74, 115.08, 
126.89, 129.30, 131.95, 141.80, 145.58, 156.78, 160.77 
ppm. IR (KBr) 2953, 2925, 2837, 2041, 1723, 1609, 1572, 
1458, 1397, 1345, 1290, 1174, 1117 cm-1. MS (EI+): 15 
C20H19BF2I2N20y m/z. calcd. 605.9 (M). found. 606 (M+). 
Polymer IV: 
Polymer IV was prepared from compound 15 with 9,9-
dihexylfluorene-2,7-diboronic acid in 54% yield according 
to the method for polymer III. 1 H NMR ( 400 MHz, CDC13): 20 
Ii 0.67 (d, 6H, 2xCH3), 0.95 (m, 16H, 8xCH2), 1.67 (s, 6H, 
2xCH3), 1.88 (4H, 2xCH2), 2.16-2.60 (m, 6H, 2xCH3), 3.80 
Photophysical Properties. 
The photophysical characteristics of BODIPY dyes, 
monomers and polymers were investigated in methylene 
chloride and DMF solutions. The absorption properties of 
the BODIPY dye 9 are characterized by a strong S0----;,S1 
(it-it*) transition at 502 nm and a weaker broad band at a 
shorter wavelength around 356 nm ascribed to the S0----;,S2 
(it-it*) transition (FIG. 6). BODIPY dyes 14 and 18 display 
similar absorption features as BODIPY dye 9. The intro-
duction of diiodo substituent to the dipyrromethene core (9, 
14 or 18) results in a significant red shift (up to 33 nm and 
38 nm) of both the UV-absorption and fluorescent maxima, 
respectively, and significantly quenches the fluorescence 
quantum yield because of the heavy atom effect (FIGS. 6-8 
and Table 2). Absorption and fluorescence spectra of 2,6-
(s, 3H, OCH3), 6.99 (2H, Ph-H), 7.07 (4H, Ph-H), 7.66 (3H, 
Bodipy-Ph-H) ppm. IR (KBr) 2927, 2856, 1724, 1610, 1529, 
1458, 1388, 1292, 1176 cm-1. 
4,4-Difluoro-8-(2,6-dimethylphenyl)-1,3,5, 7-tetram-
ethyl-4-bora-3a,4a-diaza-s-indacene (18) 
Compound 18 was prepared from 2,6-dimethylbenzalde-
hyde 16 in 67% yield according to the method for compound 
25 diiodo-substituted BODIPY monomers (10, 15 and 19) 
exhibit good mirror symmetry with similar band shapes for 
the absorption and emission spectra which was also verified 
by measuring their full width at half-maximum (FIG. 6). 
9. 1H NMR (400 MHz, CDC13): ll 1.36 (s, 6H, 2xCH3); 2.15 30 
(s, 6H, 2xCH3), 2.56 (s, 6H, 2xCH3-2,6), 5.97 (s, 2H, 
Pyr-H), 7.13-7.27 (m, 3H, Ph-H) ppm; 13C NMR (100 MHz, 
CDC13): Ii 13.49 (Py-CH3), 14.86 (Py-CH3), 19.77 (Ph-
CH3), 121.08 (Py-C), 128.39, 129.09, 130.55, 134.30, 
135.45, 141.40, 142.40, 155.49 ppm; MS (EI+): 35 
C21H23BF2N2. m/z. calcd. 352.2 (M). found. 352 (M+).20 IR 
(KBr) 2962, 2923, 2856, 1541, 1466, 1369, 1258, 1189 
cm-1. Single crystals of compound 18 (0.40x0.40x0.40 mm) 
were grown by vapor diffusion of hexane into a solution of 
the compound in ethyl acetate. A suitable crystal was cut to 40 
size, rolled in epoxy resin and mounted on a glass fiber. 
Crystal data for compound 18: C21 H23BF 2N 2, monoclinic, 
space group C2/c, a=20.442 (5) A, b=7.847 (2) A, c=25.831 
(8) A, ~=112.49 (2) 0 , V=3828.4(18) A3, Z=8, Dc=l.223 g 
cm-1, µ(Mo-Ka)=0.09 mm-1, T=293(2) K. Independent 45 
reflections measured=2496, R1=0.059, wR2=0.190 for 2496 
independent observed reflections [F>4a (F)], S=l.04 
4,4-Difluoro-8-(2,6-dimethylphenyl)-2,6-diiodo- l ,3,5, 7-
tetramethyl-4-bora-3a,4a-diaza-s-indacene (19) 
Compound 19 was prepared from 4,4-difluoro-8-(2,6- 50 
dimethylphenyl)-1,3,5, 7-tetramethyl-4-bora-3a,4a-diaza-s-
indacene 18 in 90% yield according to the method for 
compound 10. 1H NMR (400 MHz, CDC13): ll 1.23 (s, 6H, 
2xCH3), 2.12 (s, 6H, 2xCH3), 2.65 (s, 6H, 2x0H3-2,6), 
7.15-7.32 (m, 3H, Ph-H) ppm. 13C NMR (100 MHz, 55 
CDC13): Ii 15.93, 16.28, 19.83, 85.63 (Py-C-I), 128.71, 
129.70, 130.44, 133.99, 135.32, 141.37, 144.68, 156.82 
ppm. IR (KBr) 3063, 3018, 2957, 2916, 2856, 1736, 1596, 
1459, 1343, 1241, 1173, 1085 cm-1. MS (EI+): 
C21H21BF2I2N20 3. m/z. calcd. 603.99 (M). found. 604 60 
(Mk). 
Polymer V: 
Polymer V was prepared from compound 19 with 9, 
9-dihexylfluorene-2,7-diboronic acid in 52% yield, accord-
ing to the method for polymer III. 1H NMR (400 MHz, 65 
CDC13): Ii 0.66 (m, 6H, 2xCH3), 0.98 (m, 12H, 6xCH2), 
1.30 (t, 6H, 2xCH3), 1.58 (broad, 4H, 2xCH2), 1.90 (s, 
When low-band-gap BODIPY units are incorporated into 
the polyfluorene backbone, the fluorescence corresponding 
to the fluorene segment completely disappears while the 
emission consists exclusively of one peak at longer wave-
length responsible for the BODIPY units. The complete 
disappearance of the fluorene segment arises from an effi-
cient photoinduced energy transfer from the fluorene seg-
ment to the BODIPY unit which functions as a powerful trap 
in the copolymer backbone. Extended it-conjugation of the 
polymer III results in significant red shifts (55 nm and 76 
nm) of both the UV-absorption and fluorescent maxima, 
respectively, compared to its starting BODIPY dye 9. As 
shown in Table 2, the similar red shifts were also observed 
in polymers IV and V. In addition, fluorescent conjugated 
copolymers display slightly broader absorption and emis-
sion peaks due to extension of it-conjugation compared to 
their BODIPY monomers, as shown in FIG. 6. 
TABLE 2 
The UV-visible absorption and emission maxima, and fluorescent quantum 
yields of BODIPY derivatives and copolymers in CH2Cb solution. 
Absorption Emission maxima Quantum 
BODIPY maxima (nm) (nm) yield 
9 502 511 71.5% 
10 535 549 7.52% 
Polymer III 557 587 63.8% 
14 500 510 80.1% 
15 533 548 5.72% 
Polymer N 547 585 55.6% 
18 501 510 86.7% 
19 535 549 8.64% 
Polymer V 549 588 84.8% 
BODIPY dyes with different arylated moieties at the mesa 
position (9, 14 and 18) only display a 1 nm to 2 nm 
difference between their UV-visible absorption maxima or 
emission maxima although the substitution position is struc-
turally unique (Table 2). Iodization of BODIPY dyes (9, 14 
and 18) at the 2 and 6 positions does not increase this minor 
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difference (Table 1). This minor difference arises from the 
fact that the arylated moiety is not coplanar with the 
BODIPY core due to steric hindrance (FIG. 7). As a result, 
arylation at the mesa position does not significantly affect 
the absorption and emission spectral maxima of BODIPY 5 
dyes. The extended it-conjugation of polymers III, IV and V 
also fails to amplify the minor difference of emission 
maxima of their monomers. However, as shown in Table 2, 
BODIPY dyes (9, 14 and 18) possess different fluorescent 
quantum yields. BODIPY dye 18 is highly fluorescent with 10 
fluorescent quantum yield of 86.7% which is the highest 
among three BODIPY dyes (9, 14 and 18). Without wishing 
to be bound by a particular theory, this may be because the 
ortho-methyl groups on the mesa-phenyl ring introduce 15 
steric constraints on the phenyl ring, and suppress non-
radiative deactivation to increase quantum yield by restrict-
ing internal free rotation of the phenyl ring at the mesa 
position relative to the BODIPY core in the excited state 
(FIG. 7). As a result, polymer Vis highly fluorescent with a 20 
fluorescent quantum yield of 84.8% in methylene chloride 
solution, which is higher than those of polymers III and IV. 
The UV-visible absorption and emission maxima of 
BODIPY dyes (9, 10, 14, 15, 18 and 19) are relatively 
insensitive to the solvent polarity with similar shapes of the 25 
UV-visible absorption and emission spectra in methylene 
chloride and DMF (Tables 2 and 3; FIGS. 6 and 8). The 
emission maxima of 2,6-diiodo-substituted BODIPY deriva-
tives (10, 15 and 19) undergo bathochromically red shifts by 
1-2 nm in more polar solvent, (such as DMF) (Tables 2 and 30 
3). However, the fluorescent quantum yields of all BODIPY 
dyes (9, 10, 14, 15, 18 and 19) decrease in more polar 
solvent (DMF) (Tables 2 and 3). The UV-visible absorption 
and emission maxima of conjugated copolymers III, IV and 
V are also slightly red-shifted and their fluorescent quantum 35 
yields decrease significantly in a more polar solvent (DMF) 
(Tables 2 and 3; FIGS. 6 and 8). This might arise from 
increased Jt-Jt stacking interactions between the polymer 
backbones promoted in DMF solution. 
38 
nylene)s (XIII-XV) are prepared by 3,5-functionalization of 
BODIPY dyes with vinylphenyl groups. 
BODIPY-based conjugated glycopolymers are prepared 
by introducing a variety of carbohydrates (R groups) to the 
mesa-phenyl groups relative to BODIPY cores through 
well-defined oligo( ethylene glycol) tethered spacers (its 
repeat unit (m) from 2, 6, 10, 19, 27, 35 to 43) via thioether 
bridges (FIG. 13). 
Carbohydrate density and orientations of BODIPY-based 
glycopolymers is controlled by controlling functionalization 
of the mesa-phenyl groups (a-m) relative to BODIPY cores 
with oligo( ethylene glycol) tethered spacers to address the 
fundamental issues of the multivalent effects in a given 
system (FIG. 13). In addition, the density, spacing and 
orientation of carbohydrate units of BODIPY-based conju-
gated glycopolymers (polymers VII-XV) is controlled by 
using diluting BODIPY monomers with mesa-phenyl 
groups (n-v) bearing branched groups of oligo(ethylene 
glycol) monomethyl ether to optimize multivalent coopera-
tive interactions between carbohydrates and pathogenic bac-
teria or influenza virus, investigate the influence of carbo-
hydrate clustering and orientation on their multivalent 
interactions with specific receptors since the effectiveness of 
the chelate effect depends on the spatial match between the 
receptors and the carbohydrate residues and on the flexibility 
of the spacer arms (FIG. 13). 
Although functionalization of the mesa-phenyl groups 
will not significantly change absorption and emission spec-
tral maxima of BODIPY-based conjugated glycopolymers 
since the mesa-phenyl groups are not coplanar with 
BODIPY cores, it will affect fluorescence quantum yields of 
the glycopolymers. In order to enhance fluorescence quan-
tum yields of the glycopolymers in aqueous solution, ortho-
substituent groups on the mesa-phenyl rings (e-v) are used 
to introduce steric constraints on the mesa-phenyl rings, and 
suppress non-radiative deactivation by restricting internal 
free rotation of the phenyl ring at the mesa position relative 
to the BODIPY core in the excited state (FIG. 13). In 
addition, the bulky ortho-substituent groups on the meso-
phenyl ring preclude potential formation of aggregates of the 
conjugated glycopolymers by prevent Jt-Jt stacking interac-
TABLE 3 
40 tions between polymer backbones through the enhanced 
steric hindrances. 
The UV-visible absorption and emission maxima, and fluorescent quantum 
yields of BODIPY derivatives and copolymers in DMF solution. 
Absorption Emission maxima Quantum 
BODIPY maxima (nm) (nm) yield 
9 501 511 55.3% 
10 534 551 3.4% 
Polymer III 564 590 15.5% 
14 500 510 71.6% 
15 533 551 4.9% 
Polymer N 554 589 15.6% 
18 502 510 73.8% 
19 536 552 4.4% 
Polymer V 558 590 16.4% 
Example 3 
Synthesis of Highly Water-Soluble BODIPY-Based 
Conjugated Glycopolymers 
The present Example discloses preparation of a new kind 
In order to further increase stability and fluorescent quan-
tum yields of BODIPY-based conjugated glycopolymers, 
C-BODIPY- (C for "carbocycle") and E-BODIPY-based (E 
45 for "ethynyl") conjugated glycopolymers are prepared by 
replacing the usual fluorine atoms of F-BODIPY dyes with 
aryl, ethynyl and ethynylaryl subunits (FIG. 13). Although 
replacement of the usual fluorine atoms with aryl or ethy-
nylaryl subunits will not considerably change absorption and 
emission spectral maxima of BODIPY-based conjugated 
50 glycopolymers, it will not only enhance stability of the 
glycopolymers in a strong acid or base because of stabili-
zation of the tetrahedral boron center by the ethynyl donors, 
but also increase water-solubility of the glycopolymers in 
aqueous solution, and fluorescent quantum yields of the 
55 glycopolymers because the bulky aryl, ethynyl or ethy-
nylaryl substituents bearing highly-branched groups of oligo 
(ethylene glycol) monomethyl ether will increase hydrophi-
licity of BODIPY dyes, and further prevent Jt-Jt stacking 
interactions between the polymer backbones due to their 
60 steric hindrances. 
Example 4 
of fluorescent conjugated polymer, poly(2,6-B0DIPY-ethy-
nylene)s with deep-red emission at around 680 nm, by 
palladium-catalyzed Sonogashira polymerization of 2,6-di- 65 
iodo BODIPY monomers with 2,6-diethynyl BODIPY 
monomers. Near-infrared emissive poly(2,6-B0DIPY-ethy-
Synthesis of BODIPY-Based Near-Infrared 
Emissive Conjugated Glyco-Copolymers 
Different amounts from 5% to 50% of narrow-band-gap 
monomer units such as 2,1,3-benzoselenadiazole, 6,7-dim-
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ethyl[l ,2,5]thiadiazolo[3,4-g]quinoxaline and benzo[l ,2-c: 
4,5-c']bis([l,2,5]thiadiazole) are incorporated into back-
bones of BODIPY-based conjugated glycopolymers to tune 
polymer fluorescence with near-infrared emissions ranging 
40 
BODIPY-based polymers are highly florescent with 84.8% 
of fluorescent quantum yield for polymer XXVIII. 
TABLE 4 
from 700 nm to 900 nm (FIG. 14). 5 
Absorption and emission maxima of BODIPY dyes and 
polymers in methylene chloride. 
Example 5 
Synthesis of Highly Water-Soluble Conjugated 
Glycopolymers 10 
Polymer Polymer 
BODIPY dl el fl gl XXVI d2 e2 f2 g2 XXVII 
Absorption 501 533 553 538 659 502 534 554 539 665 
maxima 
Facile, versatile pre-polymerization and post-polymeriza-
tion functionalization approaches to prepare well-defined 
fluorene-based fluorescent conjugated polymers bearing 
15 
~-glucose pendants (polymers XIX and XX), and regioregu-
(nm) 
Emission 
maxima 
(nm) 
510 548 569 552 678 511 549 570 553 683 
Example 7 
Synthesis of Highly Water-Soluble BODIPY-Based 
Conjugated Glycopolymers 
Highly water-soluble BODIPY-based deep-red and near-
infrared emissive fluorescent conjugated glycopolymers 
with controlled carbohydrate density and orientation, and 
apply these glycopolymers in detection of pathogenic bac-
teria and virus is described. 
Synthesis of Deep-Red Emissive Conjugated Glycopoly 
(F -BO DIPY-Ethynylene )s. 
FIG. 20 outlines synthetic route to conjugated poly(F-
BODIPY-ethynylene) through a well-developed postpo-
lymerization functionalization approach. Monotosylate oli-
go(ethylene glycol) (2a) will be prepared by reacting oligo 
( ethylene glycol) with a stoichiometric amount of 
lar head-to-tail conjugated glycopolythiophenes (polymers 
XXI and XXII) through thioether bridges (FIGS. 15 and 16) 
have been developed. The post-polymerization functional-
ization approach offers a very effective and fast way to 20 
synthesize well-defined fluorescent conjugated glycopoly-
mers bearing a variety of carbohydrate pendants since the 
post-polymerization reaction of polymeric bromide groups 
with thiol-carbohydrates is 100% completed in a mild basic 
condition. Conjugated glycopolythiophenes with tetra( eth- 25 
ylene glycol) tethered spacers (polymers XXI and XXII) are 
highly soluble in water while the glycopolymers with hydro-
phobic hexyl tethered spacers (polymers XIX and XX) are 
insoluble in water. However, fluorene-based conjugated gly-
copolymers with poly(ethylene glycol) tethered spacers 30 
(polymers XXIII and XXIV) are highly soluble in water 
with high fluorescent quantum yield of 45% due to highly 
hydrophilic feature of poly( ethylene glycol) tethered spacers 
(FIG. 17). The repeated unit number (m) of poly(ethylene 
glycol) tethered spacer is 9.0 (FIG. 17). 35 p-toluenesulfonyl chloride in the presence of silver(!) oxide 
and a catalytic amount of potassium iodide. Various well-
defined oligo(ethylene glycol)s will be used and their 
repeated units (m) will be varied from 2, 6, 10, 19, 27, 35 to 
43. Bromide-bearing formal benzene derivative (5a) will be 
Example 6 
Synthesis of Deep-Red Emissive Conjugated 
Poly(BODIPY-Ethynylene )s 
Bromide-bearing poly(BODIPY-ethynylene) has been 
prepared for further functionalization with carbohydrates or 
peptides through thioether bridges (FIG. 18). The synthetic 
strategy to prepare bromide-bearing poly(BODIPY-ethy-
nylene )s is detailed in Example 7. Bromide-bearing poly 
(BODIPY-ethynylene) (polymer XXV) was prepared by 
palladium-catalyzed Sonogashira polymerization of 2,6-di-
iodo BODIPY monomer (a) with 2,6-diethynyl BODIPY 
monomer ( c) in DMF solution in presence of Pd(OAc )2 and 
tetrabutylanimonium acetate (FIG. 18).35 
Deep-red emissive poly(BODIPY-ethynylene)s bearing 
ethyl phenoxybutanoate groups at the mesa-positions (poly-
mers XXVI and XXVII) have also been prepared. (FIG. 18). 
Poly(BODIPY-ethynylene)s emit in deep-red region with 
fluorescent spectral maxima at around 680 nm and display 
significant red shifts (up to 163 nm and 172 nm) of both 
absorption and emission maxima compared with their start-
ing BODIPY dyes (dl, d2) (Table 4). In addition, BODIPY-
based copolymers have been prepared. (FIG. 19). Polymer 
XXVIII emits in orange region at 588 nm and shows 
significant red shifts to 48 nm and 78 nm) of both absorption 
and emission maxima compared with their starting BODIPY 
dye (h). Polymer XXIX emits at 616 nm (corresponding to 
fluorene moiety) and 680 nm (corresponding to BODIPY 
moiety), and show no shift in both absorption and emission 
maxima compared with BODIPY dye (K) in CH2Cl2 . All 
40 prepared by reacting mono-tosylated oligo(ethylene glycol) 
(2a) with 4-hydroXY-2,6-dimethylbenzaldehyde (la), and 
followed tosylation of an alcohol (3a), and replacement of 
tosylate group with bromide ion. Bromide-bearing BODIPY 
dye (7a) will be prepared through the reaction of the formyl 
45 benzene derivative (5a) with an excess of 2,4-dimethylpyr-
role under acid catalysis, and followed by oxidization with 
2,3-dichloro-5,6-dicyano-l,4-benzoquinone (DDQ) and 
treatment with BF3 -etherate in the presence of N,N-diiso-
propylethylamine (DIEA) (FIG. 20). Further iodination of 
50 BODIPY dye (7a) will afford 2,6-diiodo-tetramethyl 
BODIPY monomer (Sa). 2,6-Diethynyl BODIPY monomer 
(10a) will be prepared by palladium-catalyzed Sonogashira 
reaction of monomer Sa with ethynyltrimethylsilane in DMF 
solution in the presence of Pd(OAc)2 and tetrabutylammo-
55 nium acetate, affording BODIPY dye (9a), and followed by 
hydrolysis of compound 9a in the presence of tetrabutylam-
monium fluoride. Bromide-bearing conjugated Poly(BO-
DIPY-ethynylene) (polymer la) will be synthesized by pal-
ladium-catalyzed Sonogashira polymerization of 2,6-diiodo 
60 BODIPY monomers (Sa) with 2,6-diethynyl BODIPY 
monomer (10a) in DMF solution in presence of Pd(OAc)2 
and tetrabutylammonium. 
A series of well-defined glycopoly(BODIPY-ethynylene )s 
(polymer 2a) bearing different carbohydrate residues will be 
65 prepared by postpolymerization functionalization of poly-
mer la with a little excess of thiol-functionalized carbohy-
drate (11) in DMF in a mild basic condition (K2C03 ) through 
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100% thioether formation (Table 5). The glycopolymer will 
be put in a cellulose dialysis tube, dialysized against a large 
amount of water and lyophilized. Different oligo(ethylene 
glycol)s (m=2, 6, 10, 19, 27, 35 and 43) will be used as a 
tethered spacers between polymer backbone and carbohy- 5 
drate residues. Long oligo( ethylene glycol) (m> 10) will be 
needed to make polymer 2a soluble in water since polymer 
2a will have only one tethered spacer and BODIPY unit is 
hydrophobic. Polymer 2a is expected to have high fluores-
cent quantum yield with emission maximum at 680 nm 10 
according to our preliminary results above because the 
ortho-methyl groups on the mesa-phenyl ring introduce 
steric constraints on the phenyl ring, and suppress non-
radiative deactivation to increase quantum yield by restrict- 15 
ing internal free rotation of the phenyl ring at the mesa 
position relative to the BODIPY core in the excited state. 
A library of highly water-soluble deep-red emissive con-
jugated glycopoly(F-BODIPY-ethynylene )s with well-con-
trolled carbohydrate density and orientation will be prepared 
42 
by using different starting aldehyde derivatives (lb-lm) and 
tosylated compound (2a-2C) according to the synthetic 
approach outlined in FIG. 20. Table 5 outlines a library of 
BODIPY-based conjugated glycopolymers with different 
lengths of tethered spacers, carbohydrate densities and ori-
entations, and carbohydrate residues. Different numbers and 
positions of oligo(ethylene glycol) tethered spacers on the 
mesa-phenyl ring relative to each BODIPYunit will be used 
to control carbohydrate density and orientation, and water-
solubility and fluorescent quantum yields of the glycopoly-
mers. The library of the glycopolymers will be prepared by 
Sonogashira polymerization of one or two (1.0 equivalent) 
of 2,6-diodio monomers (lOa-lOm) with one, or two (1.0 
equivalent) of2,5-diethynyl monomers (Sa-Sm, 8n-8v), and 
followed by postpolymerization functionalization of bro-
mide-bearing polymers with different thiol-functionalized 
carbohydrates (11) (Tables 5 and 6). Monomers 8n-8v, and 
10n-10v will be used as diluting co-monomers to control 
carbohydrate density of the glycopolymers, and facilitate 
water-solubility of the glycopolymers. 
TABLE 5 
Thiol-functionalized carbohydrates (R-SH) (11)40-55 in FIGS. 20-24 
a-Mannose 
HO HO\ 9H_ 
H~O~SH 
13-Mannose H~~SH 
OH 
13-Mannose 
H~*~SH 
HO O 
a-glucose 
H~OH 
0 
HO 
HO 0.._ ./'-... 
......_,,,, '°SH 
13-galactose 
H40H 0 SH HO 
HO 
13-galactose 
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TABLE 5-continued 
Thiol-functionalized carbohydrates (R-SH) (11)40-55 in FIGS. 20-24 
H
4
0H
0 
SH 
HO 
AcHN 
13-galactosamine 
Ht <OHn 
HO~ ~SH 
AcHN 0 
a-galactosarnine 
HOH~\ 0 SH 
:a-~ 
NHAc 
13-glucosamine 
H~~~OH 
HO O O SH 
HO 
OH 
13-Maltose 
H~~~SH 
AcHN 0 
a-glucosarnine 
a-Fucose 
13-Fucose 
Ht <OHn OH 
HO~O~< O SH 
OH HO~ 
OH 
13-Lactose 
44 
HO 
OH 
HO 
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TABLE 5-continued 
Thiol-functionalized carbohydrates (R-SH) (11)40-55 in FIGS. 20-24 
Ht <OH.n OH 
HO~O~< O SH 
OH HO~ 
NHAc 
13-Lactosamine 
~1~ 
HOHo-~···to-_/H 
HO 
HO 
a-Mannose 
HO 
a-Salic acid 
HO~HO O H~ 
HO O 0 
SH 
OH HO 
OH 
13-Cellotetraose 
HO -0 H~oH 
HO 
HO 
HO 
HO 
COOH 
0 
H 
O~SH 
Manal.6Mana 
~o~O~SH 
HO HO OH 
NeuAca2,3Gali31,4Glci3 
coo::
40 
~OH 
0 
\ 0 0 
HO OHO ~SH 
OH OH 
NeuAca2,6Gali31,4Glci3 
46 
OH 
HO 
OH 
HO 
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TABLE 5-continued 
Thiol-functionalized carbohydrates (R-SH) (11)40-55 in FIGS. 20-24 
HO 
coo::
40 
~OH 
0 
\ 0 0 
HO OHO ~SH 
OH NHAc 
NeuAca2,6Gali31,4GlcNaci3 
HO 
coo4°£0~SH 
HO NHAc 
NeuAca2,3Gali31,4GlcNaci3 
HOH~f-\ 
HO~ 
H;~H~ 
O~SH 
Manal,3[Manal,6]Mana 
TABLE 6 
Starting materials (lb-lm, and 2b-2c), bromide-bearing BODIPY monomers 
(8a-8m and lOa-lOm), diluting monomers (8n-8v and lOn-lOv), bromide-bearing 
poly(2,6-BODIPY-ethynylene)s (polymers) la-lm,ln-lv, 3a-3z, and 4a-4z), and 
glycopoly(2,6-BODIPY-ethynylene)s (polymers VI, VII, VIII and IX). 
OH 
¢ 
CHO 
lb 
OH 
HO~ y 
CHO 
le 
48 
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TABLE 6-continued 
Starting materials (lb-lm, and 2b-2c), bromide-bearing BODIPY monomers 
(8a-8m and 10a-10m), diluting monomers (8n-8v and 10n-10v), bromide-bearing 
poly(2,6-BODIPY-etbynylene)s (polymers) la-lm,ln-lv, 3a-3z, and 4a-4z), and 
glycopoly(2,6-BODIPY-etbynylene)s (polymers VI, VII, VIII and IX). 
HO'(YOH 
"("CH3 
CHO 
lf 
OH 
HOyl, VOCH 
CHO 
lg 
OH 
9'0H 
CHO 
lh 
HO~OH 
OH 
CHO 
li 
¢cOH OH 
CHO 
lj 
50 
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TABLE 6-continued 
Starting materials (lb-lm, and 2b-2c), bromide-bearing BODIPY monomers 
(8a-8m and 10a-10m), diluting monomers (8n-8v and 10n-10v), bromide-bearing 
poly(2,6-BODIPY-etbynylene)s (polymers) la-lm,ln-lv, 3a-3z, and 4a-4z), and 
glycopoly(2,6-BODIPY-etbynylene)s (polymers VI, VII, VIII and IX). 
OH HO~ 
Y"OH 
CHO 
11 
OH HOyYOH 
Y"OH 
CHO 
lm 
0 
-0- 11 r-\ ri\ II"\ H3C 11-0 cf l 'cf t OCH3 0 
H----<\_ 
2b 
OR3 Q 
CHO 
3a-3m 
N......_ /N~ 
B 
!\ 
F F 
8a-8m 
N......_ /N~ 
B 
!\ 
F F 
10a-10m 
52 
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TABLE 6-continued 
Starting materials (lb-lm, and 2b-2c), bromide-bearing BODIPY monomers 
(8a-8m and 10a-10m), diluting monomers (8n-8v and 10n-10v), bromide-bearing 
poly(2,6-BODIPY-etbynylene)s (polymers) la-lm,ln-lv, 3a-3z, and 4a-4z), and 
glycopoly(2,6-BODIPY-etbynylene)s (polymers VI, VII, VIII and IX). 
N......_ /N::::,..... 
B 
!\ 
F F 
Polymers la-lm 
N......_ /N::::,..... 
B 
!\ 
F F 
Polymers I 
0 /\/\/\ 
-0- 11 --(_O O O OCH3 H3C S-0 II O O O OCH 
0 \___J \___J \___J 3 
2c 
OR2 Q 
CHO 
3n-3w 
N......_ /N::::,..... 
B 
!\ 
F F 
8n-8v 
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TABLE 6-continued 
Starting materials (lb-lm, and 2b-2c), bromide-bearing BODIPY monomers 
(8a-8m and 10a-10m), diluting monomers (8n-8v and 10n-10v), bromide-bearing 
poly(2,6-BODIPY-etbynylene)s (polymers) la-lm,ln-lv, 3a-3z, and 4a-4z), and 
glycopoly(2,6-BODIPY-etbynylene)s (polymers VI, VII, VIII and IX). 
Lf 
N......_ ./N~ 
B 
!\ 
F F 
N......_ ./N~ 
B 
!\ 
F F 
N......_ ./N~ 
B 
!\ 
F F 
10n-10v 
Polymers ln-1 v 
Polymer II 
N......_ ./N~ 
B 
I\ 
F F 
N......_ ./N~ 
B 
!\ 
F F 
/\/\/\ 
--(_
O O O OCH3 
o o o oc~ 
\__J \__J \__J 
Where m - 2, 6, 10, 19, 27, 35, and 43 
rf 
.--::;N......_ ./N 
B 
!\ 
F F 
Polymers 3a-3z 
rf 
.--::;N......_ ./N 
B 
!\ 
F F 
Where 
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TABLE 6-continued 
Starting materials (lb-lm, and 2b-2c), bromide-bearing BODIPY monomers 
(8a-8m and 10a-10m), diluting monomers (8n-8v and 10n-10v), bromide-bearing 
poly(2,6-BODIPY-etbynylene)s (polymers) la-lm,ln-lv, 3a-3z, and 4a-4z), and 
glycopoly(2,6-BODIPY-etbynylene)s (polymers VI, VII, VIII and IX). 
a 
_,:;;N......_ /N 
B 
I\ 
F F 
Polymers III 
_,:;;N......_ /N 
B 
!\ 
F F 
Polymers 4a-4z 
_,:;;N......_ /N 
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I\ 
F F 
Polymers IV 
b 
g 
_,:;;N......_ /N 
B 
I\ 
F F 
_,:;;N......_ /N 
B 
I\ 
F F 
_,:;;N......_ /N 
B 
I\ 
F F 
h 
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TABLE 6-continued 
Starting materials (lb-lm, and 2b-2c), bromide-bearing BODIPY monomers 
(8a-8m and 10a-10m), diluting monomers (8n-8v and 10n-10v), bromide-bearing 
poly(2,6-BODIPY-etbynylene)s (polymers) la-lm,ln-lv, 3a-3z, and 4a-4z), and 
glycopoly(2,6-BODIPY-etbynylene)s (polymers VI, VII, VIII and IX). 
ill 
n 
V w 
Anticipated Results: 
55 
Multi-substituent groups of oligo(ethylene glycol) on 
each of mesa-phenyl ring relative to BODIPY core will 
make BODIPY-based conjugated glycopolymers highly 
soluble in aqueous solution. Ortho-substituent groups on the 
mesa-phenyl rings (e-v) will introduce steric constraints on 
the mesa-phenyl rings, and suppress non-radiative deacti-
vation by restricting internal free rotation of the phenyl ring 60 
at the mesa position relative to the BODIPY core in the 
excited state to increase fluorescence quantum yields of the 
glycopolymers in aqueous solution. In addition, the bulky 
ortho-substituent groups on the mesa-phenyl ring with pre-
clude potential formation of aggregates of the conjugated 65 
glycopolymers by preventing Jt-Jt stacking interactions 
between polymer backbones through the enhanced steric 
k 
p q 
u 
hindrances. The polymerization time will be prolonged due 
to the bulky ortho-substituent groups on mesa-phenyl ring 
relative to BODIPY core. 
Example 8 
Synthesis of Cascade-Type Deep-Red Emissive 
Glycopoly(C-BODIPY-Ethynylene)s and 
Glycopoly(E-BO D IPY-Ethyny lene )s 
In order to further increase stability and fluorescent quan-
tum yields of BODIPY-based conjugated glycopolymers, a 
library of cascade-type C-BODIPY (C for carbocycle) and 
E-BODIPY (E for ethynyl) dyads are prepared by replacing 
the fluorine atoms with aryl, ethynyl and ethynylaryl sub-
US 9,623,123 B2 
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units to incorporate conjugated polymer backbones. Gri-
gnard reagents have been used to efficiently substitute the 
fluorine atoms and E-BODIPY dyes are reported to be very 
stable and insensitive to strong base or acid, as well as polar 
solvents and reagents, which is due to stabilization of the 5 
tetrahedral boron center by the ethynyl donors. A series ofC-
or E-BODIPY monomers (13a-13m, 13n-13v) are prepared 
by reacting 2,5-diiodo BODIPY monomers (Sa-Sm, 8n-8v) 
in Table 6 with Grignard reagents (12a, 12b, 12C or 12d) in 
dry THF at 60° C. The bromide groups of BODIPY dyes 10 
(Sa-Sm) will be intact under Grignards reaction condition. 
2,6-Diethynyl C- or E-BODIPY monomers (15a-15m, 15n-
15v) are prepared by palladium-catalyzed Sonogashira reac-
tion of monomers (13a-13m, 13n-13v) with ethynyltrimeth-
ylsilane in DMF solution in the presence of Pd(OAc )2 and 15 
tetrabutylanmionium acetate, affording BODIPY dyes (14a-
14m, 14n-14v ), and followed by hydrolysis of intermediates 
(14a-14m, 14n-14v) in the presence oftetrabutylammonium 
fluoride. Bromide-bearing conjugated Poly(BODIPY-ethy-
nylene )s (polymers 5a-5m) are synthesized by palladium- 20 
catalyzed Sonogashira polymerization of one of 2,6-diiodo 
C- or E-BODIPY monomers (13a-13m) with one of 2,6-
diethynyl C- or E-BODIPY monomers (15a-15m) in DMF 
solution in the presence of Pd(OAc)2 and tetrabutylammo-
nium acetate (FIG. 21). Well-defined glycopoly(C- or E-BO- 25 
DIPY-ethynylene)s (polymers XXV) bearing different car-
bohydrate residues are prepared by post-polymerization 
functionalization of bromide-bearing polymers 5a-5m with a 
little excess of thiol-functionalized carbohydrate (11) in 
DMF in a mild basic condition (K2 C03 ) through 100% 30 
thioether formation (Table 5). Polymers VII, VIII, XIX with 
controlled density of carbohydrate residues will be prepared 
by polymerizing one or two (1.0 equivalent) of monomers 
15a-15m with one or two (1.0 equivalent) of monomers 
13n-13v according to the approach for polymer XXV (FIG. 35 
21). 
Anticipated Results: 
Replacement of the fluoride atoms with aryl, ethynyl and 
ethynylaryl subunits will not only significantly enhance 
stability of glycopoly(C- or E-BODIPY-ethynylene)s in a 40 
strong acid or base because of stabilization of the tetrahedral 
boron centers by the ethynyl donors, but also further 
increase water-solubility of the glycopolymers in aqueous 
solution, and fluorescent quantum yields of the glycopoly-
mers because the bulky aryl, ethynyl, ethynylaryl substitu- 45 
ents bearing highly-branched groups of oligo(ethylene gly-
col) monomethyl ether will significantly increase 
hydrophilicity of BODIPY dyes, and further prevent it-it 
stacking interactions between the polymer backbones. 
Polymerization time may need to be prolonged due to 50 
introduction of bulky groups to the monomers. 
Example 9 
62 
2,6-diethynyl F-, C- or E-BODIPY monomers (10n-10v, 
15n-15v) in Table 6 and FIG. 21 with 4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (pinacolborane) in mixed solution of 
THF and toluene at 80° C. Glycopoly(BODIPY-vinylene)s 
(polymers X) are prepared by palladium-catalyzed Suzuki 
polymerization of one (1.0 equivalent) of BODIPY mono-
mers (16a-16h) with one of bromide-bearing 2,6-diiodo 
BODIPY monomers (Sa-Sm, 13a-13m) in l-methyl-2-pyr-
rolidinone (NMP) solution at 90° C., affording bromide-
bearing poly(BODIPY-vinylene)s (polymers 6a-6m), and 
followed by postpolymerization functionalization of bro-
mide-bearing poly(BODIPY-vinylene)s (polymers 6a-6m) 
with thiol-functionalized carbohydrates (11) in Table 4. A 
library of glycopoly(BODIPY-vinylene)s with various car-
bohydrate density and orientation (Polymers XI and XII) are 
prepared by polymerizing one or two (1.0 equivalent) of 
BODIPY monomers (16a-16h) with one or two (1.0 equiva-
lent) of BODIPY monomers (Sa-Sm, 13a-13m) in Table 6 
and FIG. 21 for a series of bromide-bearing poly(F-, C- and 
E-BODIPY-vinylene )s, and followed by functionalization of 
the bromide-bearing polymers with thiol-functionalized car-
bohydrates(ll) in Table 5 (FIG. 22). 
Anticipated Results: 
Bromide groups of monomers (Sa-Sm, 13a-13m) will be 
intact in palladium-catalyzed Suzuki polycondensation. 
Glycopoly(F-, C- and E-BODIPY-vinylene)s (polymer 
X-XII) will emit in near-infrared region with emission 
maxima larger than 700 nm due to their more extended 
it-conjugation than deep-red emissive poly(F-, C-, E-BO-
DIPY-ethynylene)s (polymers X-XIV). 
Example 10 
Synthesis of Near-Infrared Emissive 
Glycopoly(F -BO DIPY-Ethyny lene )s 
In order to further tune fluorescence of glycopoly(BO-
DIPY-ethynylene )s with near-infrared emission, it-conjuga-
tion of BODIPY monomers is extended by condensation 
reactions of BODIPY monomers (8n-8v) with aldehyde 
derivative (3w), affording highly water-soluble BODIPY 
monomers (15a-15h) due to several highly branched oligo 
( ethylene glycol) monomethyl ether groups (FIG. 23). 
Highly water-soluble near-infrared emissive conjugated gly-
copoly(BODIPY-ethynylene )s (polymers XIII) are prepared 
by palladium-catalyzed Sonogashira polymerization of one 
of BODIPY monomers (17a-17h) with one of BODIPY 
monomers (lOa-lOm) in Table 6 in DMF in the presence of 
Pd(OAc )2 and tetrabutylammonium acetate, resulting in bro-
mide-bearing polymer 7a-7m, and followed by postpolymer-
ization functionalization of polymer 7a-7m with thiol-func-
tionalized carbohydrate (11) in Table 4 (FIG. 23). A library 
Synthesis of Near-Infrared Emissive Glycopoly(F-, 
C- and E-BODIPY-Vinylene)s 
55 of the glycopolymers with various carbohydrate density and 
orientation (Polymers XIV and XV) are prepared by polym-
erizing one or two (1.0 equivalent) of BODIPY monomers 
(16a-16h) with one or two (1.0 equivalent) of BODIPY According to our preliminary results, poly(BODIPY-ethy-
nylene )s emit deep-red emission with emission spectral 
maximum at 680 nm. In order to tune the fluorescence of 60 
conjugated glycopolymers with near-infrared emission, 
highly water-soluble glycopoly(BODIPY-vinylene)s are 
prepared which emit near-infrared emission due to more 
extended it-conjugation of their polymer backbones than 
those of poly(BODIPY-ethynylene )s (FIG. 22). 2,6-bis( 4.4, 65 
5,5-tetramethyl-1,3,2-dioxoborolan-2-yl-ethenyl) BODIPY 
monomers (16a-16h) are obtained by reaction of one of 
monomers (lOa-lOm) in Table 5 for a series of bromide-
bearing poly(BODIPY-ethynylene)s, and followed by func-
tionalization of the bromide-bearing polymers with thiol-
functionalized carbohydrates (11) in Table (FIG. 23). 
Anticipated results: The chemical transformation of the 
3,5-methyl groups of 2,5-diodo-BODIPY dyes (8n-8v) to 
two vinylphenyl groups will cause a dramatic bathochromic 
shift to 680 nm in emission of BODIPY dyes (17a-l 7h) 
US 9,623,123 B2 
63 
relative to 2,5-diodo-BODIPY dyes which emit around 548 
nm. The enhanced delocalization imparted by a more con-
jugated and planar vinyl system will reduce the energy 
required to reach the excited state. As a result, the conju-
gated glycopoly(BODIPY-ethynylene)s (Polymer XIII-XV) 5 
will have significant bathochromic shift and emit in near-
infrared region. The polymerization time may need to be 
prolonged due to the bulky monomers 16a-16h. In addition, 
water-solubility of glycopoly(BODIPY-ethynylene )swill be 
further enhanced by strong hydrophilic feature of monomers 10 
17a-17h which will have more than six (up to twenty) 
hydrophilic groups of oligo(ethylene glycol) monomethyl 
ether (FIG. 23 and Table 6). 
64 
Example 12 
Synthesis of Fluorescent Conjugated 
Glycopolymers A-E 
Polymers A-E are shown in FIG. 25. 
Instrumentation. 
1 H NMR and 13C NMR spectra were taken on a 400 MHz 
Varian Unity Inova spectrophotometer instrument. 1H and 
13C NMR spectra were recorded in CDC13 , and chemical 
shifts (5) are given in ppm relative to solvent peaks (at 7.24 
ppm for 1H spectra and at 77.3 for 13C spectra) as internal 
standard. UV spectra were taken on a Hewlett-Packard 
8452A Diode Array UV-visible spectrophotometer. Fluores-
Example 11 
Synthesis of BODIPY-Based Near-Infrared 
Emissive Glyco-Copolymers 
15 cence spectra were recorded on a Spex Fluorolog 1681 0.22 
m steady-state fluorometer. Fluorescence quantum yields of 
BODIPY dyes and polymers were measured in methylene 
chloride and calculated by using fluorescein excited at 490 
nm in 0.1 N NaOH as the reference (its quantum efficiency 
20 of 85%). Fluorescence lifetimes were measured on a 
GL-3300 Nitrogen Laser laserstrobe PTI instrument and 
analyzed using FeliX32 software. Glycopoly(BODIPY-ethynylene)s (polymers V-IX) will 
emit in deep-red region with emission spectra maxima at 
680 nm according to our preliminary results. Narrow-band-
gap monomer units are incorporated such as benzo[ c] [1,2, 25 
5]thiadiazole, 2,1,3-benzoselenadiazole, 6, 7-dimethyl[l ,2,s] 
thiadiazolo[3,4-g]quinoxaline and benzo[l ,2-C:4,5-c']bis 
([1,2,5]thiadiazole) to backbones of poly(BODIPY-
ethynylene)s to tune the polymer fluorescence with near- 30 
infrared emission ranging from 700 nm to 900 nm (FIG. 24). 
Bromide-bearing conjugated BODIPY-based copolymers 
(polymers Sa-Sm) are synthesized by palladium-catalyzed 
Sonogashira polymerization of one of 2,6-diiodo F-, C- or 
E-BODIPY monomers (Sa-Sm, 13a-13m) with one of nar- 35 
row-band-gap monomers (18a-18e) in DMF solution in the 
presence of Pd(OAc)2 and tetrabutylammonium acetate 
(FIG. 21). Well-defined F-, C- or E-BODIPY-based near-
infrared emissive copolymers (polymers XVII) bearing dif-
ferent carbohydrate residues are prepared by post-polymer- 40 
ization functionalization of bromide-bearing polymers 
Sa-Sm with a little excess of thiol-functionalized carbohy-
drate (11) in DMF in a mild basic condition (K2C03 ) through 
100% thioether formation (Table 5). BODIPY-based glyco-
copolymers with different amount of narrow-band-gap 45 
monomer units (polymer XVII) are prepared by polymeriz-
ing one (1.0 equivalent) of monomers (Sa-Sm, 13a-13m) 
with 1.0 equivalent of one of narrow-band-gap monomers 
(18a-18e) and one of monomer (lOa-10, 15a-15m) accord- 50 
ing to the approach for polymer XVI (FIG. 24). BODIPY-
based glyco-copolymers with less density of carbohydrate 
residues (polymer XVIII) are prepared by polymerizing one 
(1.0 equivalent) of monomers (8v-8v, 13n-13v) with 1.0 
equivalent of one of narrow-band-gap monomers (18a-l 8e) 55 
and one of monomer (lOa-lOm, 15a-15m) according to the 
approach for polymer XVI (FIG. 24). 
Anticipated Results: 
Incorporation of small amount of narrow-band-gap mono-
mers (from 5% to 50%) will efficiently tune fluorescence of 
poly(BODIPY-ethynylene )s to near-infrared emission at 
more than 700 nm due to very effective photoinduced energy 
transfer along it-conjugated polymer backbones. The 
amount of narrow-band-gap monomers will need to be 
optimized to have highly water-soluble BODIPY-based con-
jugated glycopolymers with near-infrared emission. 
Materials. 
Unless otherwise indicated, all reagents and solvents were 
obtained from commercial suppliers (Aldrich, Sigma, Fluka, 
Acros Organics, Fisher Scientific, Lancaster) and were used 
without further purification. Air- and moisture-sensitive 
reactions were conducted in oven-dried glassware using a 
standard Schlenk line or drybox techniques under an inert 
atmosphere of dry nitrogen. 4,4-Difluoro-8-( 4-methoxyphe-
nyl)-1,3,5,7-tetramethyl-4-bora-3a, 4a-diaza-s-indacene (2) 
and 1,4-diethynyl-2,5-didecyloxybenzene (7) were prepared 
according to the reported procedure. 
BODIPY Dyes 4 and 5 
The synthetic scheme to the BODIPY dyes 4 and 5 is 
shown in FIG. 26 and detailed below. 
4,4-Difluoro-8-( 4-methoxyphenyl)-2,6-diiodo-l, 3, 5, 
7-tetramethyl-4-bora-3a, 4a-diaza-s-indacene (3) 
When iodic acid (11.26 mmol, 1.98 g) in 4 mL of water 
was added dropwise to the ethanol solution (50 mL) con-
taining BODIPY dye (2) (5.63 mmol 2.0 g) and iodine (6.19 
mmol 1.57 g) over 30 min, the mixture was stirred for 3 h. 
The mixture was concentrated under reduced pressure, dis-
solved in CH2Cl2 , and washed twice with water and satu-
rated sodium chloride solution. The organic layer was col-
lected, dried over anhydrous Na2S04 , and concentrated 
under reduced pressure. The crude product was purified 
according to a reported procedure to yield compound 3 as 
red crystals (3.2 g, 94%). 
2,6-diiodo-BODIPY Dye bearing monostyryl and distyryl 
groups ( 4, 5) 
Piperidine (2.88 mL) and acetic acid (2.44 mL) were 
added to the solution of benzene (120 mL) containing 
2,6-diiodo BODIPY dye (3) (1.326 mmol, 0.80 g) and 
compound3 (5.18 mmol, 1.93 g) in a 250-mLflask.Afterthe 
mixture was stirred and refluxed by using a Dean Stark trap 
for 4 hours, it was cooled to room temperature and concen-
60 trated under reduced pressure. The crude product was dis-
solved in ethyl acetate and washed twice with water. The 
organic phase was collected, dried over Na2 S04 , and fil-
tered. After the filtrate was concentrated, the residue was 
purified by silica gel column chromatography using hexane/ 
65 EtOAc (5/1 to 3/1, v/v) to afford dark blue solid compound 
4 (540 mg, 43%), dark green solid compound 5 (410 mg, 
24%). BODIPY Dye bearing monostyryl group (4): 1H 
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NMR (400 MHz, CDC13 ): Ii 8.05 (d, J=16.8 Hz, lH), 7.49 
(d, J=16.8 Hz, lH), 7.26 (d, J=S.4 Hz, lH), 7.14 (m, 2H), 
7.02 (d, J=S.O Hz, 2H), 6.88 (d, J=S.O Hz, lH), 4.18-4.06 (m, 
SH), 3.87 (s, 3H), 2.68 (s, 3H), 2.59-2.53 (m, 4H), 2.18-2.13 
(m, 4H), 1.48 (s, 3H), 1.44 (s, 3H), 1.26 (t, J=7.0 Hz, 6H). 5 
13C NMR (100 MHz, CDC13 ): ll 173.4, 173.3, 160.7, 156.8, 
150.5, 149.2, 146.3, 145.2, 140.5, 139.2, 132.8, 132.5, 
117.2, 115.1, 113.9, 113.2, 86.3, 82.6, 68.5, 68.2, 60.6, 55.6, 
30.9, 24.9, 24.8, 17.9, 17.4, 16.4, 14.5. IR (cm- 1): 2924, 
1728, 1511, 1468, 1346, 1246, 1164, 1109, 995,706. ESI- 10 
MS: M+ (C41H48BF2I2 N20 7 ) Calcd: m/z=983.0. Found: 
m/z=980.3. The compound shows absorption maximum at 
597 nm and emission maximum at 631 nm in CH2Cl2 
solution; BODIPY Dye bearing distyryl group (5): 1 H NMR 
(400 MHz, CDC13 ): 58.04 (d, J=16.8 Hz, 2H), 7.51 (d, 15 
J=16.4 Hz, 2H), 7.23 (d, J=9.2 Hz, 2H), 7.17 (d, J=S.4 Hz, 
2H), 7.10 (s, 2H), 7.01 (d, J=S.4 Hz, 2H), 6.89 (d, J=S.4 Hz, 
2H), 4.15-4.05 (m, 16H), 3.85 (s, 3H), 2.55-2.51 (m, SH), 
2.16-2.09 (m, SH), 1.46 (s, 6H), 1.27-1.20 (m, 12H) ppm. 
13C NMR (100 MHz, CDC13 ): 5173.4, 173.3, 160.7, 150.5, 20 
149.1, 145.9, 139.4, 138.9, 133.6, 130.5, 129.8, 127.4, 
121.7, 117.3, 115.0, 114.0, 113.7, 83.3, 68.5, 68.2, 60.6, 
60.5, 55.6, 30.9, 24.9, 24.8, 17.9, 14.4 ppm. IR (cm- 1): 
2978, 2933, 1726, 1595, 1509, 1431, 1354, 1244, 1170, 
1094, 1010, 770, 708. ESI-MS: M+ (C62H76BF2 I2 N20l 3 + 25 
Na) Calcd: m/z=l382.0. Found: m/z=l381.8. The com-
pound shows absorption maximum at 665 nm and emission 
maximum at 701 nm in CH2Cl2 solution. 
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diisopropylamine (40 mL) were added to the flask under a 
nitrogen atmosphere, the mixture was stirred under reflux 
for 24 h. Polymer B was purified by using the procedure for 
polymer A to obtain dark-violet solid (0.182 g). 1H NMR 
(400 MHz, CDC13 ): 58.20 (br.d, 2H), 7.63 (br.d, 2H), 
7.16-7.10 (br. m, 4H), 7.03 (br. s, 2H), 7.02 (br. d, 2H), 6.88 
(br. d, 2H), 6.43 (br. s, 2H), 4.15-4.08 (br.m, 16H), 3.99 (br. 
m, 2H), 3.87 (br. m, 7H), 2.66 (br. s, 6H), 2.57-2.52 (br.m, 
SH), 2.18-2.14 (m, SH), 1.76 (br. m, 6H), 1.66 (br. s, 12H), 
1.56-1.23 (br. m, 66H), 0.86-0.85 (br.m, 9H) ppm. 13C NMR 
(100 MHz, CDC13 ): Ii 173.4, 173.3, 160.7, 154.5, 152.3, 
150.7, 149.2, 144.6, 143.4, 139.1, 133.5, 131.5, 130.4, 
125.2, 122.1, 117.4, 114.9, 113.9, 113.2, 106.3, 94.6, 91.5, 
74.0, 69.8, 68.6, 68.2, 60.6, 60.5, 55.5, 32.1, 31.8, 30.9, 30.5, 
29.9, 29.8, 29.5, 26.4, 26.2, 24.9, 24.8, 23.6, 22.9, 14.4, 14.3 
ppm. IR (cm- 1): 2921, 2852, 1733, 1506, 1313, 1238, 1179, 
1082, 1004, 758, 709; The compound shows absorption 
maximum at 738 nm and emission maximum at 760 nm in 
CH2Cl2 solution. 
Polymers C and D 
The synthetic route to Polymers C and Dis shown in FIG. 
28 and detailed below. 
Compound 8. 
2,5-diiodo-3-decylthiophene (7) (4.20 mmol, 2 g), Cul (4 
mg), and Pd(PPh3 ) 2 Cl2 (10 mg) were added to a 100-mL 
three-neck flask under a nitrogen atmosphere. After 
degassed anhydrous THF (20 mL), diisopropylamine (20 
Polymers A and B 
The synthetic scheme to Polymers A and B is shown in 
FIG. 27 and detailed below. 
Polymer A: 
30 mL), and trimethylsilylacetylene (12.6 mmol, 1.2 g) were 
added to the flask under a nitrogen atmosphere, the mixture 
was stirred at room temperature for 12 h. The mixture was 
concentrated, dissolved in 50 mL of CH2 Cl2 and washed 
twice with water and saturated saline solution. When the 
BODIPY dye bearing monostyryl group (4) (0.15 mmol, 35 
150 mg), 2,6-diethynyl BODIPY dye (6) (0.18 mmol, 169 
mg), and Cul (3 mg) were added to a 100-mL three-neck 
flask under a nitrogen atmosphere. Pd(PPh3 ) 4 (6 mg) was 
added to the flask in a glove box under a nitrogen atmo-
sphere. When degassed anhydrous THF (40 mL) and diiso- 40 
propylamine (40 mL) were added to the flask under a 
nitrogen atmosphere, the resulting mixture was stirred under 
reflux for 24 h. After removal of the solvent, the residue was 
dissolved in 250 mL of methylene chloride and washed with 
water three times. After the organic layer was collected, 45 
dried over anhydrous MgS04 , and filtered, the filtrate was 
concentrated under reduced pressure and added to 250 mL 
organic layer was collected, dried over anhydrous MgS04 , 
and filtered, the filtrate was concentrated under reduced 
pressure. The product was purified by silica gel column 
chromatography using hexane/EtOAc (98/2 v/v) to yield 
thick liquid (1.46 g, 84%). 1H NMR (400 MHz, CDC13 ): 
56.94 (s, lH), 2.59 (t, J=7.6 Hz, 2H), 1.56 (t, J=6.8 Hz, 2H), 
1.31-1.26 (m, 14H), 0.87 (t, J=6.8 Hz, 3H), 0.19 (s, 18H) 
ppm. 13C NMR (100 MHz, CDC13 ): 5148.6, 133.6, 122.9, 
120.1, 101.9, 99.6, 97.6, 97.1, 32.1, 30.1, 29.8, 29.7, 29.5, 
29.3, 22.9, 14.3, 0.09 ppm. 
2,5-diethynyl-3-decylthiophene (9) 
When tetrabutylamine fluoride (5.63 mmol 2.0 g) was 
added to the degassed solution of compound 8 (12.1 mmol, 
0.50 g) in dry THF (50 mL) at - 70° C. through syringe, the 
resulting mixture was stirred at room temperature for two 
hours. After the reaction was quenched with dilute acetic 
acid and 50 mL of dichloromethane was added to the flask, 
the mixture was washed twice with water and saturated 
saline solution. When the organic layer was collected, died 
over anhydrous MgS04 , and filtered, the filtrate was con-
centrated. The residue was purified by colunm chromatog-
raphy using hexane/EtOAc (95/5 v/v) to yield yellow liquid 
(0.28 g, 87%). The compound was immediately stored at 4° 
C. 1H NMR (400 MHz, CDC13 ): Ii 7.00 (s, lH), 3.42 (d, 
J=l.2 Hz, lH), 3.30 (d, J=0.8 Hz, lH), 2.63 (t, J=7.0 Hz, 
of ethanol to precipitate the polymer. The precipitated solid 
was collected, washed with ethanol and hexane, and dried 
under vacuum for 24 h at room temperature to obtain 50 
dark-violet solid (0.202 g). 1H NMR (400 MHz, CDC13 ): 
58.19 (br.d, lH), 7.56 (br.d, lH), 7.16-7.10 (br.m, 4H), 
7.02-7.00 (br. m, 2H), 6.84 (br. d, lH), 6.42 (br. s, 2H), 
4.14-4.06 (br. m, SH), 3.98 (br.m, 2H), 3.86 (br. m, 7H), 
2.68-2.64 (br. m, 9H), 2.57-2.52 (br. m, 4H), 2.18-2.13 (br. 55 
m, 4H), 1.76 (br. m, 6H), 1.66 (br. s, 6H), 1.54-1.23 (br. m, 
66H), 0.86-0.85 (br. m, 9H). IR (cm- 1): 2922, 2852, 1734, 
1509, 1313, 1228, 1164, 1086, 1000, 759; The compound 
shows absorption maximum at 697 nm and emission maxi-
mum at 715 nm in CH2 Cl2 solution. 60 2H), 1.58 (t, J=7.0 Hz, 2H), 1.31-1.27 (m, 14H), 0.89 (t, 
1=6.4 Hz, 3H) ppm. 13C NMR (100 MHz, CDC13 ): ll 148.8, 
133.9, 122.3, 119.1, 84.2, 81.9, 76.9, 76.2, 32.2, 30.2, 29.9, 
29.8, 29.6, 29.5, 29.4, 22.9, 14.4 ppm. 
Polymer B: 
2,6-diiodo BODIPY dye bearing distyryl groups (5) (0.11 
mmol, 150 mg), 2,6-diethynyl BODIPY dye (6) (0.13 mmol, 
122 mg), and Cul (3 mg) were added to a 100-mL three-neck 
flask under a nitrogen atmosphere. Pd(PPh3 ) 4 (6 mg) was 65 
added to the flask in the glove box under a nitrogen 
atmosphere. After degassed anhydrous THF (40 mL) and 
Polymer C. 
2,5-Diiodo BODIPY dye bearing distyryl groups (5) (0.11 
mmol, 150 mg), 2,5-diethynyl-3-decylthiophene (9) (0.14 
mmol, 36 mg), and Cul (3 mg) were added to a 100-mL 
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three-neck flask under a nitrogen atmosphere. Pd(PPh3 ) 4 (6 
mg) was added to the flask in the glove box under a nitrogen 
atmosphere. When degassed anhydrous THF (40 mL) and 
diisopropylamine (40 mL) were added to the flask under a 
nitrogen atmosphere, the mixture was stirred under reflux 5 
for 24 h. The mixture was concentrated and added dropwise 
68 
1004, 759, 720. The compound shows absorption maximum 
at 634 nm and emission maximum at 669 nm in CH2Cl2 
solution. 
Optical Properties of BODIPY Polymeric and Copoly-
meric Dyes. 
The photophysical characteristics of BODIPY intermedi-
ate, monomeric and polymeric dyes were investigated in 
methylene chloride. The absorption properties of the 
BODIPY dye 2 in methylene chloride solution are charac-
terized by a strong S0 ----;,S 1 (it-it*) transition at 502 nm and 
a weaker broad band at a shorter wavelength around 356 nm 
due to the S0 ----;,S2 (it-it*) transition (FIG. 30). The introduc-
tion of diiodo substituent to the dipyrromethene core (2) 
results in a significant red shift (up to 33 nm and 38 nm) of 
both the UV-absorption and fluorescent maxima, respec-
tively (FIGS. 30 and 31), and significantly quenches the 
fluorescence quantum yield because of the heavy atom effect 
(Table 7). Absorption and fluorescence spectra of 2,6-di-
iodo-substituted BODIPY dye 2 exhibit good mirror sym-
to 250 mL of ethanol under stirring to precipitate the 
polymer. The precipitated polymer was collected, washed 
with water, ethanol, acetone and hexane and dried under 
vacuum for 24 h at room temperature to afford dark-violet 10 
solid (0.113 g). 1H NMR (400 MHz, CDC13 ): 58.22 (br. d, 
2H), 7.65 (br. d, 2H), 7.16-7.10 (br. m, 4H), 7.05 (br. s, 2H), 
7.02 (br. m, 3H), 6.89 (br. d, 2H), 4.15-4.08 (br. m, 16H), 
3.87 (br. s, 3H), 2.67-2.63 (br. m, !OH), 2.16-2.09 (br.m, 15 
SH), 1.58 (br.t, 2H), 1.46 (br.s, 6H), 1.30-1.20 (br. m, 26H), 
0.87 (br. t, 3H) ppm. IR (cm- 1): 2921, 2852, 1732, 1509, 
1457, 1262, 1249, 1175, 1135, 1044, 958, 750, 723; The 
compound shows absorption maximum at 713 nm and 
emission maximum at 758 nm in CH2 Cl2 solution. 20 metry with similar band shapes for the absorption and 
emission spectra which was also verified by measuring their 
full width at half-maximum (FIGS. 30 and 31). Further 
condensation of 2,6-diiodo BODIPY dye bearing methyl 
substituents at 3 and 5 positions (3) with aldehyde derivative 
Polymer D. 
2,5-Diiodo BODIPY dye bearing monostyryl group (4) 
(0.10 mmol, 100 mg), diethynyl-3-decylthiophene (9) (0.12 
mmol, 34 mg), and Cul (3 mg) were added to a 100-mL 
three-neck flask under a nitrogen atmosphere. Pd(PPh3 ) 4 (6 
mg) was added to the flask in the glove box under a nitrogen 
atmosphere. When degassed anhydrous THF (40 mL) and 
anhydrous diisopropylamine (40 mL) were added to the 
flask under a nitrogen atmosphere, the mixture was stirred 
under reflux for 24 h. The polymer D was purified by using 
the same procedure for polymer C to afford dark-violet solid 
(0.082 g). 1H NMR (400 MHz, CDC13 ): 58.17 (br.d, lH), 
7.54 (br.d, lH), 7.15-7.08 (br.m, 4H), 7.02-6.98 (br.m, 3H), 
6.82 (br.d, lH), 4.12-4.03 (br.m, SH), 3.87 (br.s, 3H), 35 
2.67-2.63 (br.m, 5H), 2.58-2.51 (br.m, 4H), 2.16-2.13 (br.m, 
4H), 1.58 (br.t, 2H), 1.48-1.24 (br.m, 26H), 0.88 (br.t, 3H) 
ppm. IR (cm- 1): 2921, 2851, 1732, 1509, 1403, 1247, 1178, 
1022, 1007, 835; The compound shows absorption maxi-
mum at 649 nm and emission maximum at 694 nm in 40 
Polymer E 
The synthetic route to Polymer Eis shown in FIG. 29 and 
detailed below. 
Polymer E. 
2,6-diethynyl-BODIPY dye (6) (0.14 mmol, 150 mg), 
2,5-diiodo-3-decylthiophene (8) (0.12 mmol, 60 mg), and 
Cul (3 mg) were added to a 100-mL three-neck flask under 
25 gave longer wavelength absorbing BODIPY dyes bearing 
alkoxymonostyryl and alkoxydistyryl (4,5). The extended 
it-conjugation in these dyes results in significant red shifts in 
both absorption and emission spectra compared with their 
precursor BODIPY dye (3). Alkoxymonostyryl-bearing 
30 BODIPY dye (4) shows absorption and emission maxima at 
579 nm and 631 nm with red shifts of 79 nm and 121 nm in 
absorption and emission spectra, respectively, compared 
with its starting BODIPY dye (2). Alkoxydistyryl-bearing 
BODIPY dye (5) displays red shifts of 165 nm and 170 nm 
in absorption and emission spectra with absorption and 
emission maxima of 665 nm and 701 nm, respectively, 
compared with its starting BODIPY dye (2) (Table 7). Both 
alkoxymonostyryl- and alkoxydistyryl-substituted BODIPY 
dyes ( 4,5) exhibit low fluorescence quantum yields because 
of heavy atom effect. Palladium-catalyzed Sonogashira 
polymerization of alkoxymonostyryl- and alkoxydistyryl-
substituted BODIPY dyes (4,5) with 2,6-diethynyl-substi-
tuted BODIPY (6) resulted in near-infrared emissive 
BODIPY polymeric dyes (polymers A and B) with the 
45 further extended it-conjugation, respectively. Polymer A 
shows significant red shifts of 100 nm and 84 nm in 
absorption and emission with absorption and emission 
maxima of 679 nm and 715 nm, respectively, compared with 
its alkoxymonostyryl-substituted BODIPY monomeric dye 
50 (4). Polymer B display absorption and emission maxima at 
738 nm and 760 nm with significant red shifts of73 nm and 
59 nm in absorption and emission with, respectively, com-
pared with its alkoxydistyryl-substituted BODIPY mono-
a nitrogen atmosphere. Pd(PPh3 ) 4 (6 mg) was added to the 
flask in the glovebox under a nitrogen atmosphere. Anhy-
drous THF (40 mL) and diisopropylamine (40 mL) were 
added to the flask in a nitrogen atmosphere. When the 
mixture was stirred under reflux for 24 h, the mixture was 55 
added dropwise to 500 mL of ethanol to precipitate the 
polymer. The precipitated polymer was collected, washed 
with water, ethanol, acetone and hexane and dried under 
vacuum for 24 h at room temperature to obtain dark-violet 
solid (0.132 g). 1H NMR (400 MHz, CDC13 ): 56.95 (br.s, 
lH), 6.45 (br. s, 2H), 4.02 (br. s, 2H), 3.91 (br. s, 4H), 2.67 
(br. s, 6H), 1.77 (br. t, 4H), 1.64 (br.s, 6H), 1.49-1.44 (br. m, 
6H), 1.24 (br. m, 72H), 0.85 (br. t, 12H) ppm. 13C NMR (100 
MHz, CDC13 ): Ii 158.7, 154.6, 147.5, 143.2, 142.5, 139.2, 
132.4, 131.5, 115.8, 106.3, 90.2, 88.8, 73.9, 69.7, 32.2, 32.1, 
30.5, 30.3, 29.9, 29.8, 29.6, 29.5, 26.3, 26.2, 22.9, 14.3, 13.9, 
13.5 ppm. IR (cm- 1): 2921, 2852, 1525, 1315, 1229, 1111, 
meric dye (5) (FIGS. 30 and 31). 
Palladium-catalyzed Sonogashira polymerization of 
alkoxydistyryl- and alkoxymonostyryl-substituted BODIPY 
dyes (5,4) with 2,5-diethynyl-3-decylthiophene (10) resulted 
in near-infrared and deep-red emissive BODIPY copoly-
meric dyes with emission maxima of 758 nm and 694 nm 
60 (polymers C and D), respectively (FIG. 32). Palladium-
catalyzed Sonogashira polymerization of 2,6-diethynyl-sub-
stituted BODIPY dyes (6) with 2,5-diiodo-3-decylthiophene 
(8) resulted in red emissive BODIPY copolymeric dye with 
emission maxima of 634 nm and 669 nm (polymers E), 
65 respectively. All BODIPY copolymeric dyes display low 
fluorescence quantum yields because of heavy sulfur atom 
effect (Table 7). 
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Solid-state absorption and emission spectra were col-
lected to evaluate effect of the polymer aggregation on their 
optical properties as the absorption and emission spectra of 
the film reflect polymer Jt-Jt stacking effects. The solid state 
film was prepared by spin-casting methylene chloride solu-
tions of the polymers onto quartz discs. The absorption 
spectra of the polymers in thin films became a little broader, 
and maximum peaks were obviously red-shifted compared 
with those in methylene chloride solutions. The fluorescence 
spectra of the polymers in solid state thin films retain most 
of the spectra features in solution and exhibit further red 
shifts with their absorption and emission maxima in near-
infrared region compared with those in methylene chloride 
solution, indicating the presence of intermolecular electronic 
interaction and/or increase in coplanarity of the polymer in 
the solid state (Table 8). 
TABLE 7 
70 
photometer. Fluorescence spectra were recorded on a Spex 
Fluorolog 1681 0.22 m steady-state fluorometer. Fluores-
cence quantum yields of BODIPY dyes and polymers were 
measured in methylene chloride and D MF, and calculated by 
5 using fluorescein excited at 490 nm in 0.1 N NaOH as the 
reference quantum efficiency ( <Pn =85% ).30031 Molecular 
weights of the polymers were determined by gel permeation 
chromatography (GPC) by using a Waters Associates Model 
6000A liquid chromatograph. Three American Polymer 
10 Standards Corp. Ultrastyragel columns in series with poros-
ity indices of 103 , 104 , and 105 A were used and housed in 
an oven thermostated at 30° C. Mobile phase was HPLC 
grade THF which was filtered and degassed by vacuum 
filtration through a 0.5 µm fluoropore filter prior to use. The 
15 polymers were detected by a Waters Model 440 ultraviolet 
absorbance detector at a wavelength of 254 nm and a Waters 
Absorption and emission maxima, fluorescence quantum yields and lifetimes of 
BODIPY dyes and 12olymeric dyes in methylene chloride solution 
BODIPY dyes or 12olymers 
2 3 4 5 6 A 
absorption maxima (nm) 500 533 597 665 539 697 
emission maxima (nm) 510 548 631 701 554 715 
Quantum yield(%) 80 5.7 2.6 4 52 11 
fluorescence lifetime (ns) 3.8 1.7 1.75 2.32 3 0.86 
TABLE 8 
Absorption and Emission Maxima of thin films on quartz surface 
Thin film Thin film 
BODIPY polymers 
Thin film 
Polymer A Polymer B Polymer E 
absorption maxima (nm) 
emission maxima (nm) 
759 
769 
Thermal Stabilities of the Polymers. 
784 706 
810 727 
Thermal stabilities of BODIPY polymeric and copoly-
meric dyes were evaluated by thermogravimetrc analysis 
(TGA) at the heating rate of 20° C./min under nitrogen 
atmosphere. The thermograms show that polymers A, B and 
C lost 5% of their weight at 250° C. (the decomposition 
temperature (T d) that corresponds to weight loss of 5% ), 
respectively, which suggests their good thermal stability 
(FIG. 33). Differential scanning calorimetry (DSC) of poly-
mers did not give a clear phase, may be because of rigid 
backbone of the BODIPY. 
Example 13 
Synthesis of Fluorescent Conjugated 
Glycopolymers A-C 
The structures of Polymers A-C are shown in FIG. 34. 
Experimental Section 
Instrumentation 
1 H NMR and 13C NMR spectra were taken on a 400 MHz 
Varian Unity Inova spectrophotometer instrument. 1 H and 
13C NMR spectra were recorded in CDC13 , chemical shifts 
(o) are given in ppm relative to solvent peaks (1H: o 7.26; 
13C: o 77.3) as internal standard. UV spectra were taken on 
a Hewlett Packard 8452A Diode Array UV-visible spectra-
B C D E 
738 713 649 634 
760 758 694 669 
13 1.3 1.1 1.2 
0.71 0.52 0.69 0.41 
30 Model 2410 refractive index detector. Molecular weights 
were measured relative to polystyrene standards. 
Materials. 
Unless otherwise indicated, all reagents and solvents were 
35 obtained from commercial suppliers (Aldrich, Sigma, Fluka, 
Acros Organics, Fisher Scientific, Lancaster), and were used 
without further purification. Air- and moisture-sensitive 
reactions were conducted in oven-dried glassware using 
standard Schlenk line or dry box techniques under an inert 
40 atmosphere of dry nitrogen. 
Polymer A 
The synthetic route to Polymer A is shown in FIG. 35 and 
45 detailed below. 
Compound 1 a: 
When 150 mL of degassed DMF was added to in a 500 
mL three-neck round-bottom flask containing 4-hydroxy-
bezaldehyde (40.9 mmol, 5 g), 1-bromododecane (49.2 
50 mmol, 12.2 g) and K2C03 (122 mmol, 16.8 g) under a 
nitrogen atmosphere, the mixture was stirred for 4 hours at 
80° C. under a nitrogen atmosphere. After completion of the 
reaction (which was monitored by TLC), the reaction mix-
55 ture was concentrated under reduced pressure, added to 
water and extracted with EtOAc. The organic layer was 
washed twice with water and saturated NaCl solution, dried 
over anhydrous MgS04 and concentrated under reduced 
pressure. The resulting crude product was purified by silica 
60 gel column chromatography using hexane/EtOAc (80/20, 
v/v) to obtain brown liquid (11.6 g, 98%). 1H NMR (400 
MHz, CDC13 ) o 9.86 (s, lH), 7.81 (d, J=8.8 Hz, 2H), 6.97 
(d, J=8.8 Hz, 2H), 4.01 (t, 1=6.6 Hz, 2H), 1.81-1.77 (m, 2H), 
1.46-1.44 (m, 2H), 1.42-1.25 (m, 16H), 0.86 (t, J=6.8 Hz, 
65 3H); 13C NMR (100 MHz, CDC13 ) o 191.0, 164.9, 132.2, 
130.0, 115.0, 68.6, 32.1, 29.8, 29.7, 29.5, 29.2, 26.1, 22.9, 
14.3. 
US 9,623,123 B2 
71 
Compound 3a: 
la (17.4 mmol, 5.06 g) and 2,4-dimethylpyrrole (34.9 
mmol, 3.32 g) were dissolved in 1200 mL of dry CH2Cl2 in 
a 2000-mL three-neck flask. Eight drops ofTFA were added 
to the reaction mixture, and resulting mixture was stirred in 5 
dark for 12 hours under nitrogen atmosphere at room 
temperature. After the complete consumption of aldehyde 
(la) (which was conformed by TLC), DDQ (2,3-dichloro-
5,6-dicyano-l,4-benzoquinone) (17.4 mmol 3.95 g) in 100 
mL ofCH2 Cl2 was added to the reaction mixture. When the 10 
mixture was stirred for 30 minutes, 35 mL of diisopropyl-
ethylamine (DIEA) and 35 mL of BF3 .0Et2 were added to 
the mixture. After the mixture was further stirred for 30 
minutes, it was concentrated to 200 mL and filtered. The 
filtrate was washed once with sodium bicarbonate solution 15 
and twice with water, dried over anhydrous MgS04 and 
concentrated under reduced pressure. The crude product was 
purified by colunm chromatography using hexane/EtOAc 
(90/10 to 70/30, v/v) to obtain dark brown crystalline solid 
(3.15 g, 36%). 1H NMR (400 MHz, CDC13 ) ll 7.13 (d, 1=8.4 20 
Hz, 2H), 6.97 (d, 1=8.4 Hz, 2H), 5.95 (s, 2H), 3.99 (t, 1=6.6 
Hz, 2H), 2.53 (s, 6H), 1.82-1.78 (m, 2H), 1.49-1.42 (m, SH), 
1.36-1.26 (m, 16H), 0.87 (t, 1=6.6 Hz, 3H); 13C NMR (100 
MHz, CDC13 ) Ii 159.9, 155.4, 143.4, 142.2, 132.1, 129.3, 
127.0, 121.3, 115.3, 68.4, 32.1, 29.9, 29.8, 29.6, 29.5, 29.4, 25 
26.3, 22.9, 14.8, 14.3. IR(cm- 1): 2922, 2850, 1540, 1508, 
1465, 1408, 1306, 1247, 1182, 1155, 1084, 971, 832, 811, 
704. ESI-MS. M+ (C31 H43BF2N20) Calcd: m/z=508.5. 
Found: m/z=509.2. 
72 
CDC13 ) Ii 7.08 (d, 1=8.8 Hz, 2H), 6.98 (d, 1=8.8 Hz, 2H), 
4.00 (t, 1=6.6 Hz, 2H), 2.61 (s, 6H), 1.83-1.79 (m, 2H), 
1.47-1.46 (m, SH), 1.36-1.25 (m, 16H), 0.87 (t, 1=6.6 Hz, 
3H), 0.19 (s, 18H); 13C NMR (100 MHz, CDC13 ) Ii 160.3, 
158.7, 145.2, 143.3, 131.7, 129.2, 126.3, 116.2, 115.4, 
101.8, 97.4, 68.5, 32.1, 29.9, 29.8, 29.6, 29.5, 29.4, 29.2, 
26.3, 22.9, 14.4, 13.8, 0.28. 11B NMR (400 MHz, CDC13 ): 
3.82 (t, 1=97.6 MHz). IR(cm- 1): 2922, 2853, 2150, 1608, 
1526, 1469, 1393, 1365, 1316, 1247, 1195, 1093, 833, 703. 
ESI-MS. M+ (C41H59BF2N20Si2 ) Calcd: m/z=700.9. 
Found: m/z=700.9. 
Compound 6a: 
When compound 5a (2.1 mmol, 1.50 g) was dissolved in 
degassed THF (8 mL) in a 100-mL flask at -70° C., 
tetrabutylammonium fluoride (TBAF) (5.2 mmol, 1.3 g, 5.2 
mL of IM solution) was added dropwise to the mixture via 
syringe. The reaction temperature was brought to the room 
temperature and the mixture was further stirred for 2 hours. 
After completion of the reaction, the mixture was acidified 
with acetic acid and extracted with CH2Cl2 . The extracted 
organic layer washed twice with water and saturated saline 
solution, dried over anhydrous MgS04 , and concentrated 
under reduced pressure. The crude product was purified by 
column chromatography using hexane/EtOAc (20/80, v/v) 
to give the desired product as orange-pink crystalline solid 
(0.84 g, 72%). 1H NMR (400 MHz, CDC13 ) ll 7.11 (d, 1=8.8 
Hz, 2H), 7.00 (d, 1=8.8 Hz, 2H), 4.00 (t, 1=6.6 Hz, 2H), 3.3 
(s, 2H), 2.63 (s, 6H), 1.83-1.79 (m, 2H), 1.51-1.46 (m, SH), 
1.44-1.26 (m, 16H), 0.87 (t, 1=6.6 Hz, 3H); 13C NMR (100 
Compound 4a: 
When iodic acid (12.3 mmol, 2.18 g) in 5 mLofwaterwas 
added dropwise to the ethanol solution (50 mL) containing 
compound 3a (5.9 mmol 3.0 g) and iodine (12.9 mmol 1.65 
g) over 30 minutes, the mixture was stirred for 2 hours. After 
the completion of the reaction, the unreacted iodine was 
quenched with sodium thiosulphate and the mixture was 
concentrated under reduced pressure and dissolved in 
CH2 Cl2 , and washed twice with water and saturated saline 
solution. The organic layer was collected, dried over anhy-
drous MgS04 and concentrated under reduced pressure. The 
crude product was purified by colunm chromatography to 
yield 4a as red crystals ( 4.4 g, 98% ). 1 H NMR ( 400 MHz, 
CDC13 ) Ii 7.10 (d, 1=8.8 Hz, 2H), 7.00 (d, 1=8.8 Hz, 2H), 
4.00 (t, 1=6.6 Hz, 2H), 2.62 (s, 6H), 1.84-1.80 (m, 2H), 
1.48-1.43 (m, SH), 1.38-1.26 (m, 16H), 0.87 (t, 1=6.6 Hz, 
3H); 13C NMR (100 MHz, CDC13 ) Ii 160.4, 156.7, 145.6, 
142.0, 132.0, 129.2, 126.6, 115.6, 85.8, 68.5, 32.2, 29.9, 
29.8, 29.7, 29.6, 29.5, 26.3, 22.9, 17.4, 16.2, 14.4; IR 
(cm- 1): 2923, 2853, 1528, 1465, 1398, 1344, 1307, 1248, 
1178, 998. M+ (C31 H41 BF2I2N2 0) Calcd: m/z=760.3. 
Found: m/z=760.0. 
30 MHz, CDC13 ) Ii 160.3, 158.8, 145.8, 143.3, 131.6, 129.2, 
126.2, 115.5, 115.2, 84.2, 76.2, 68.5, 32.1, 29.9, 29.8, 29.6, 
29.5, 29.4, 26.2, 22.9, 14.3, 13.7; 118 NMR (400 MHz, 
CDC13 ): 3.82 (t, 1=97.6 MHz). IR(cm- 1): 3299, 2921, 2852, 
2105, 1726, 1602, 1532, 1468, 1392, 1313, 1288, 1248, 
Compound 5a: 
Compound 4a (3.28 mmol, 2.5 g), Cul (0.02 mmol, 0.004 
g) and Pd(PPh3 ) 2Cl2 (0.02 mmol, 0.015 g) were added to a 
250-mL three-neck round-bottom flask under a nitrogen 
atmosphere. When 20 mL of anhydrous degassed THF, 30 
mL of anhydrous diisopropylamine, and trimethylsilylacety-
lene (8.2 mmol, 0.8 g) were added to the flask, the mixture 
was stirred under reflux for 12 hours. After the completion 
35 1161, 1125, 1070, 1007, 833, 800, 708. ESI-MS. M+ 
(C35H43BF2N20) Calcd: m/z=556.5. Found: m/z=557.2. 
Polymer A: 
Compound 4a (0.133 mmol, 0.100 g), compound 6a 
(0.144 mmol, 0.080 g), Cul (0.01 mmol, 0.002 g) were 
40 added to 100-mL flask under a nitrogen atmosphere. In the 
glove box, Pd(PPh3 ) 4 (0.01 mmol, 0.012 g) was added to the 
flask. When a degassed mixed solution of anhydrous THF 
(20 mL) and anhydrous diisopropylamine (20 mL) were 
added to the flask, the mixture was stirred under reflux for 
45 24 hours. After removal of the solvent, the residue was 
dissolved in methylene chloride (5 mL) added to 400 mL of 
ethanol and stirred for 2 hrs to precipitate the polymer. The 
precipitated solid was filtered and washed with excess 
ethanol and hexane. The obtained solid dried under vacuum 
50 for 24 h at room temperature to obtain dark-violet solid 
(0.150 g). 1H NMR (400 MHz, CDC13 ) ll 7.09 (br, 2H), 6.99 
(br, 2H), 3.99 (br, 2H), 2.62 (s, 6H), 1.82 (br, 2H), 1.66 (br, 
6H), 1.51 (br, 4H), 1.26 (br, 14H), 0.87 (br, 3H); 13C NMR 
(100 MHz, CDC13 ) Ii 160.3, 158.8, 145.7, 142.3, 131.7, 
55 129.1, 126.2, 115.5, 113.6, 88.9, 68.5, 32.1, 29.9, 29.8, 29.6, 
29.5, 29.4, 26.2, 22.9, 14.3, 13.7; IR(cm- 1): 3675, 2988, 
2972, 2902, 1406, 1394, 1383, 1249, 1242, 1230, 1075, 
1066, 1057, 892, 880. 
of the reaction (which was monitored by TLC), the reaction 60 
mixture was concentrated and dissolved in 50 mL of 
CH2 Cl2 , washed twice with water and saturated saline 
solution. The organic layer was collected, dried over anhy-
drous MgS04 , and concentrated under reduced pressure. 
The product was purified by neutralized silica gel column 65 
chromatography using hexane/EtOAc (95/5 to 80/20, v/v) to 
yield orange-red solid (1.86 g, 81%). 1H NMR (400 MHz, 
Polymer B 
The synthetic route to Polymer B is shown in FIG. 36 and 
detailed below. 
Compound lb: 
When 150 mL of degassed DMF was added to in a 500 
mL three-neck round-bottom flask containing 3,4-dihy-
droxybezaldehyde (22.3 mmol, 3 g), 1-bromododecane 
US 9,623,123 B2 
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(49.2 mmol, 12.2 g) and K2 C03 (122 mmol, 16.8 g) under 
a nitrogen atmosphere, the mixture was stirred for 4 hours at 
80° C. under a nitrogen atmosphere. After completion of the 
reaction (which was monitored by TLC), the reaction mix-
ture was concentrated under reduced pressure, added to 5 
water and extracted with EtOAc. The organic layer was 
washed twice with water and saturated NaCl solution, dried 
over anhydrous MgS04 and concentrated under reduced 
pressure. The resulting crude product was purified by silica 
gel colunm chromatography using hexane/EtOAc (80/20, 10 
v/v) to obtain white solid (10.3 g, 98%). 1H NMR (400 
MHz, CDC13 ) Ii 9.81 (s, lH), 7.41-7.37 (m, 2H), 6.93 (d, 
1=8.4 Hz, lH), 4.08-4.02 (m, 4H), 1.86-1.80 (m, 4H), 
1.47-1.44 (m, 4H), 1.34-1.24 (m, 32H), 0.86 (t, 1=6.8 Hz, 
6H); 13C NMR (100 MHz, CDC13 ) Ii 191.2, 154.9, 149.7, 15 
130.1, 126.8, 112.0, 111.2, 69.3, 32.1, 29.9, 29.8, 29.7, 29.6, 
29.5, 29.3, 29.2, 26.2, 26.1, 22.9, 14.3. 
Compound 3b. 
lb (17.4 mmol, 8.25 g) and 2,4-dimethylpyrrole (34.88 
mmol, 3.32 g) were dissolved in 1200 mL of dry CH2Cl2 in 20 
a 2000-mL three-neck flask. Eight drops ofTFA were added 
to the reaction mixture, and resulting mixture was stirred in 
dark for 12 hours under nitrogen atmosphere at room 
temperature. After the complete consumption of aldehyde 
(lb) (which was conformed by TLC), DDQ (2,3-dichloro- 25 
5,6-dicyano-1,4-benzoquinone) (17.4 mmol 3.95 g) in 100 
mL of CH2 Cl2 was added to the reaction mixture. When the 
mixture was stirred for 30 minutes, 35 mL of diisopropyl-
ethylamine (DIEA) and 35 mL of BF3 .0Et2 were added to 
the mixture. After the mixture was further stirred for 30 30 
74 
1508, 1463, 1397, 1345, 1311, 1263, 1243, 1213, 1184, 
1140, 1119, 1082, 992, 915, 759, 724. ESI-MS. M+ 
(C43H65BF2 I2 N20 2 ) Calcd: m/z=944.6. Found: m/z=944.7. 
Compound 5b. 
Compound 4b (3.2 mmol, 3.0 g), Cul (0.02 mmol, 0.004 
g) and Pd(PPh3 ) 2Cl2 (0.02 mmol, 0.015 g) were added to a 
250-mL three-neck round-bottom flask under a nitrogen 
atmosphere. When 20 mL of anhydrous degassed THF, 30 
mL of anhydrous diisopropylamine, and trimethylsilylacety-
lene (8.0 mmol, 0.78 g) were added to the flask, the mixture 
was stirred under reflux for 12 hours. After the completion 
of the reaction (which was monitored by TLC), the reaction 
mixture was concentrated and dissolved in 50 mL of 
CH2Cl2 , washed twice with water and saturated saline 
solution. The organic layer was collected, dried over anhy-
drous MgS04 , and concentrated under reduced pressure. 
The product was purified by neutralized silica gel column 
chromatography using hexane/EtOAc (95/5 to 80/20, v/v) to 
yield orange-red solid (2.2 g, 80%). 1H NMR (400 MHz, 
CDC13 ) ll 6.95 (d, 1=8.4 Hz, lH), 6.73-6.70 (m, 2H), 4.02 (t, 
1=6.8 Hz, 2H), 3.92 (t, 1=6.8 Hz, 2H), 2.62 (s, 6H), 1.87-
1.78 (m, 4H), 1.55 (s, 6H), 1.52-1.24 (m, 32H), 0.88-0.84 
(m, 6H), 0.19 (s, 18H); 13C NMR (100 MHz, CDC13 ) Ii 
158.8, 150.2, 145.1, 143.1, 131.5, 126.6, 120.4, 116.3, 
114.1, 113.2, 101.8, 97.4, 69.7, 69.5, 32.1, 29.9, 29.8, 29.8, 
29.7, 29.6, 29.5, 29.4, 26.3, 26.2, 22.9, 14.3, 13.7, 0.28; 11 B 
NMR (400 MHz, CDC13 ): 3.82 (t, 1=97.6 MHz). IR(cm- 1): 
2919,2850,246, 1531, 1517, 1470, 1391, 1316, 1268, 1249, 
1197, 1139, 1092, 1072, 1013, 1003, 840, 761, 725, 700. 
ESI-MS. M+ (C53H83BF2N2 0 2 Si2 ) Calcd: m/z=885.2. 
Found: m/z=885.3. 
Compound 6b. 
When compound 5b (2.2 mmol, 2.0 g) was dissolved in 
degassed THF (50 mL) in a 250-mL flask at -70° C., 
minutes, it was concentrated to 200 mL and filtered. The 
filtrate was washed once with sodium bicarbonate solution 
and twice with water, dried over anhydrous MgS04 and 
concentrated under reduced pressure. The crude product was 
purified by colunm chromatography using hexane/EtOAc 
(90/10 to 80/20, v/v) to obtain dark brown crystalline solid 
(4.2 g, 35%). 1H NMR (400 MHz, CDC13 ) Ii 6.94 (d, 1=8.8 
Hz, lH), 6.77-6.75 (m, 2H), 5.96 (s, 2H), 4.02 (t, 1=6.8 Hz, 
2H), 3.93 (t, 1=6.8 Hz, 2H), 2.53 (s, 6H), 1.86-1.77 (m, 4H), 
1.46 (s, 6H), 1.43-1.24 (m, 32H), 0.88-0.85 (m, 6H); 13C 
NMR (100 MHz, CDC13 ) Ii 155.5, 150.0, 149.8, 143.4, 
142.1, 132.2, 127.3, 121.2, 120.6, 115.0, 113.6, 69.7, 69.4, 
32.1, 29.9, 29.8, 29.7, 29.6, 29.5, 29.4, 29.1, 26.3, 26.1, 22.9, 
14.8, 14.6, 14.3; IR(cm- 1): 2921, 2852, 1543, 1509, 1467, 
1412, 1372, 1306, 1263, 1156, 1136, 1121, 1084, 979,817, 
760, 723. ESI-MS. M+ (C43H67BF2 N2 0 2 ) Calcd: 
m/z=692.8. Found: m/z=693.1. 
35 tetrabutylammonium fluoride (TBAF) (5.6 mmol, 1.47 g, 
5.6 mL of IM solution) was added dropwise to the mixture 
via syringe. The reaction temperature was brought to the 
room temperature and the mixture was further stirred for 2 
hours. After completion of the reaction, the mixture was 
Compound 4b. 
When iodic acid (12.1 mmol, 2.13 g) in 5 mLofwaterwas 
added dropwise to the ethanol solution (50 mL) containing 
compound 3b (5.7 mmol 4.0 g) and iodine (12.9 mmol 1.62 
40 acidified with acetic acid and extracted with CH2Cl2 . The 
extracted organic layer washed twice with water and satu-
rated saline solution, dried over anhydrous MgS04 , and 
concentrated under reduced pressure. The crude product was 
purified by column chromatography using hexane/EtOAc 
45 (20/80, v/v) to give the desired product as orange-pink 
crystalline solid (1.1 g, 70%). 1H NMR (400 MHz, CDC13 ) 
Ii 6.96 (d, 1=8.4 Hz, lH), 6.73-6.72 (m, 2H), 4.04 (t, 1=6.8 
Hz, 2H), 3.92 (t, 1=6.8 Hz, 2H), 3.3 (s, 2H), 2.63 (s, 6H), 
1.87-1.61 (m, 4H), 1.51 (s, 6H), 1.49-1.24 (m, 32H), 0.88-
50 0.84 (m, 6H); 13C NMR (100 MHz, CDC13 ) ll 158.8, 150.2, 
145.8, 143.6, 131.5, 126.4, 120.4, 115.2, 114.0, 113.1, 84.3, 
76.2, 69.7, 69.4, 32.1, 29.9, 29.8, 29.7, 29.6, 29.4, 26.3, 26.1, 
22.9, 14.3, 13.7, 13.6; 11B NMR (400 MHz, CDC13 ): 3.82 (t, 
1=97.6 MHz). IR(cm- 1): 3309, 2921, 2852, 2107, 1526, 
g) over 30 minutes, the mixture was stirred for 2 hours. After 
the completion of the reaction, the unreacted iodine was 
quenched with sodium thiosulphate solution and the mixture 
was concentrated under reduced pressure and dissolved in 
CH2 Cl2 , and washed twice with water and saturated saline 
solution. The organic layer was collected, dried over anhy-
drous MgS04 and concentrated under reduced pressure. The 
crude product was purified by colunm chromatography to 
yield 4b as red crystals (5.2 g, 98%). 1H NMR (400 MHz, 60 
CDC13 ) Ii 6.96 (d, 1=8.4 Hz, lH), 6.73-6.71 (m, 2H), 4.04 (t, 
1=6.8 Hz, 2H), 3.92 (t, 1=6.8 Hz, 2H), 2.62 (s, 6H), 1.87-
1.77 (m, 4H), 1.48 (s, 6H), 1.45-1.24 (m, 32H), 0.88-0.84 
(m, 6H); 13C NMR (100 MHz, CDC13 ) Ii 156.8, 150.3, 
150.2, 145.6, 141.8, 131.9, 127.0, 120.5, 114.1, 113.2, 85.7, 65 
69.7, 69.5, 32.1, 29.9, 29.8, 29.7, 29.6, 29.5, 29.4, 26.2, 26.1, 
22.9, 17.2, 16.2, 14.3; IR(cm- 1): 2917, 2849, 1542, 5122, 
55 1468, 1403, 1390, 1366, 1312, 1263, 1180, 1137, 1080, 
1003, 761, 725. ESI-MS. M+ (C47H67BF2 N20 2 ) Calcd: 
m/z=740.8. Found: m/z=739.1. 
Polymer B. 
Compound 4b (0.105 mmol, 0.100 g), compound 6b 
(0.115 mmol, 0.085 g), Cul (0.01 mmol, 0.002 g) were 
added to 100-mL flask under a nitrogen atmosphere. In the 
glove box, Pd(PPh3 ) 4 (0.01 mmol, 0.012 g) was added to the 
flask. When a degassed mixed solution of anhydrous THF 
(20 mL) and anhydrous diisopropylamine (20 mL) were 
added to the flask, the mixture was stirred under reflux for 
24 hours. After removal of the solvent, the residue was 
dissolved in methylene chloride (5 mL) added to 400 mL of 
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ethanol and stirred for 2 hrs to precipitate the polymer. The 
precipitated solid was filtered and washed with excess 
ethanol and hexane. The obtained solid dried under vacuum 
for 24 h at room temperature to obtain dark-violet solid 
(0.155 g). 1H NMR (400 MHz, CDC13 ) ll 6.94 (br, lH), 6.73 5 
(br, 2H), 4.02 (br, 2H), 3.92 (br, 2H), 2.62 (s, 6H), 1.84 (br, 
2H), 1.79 (br, 2H), 1.56 (s, 6H), 1.49-1.24 (m, 32H), 
0.88-0.86 (m, 6H); 13C NMR (100 MHz, CDC13 ) Ii 157.9, 
150.0, 143.2, 142.5, 134.8, 131.6, 120.3, 116.3, 113.8, 113.1, 
88.8, 69.5, 69.3, 31.9, 29.7, 29.6, 29.5, 29.4, 29.2, 26.0, 22.7, lO 
16.9, 14.1, 13.5; IR(cm- 1): 2921, 2852, 1514, 1467, 1435, 
1389, 131~ 1262, 1227, 1162, 1083, 995,813, 76~ 724. 
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NMR (100 MHz, CDC13 ) Ii 191.4, 153.7, 144.1, 131.7, 
108.1, 73.8, 69.4, 32.1, 30.6, 29.9, 29.8, 29.6, 29.5, 26.3, 
26.2, 22.9, 14.3. 
Compound 3c. 
le (17.4 mmol, 11.4 g) and 2,4-dimethylpyrrole (34.88 
mmol, 3.32 g) were dissolved in 1200 mL of dry CH2Cl2 in 
a 2000-mL three-neck flask. Eight drops ofTFA were added 
to the reaction mixture, and resulting mixture was stirred in 
dark for 12 hours under nitrogen atmosphere at room 
temperature. After the complete consumption of aldehyde 
(le) (which was conformed by TLC), DDQ (2,3-dichloro-
5,6-dicyano-l,4-benzoquinone) (17.4 mmol 3.95 g) in 100 
mL of CH2 Cl2 was added to the reaction mixture. When the 
mixture was stirred for 30 minutes, 35 mL of diisopropyl-Polymer C 
The synthetic route to Polymer C is shown in FIG. 37 and 
detailed below. 
15 ethylamine (DIEA) and 35 mL ofBF3 .0Et2 were added to 
the mixture. After the mixture was further stirred for 30 
Compound 02. 
When 200 mL of degassed DMF was added to in a 500 20 
mL three-neck round-bottom flask containing methyl-3,4,5-
trihydroxybenzoate (13.6 mmol, 2.5 g), 1-bromododecane 
(47.6 mmol, 11.8 g) and K2C03 (54 mmol, 7.5 g) under a 
nitrogen atmosphere, the mixture was stirred for 4 hours at 
80° C. under a nitrogen atmosphere. After completion of the 25 
reaction (which was monitored by TLC), the reaction mix-
ture was concentrated under reduced pressure, added to 
water and extracted with hexane. The organic layer was 
washed twice with water and saturated NaCl solution, dried 
over anhydrous MgS04 and concentrated under reduced 30 
pressure. The resulting crude product was purified by silica 
gel colunm chromatography using hexane/EtOAc (98/2, v/v) 
to obtain white solid (9.2 g, 98%). 1H NMR (400 MHz, 
CDC13 ) ll 7.23 (s, 2H), 4.02-4.00 (m, 6H), 3.86 (s, 3H), 1.80 35 ( q, 1=6.8 Hz, 6H), 1.49-1.44 (m, 6H), 1.33-1.25 (m, 48H), 
0.88-0.84 (m, 9H); 13C NMR (100 MHz, CDC13 ) Ii 167.1, 
153.0, 142.6, 124.9, 108.2, 73.7, 69.4, 52.3, 32.1, 30.5, 29.9, 
29.8, 29.7, 29.6, 29.5, 26.3, 26.1, 22.9, 14.3. 
minutes, it was concentrated to 200 mL and filtered. The 
filtrate was washed once with sodium bicarbonate solution 
and twice with water, dried over anhydrous MgS04 and 
concentrated under reduced pressure. The crude product was 
purified by column chromatography using hexane/EtOAc 
(95/5 v/v) to obtain dark brown crystalline solid ( 4.5 g, 
30%). 1H NMR (400 MHz, CDC13 ) Ii 6.45 (s, 2H), 5.97 (s, 
2H), 3.99 (t, 1=6.4 Hz, 2H), 3.90 (t, 1=6.4 Hz, 4H), 2.53 (s, 
6H), 1.75 (q, 1=6.8 Hz, 6H), 1.52 (s, 6H), 1.48-1.42 (m, 6H), 
1.40-1.24 (m, 48H), 0.88-0.85 (m, 9H); 13C NMR (100 
MHz, CDC13 ) Ii 155.6, 154.3, 143.3, 142.0, 138.9, 131.6, 
129.8, 121.2, 106.6, 73.9, 69.6, 32.1, 30.5, 29.9, 29.8, 29.6, 
29.5, 26.3, 26.2, 22.9, 14.7, 14.4, 14.3; IR (cm- 1): 2922, 
2853, 1544, 1509, 1467, 1417, 1373, 1327, 1307, 1156, 
1113, 1086, 1026, 977, 834, 804, 758, 721. ESI-MS. M+ 
(C55H91 BF2 N20 3 ) Calcd: m/z=877.1. Found: m/z=877.5. 
Compound 4c. 
When iodic acid (9.5 mmol, 1.6 g) in 5 mL of water was 
added dropwise to the ethanol solution (50 mL) containing 
compound 3c (4.5 mmol 4.0 g) and iodine (9.9 mmol 1.3 g) 
over 30 minutes, the mixture was stirred for 2 hours. After 
the completion of the reaction, the unreacted iodine was 
quenched with sodium thiosulphate solution and the mixture 
Compound 03. 
Compound 02 (13.1 mmol, 9 g) in 50 ml of dry diethy-
lether was added to LiAIH4 (26.2 mmol, 1 g) suspended in 
100 ml diethylether in a dry 250 mL three-neck round-
bottom flask. After stirring for 24 hrs, the reaction was 
quenched with ethanol and water at 0° C. the resulting 
solution was filtered and washed twice with water, dried 
over anhydrous MgS04 and concentrated under reduced 
pressure. The resulting crude product was purified by silica 
gel colunm chromatography to obtain white solid (5.6 g, 
65%). 1H NMR (400 MHz, CDC13 ) Ii 6.52 (s, 2H), 4.55 (s, 
2H), 3.96-3.91 (m, 6H), 3.60 (t, 1=6.4 Hz, lH), 1.79-1.68 
(m, 6H), 1.50-1.41 (m, 6H), 1.40-1.25 (m, 48H), 0.90-0.85 
(m, 9H); 13C NMR (100 MHz, CDC13 ) Ii 153.4, 137.7, 
136.3, 105.5, 73.6, 69.3, 65.8, 63.2, 33.0, 32.1, 30.5, 29.9, 
29.6, 26.3, 26.0, 22.9, 14.3. 
40 was concentrated under reduced pressure and dissolved in 
CH2Cl2 , and washed twice with water and saturated saline 
solution. The organic layer was collected, dried over anhy-
drous MgS04 and concentrated under reduced pressure. The 
crude product was purified by colunm chromatography to 
45 yield 4c as red crystals (4.8 g, 96%). 1H NMR (400 MHz, 
CDC13 ) Ii 6.41 (s, 2H), 4.01 (t, 1=6.4 Hz, 2H), 3.89 (t, 1=6.4 
Hz, 4H), 2.62 (s, 6H), 1.75 (q, 1=6.8 Hz, 6H), 1.53 (s, 6H), 
1.49-1.43 (m, 6H), 1.40-1.24 (m, 48H), 0.88-0.84 (m, 9H); 
13C NMR (100 MHz, CDC13 ) Ii 156.9, 154.6, 145.6, 141.7, 
50 139.2, 131.5, 129.4, 106.3, 85.7, 74.0, 70.0, 32.1, 30.5, 29.9, 
29.8, 29.6, 1368, 1343, 1330, 1305, 1166, 1115, 993, 918, 
831. ESI-MS. M+ (C55H89BF2 I2 N20 3 ) Calcd: m/z=1128.9. 
Found: m/z=1129.1. 
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Compound le. 
Compound 03 (8.3 mmol, 5.5 g) and pyridiniumchloro-
cromate (PCC) (12.4 mmol, 2.6 g) were taken in a 250 ml 
round bottom flask and 100 ml of dry CH2 Cl2 was added in 
nitrogen atmosphere. After refluxing for 4 hrs the mixture 60 
was filtered and the organic layer was washed with brine, 
dried over anhydrous MgS04 and concentrated under 
reduced pressure. The resulting crude product was purified 
by silica gel colunm chromatography to obtain white solid 
(5.1 g, 95%). 1H NMR (400 MHz, CDC13 ) Ii 9.81 (s, lH), 65 
7 .06 (s, 2H), 4.06-4.00 (m, 6H), 1.84-1.77 (m, 6H), 1.46-
1.42 (m, 6H), 1.33-1.25 (m, 48H), 0.88-0.85 (m, 9H); 13C 
Compound Sc. 
Compound 4c (3.5 mmol, 4.0 g), Cul (0.02 mmol, 0.004 
g) and Pd(PPh3 ) 2Cl2 (0.02 mmol, 0.015 g) were added to a 
250-mL three-neck round-bottom flask under a nitrogen 
atmosphere. When 20 mL of anhydrous degassed THF, 30 
mL of anhydrous diisopropylamine, and trimethylsilylacety-
lene (8.8 mmol, 0.86 g) were added to the flask, the mixture 
was stirred under reflux for 12 hours. After the completion 
of the reaction (which was monitored by TLC), the reaction 
mixture was concentrated and dissolved in 50 mL of 
CH2Cl2 , washed twice with water and saturated saline 
solution. The organic layer was collected, dried over anhy-
drous MgS04 , and concentrated under reduced pressure. 
The product was purified by neutralized silica gel colunm 
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chromatography using hexane/EtOAc (95/5 to 90/10, v/v) to 
yield orange-red solid (2.9 g, 78%). 1H NMR (400 MHz, 
CDC13) Ii 6.40 (s, 2H), 4.00 (t, 1=6.4 Hz, 2H), 3.88 (t, 1=6.4 
Hz, 4H), 2.61 (s, 6H), 1.76 (q, 1=6.8 Hz, 6H), 1.59 (s, 6H), 
1.49-1.43 (m, 6H), 1.40-1.24 (m, 48H), 0.88-0.84 (m, 9H), 5 
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B>polymer A as the introduction of more side chains to each 
BODIPY core enhances salvation of conjugated polymers. 
Photophysical Properties 
0.19 (s, 18H); 13C NMR (100 MHz, CDC13) ll 158.9, 154.5, The absorption properties of green emissive BODIPY dye 
145.1, 143.0, 139.1, 131.2, 129.1, 116.4, 106.2, 101.9, 97.3, (3a) are characterized by a strong S0-s1 (it-it*) transition at 
73.9, 69.7, 32.1, 30.5, 29.9, 29.8, 29.6, 29.5, 26.3, 26.2, 22.9, 501 nm and a weaker broad band around 350 nm ascribed to 
14.3, 13.7, 13.5, 0.28; IR(cm-1): 2922, 2853, 2151, 1536, the S0-s2 (it-it*) transition (FIG. 38). Introduction of 
1469, 1420, 1391, 1316, 1248, 1197, 1101, 1004, 943, 853, 10 2,6-diiodo substituents to the BODIPY core leads to a large 
760, 721. 118 NMR (400 MHz, CDC13): 3.82 (t, 1=97.6 red shifts (33 nm and 38 nm) of both the UV-absorption and fluorescence maxima, respectively, significantly depresses MHz). ESI-MS. M+ (C65H107BF2N20 3Si2 ) Calcd: 
m/z=l069 _5_ Found: m/z=l069 _5_ the fluorescence quantum yield because of efficient inter-
system crossing induced by the heavy atom effect of iodine 
Compound 6c. 15 (FIG. 38, Table 9). 2,6-Diethynylation of 2,6-diiodo-tetram-
When compound Sc (2.2 mmol, 2.4 g) was dissolved in ethyl BODIPY (4a) results in a little red shift due to the 
degassed THF (50 mL) in a 250-mL flask at -70° C., enhanced conjugation. However, polymer A emits in deep 
tetrabutylammonium fluoride (TBAF) (5.6 mmol, 1.47 g, red region at 680 nm, and exhibits pronounced bathochro-
5.6 mL of IM solution) was added dropwise to the mixture mic shifts (149 nm and 211 nm) of both the absorption and 
via syringe. The reaction temperature was brought to the 20 fluorescence maxima relative to the initial BODIPY dye (3a) 
room temperature and the mixture was further stirred for 2 because of its significant extension of it-conjugation (FIG. 
hours. After completion of the reaction, the mixture was 40 and Table 9). Polymer B displays an absorption maxi-
acidified with acetic acid and extracted with CH2 Cl2 . The mum at 662 nm and fluorescence maximum at 684 nm, a 
extracted organic layer washed twice with water and satu- slight red shifted relative to polymer A. Polymer C displays 
rated saline solution, dried over anhydrous MgS04, and 25 a slight red shift compared with polymer B as it shows 
concentrated under reduced pressure. The crude product was absorption maximum at 669 nm and fluorescence maximum 
purified by column chromatography using hexane/EtOAc at 690 nm (FIG. 40). The absorption peaks of conjugated 
(20/80, v/v) to give the desired product as dark orange-pink polymers become broader than BODIPY monomers due to 
crystalline solid (1.4 g, 72% ). 1 H NMR ( 400 MHz, CDCl3) the extended it-conjugation (FIG. 40). In addition, polymers 30 A, B and C display a little more Stokes shifts than their 
Ii 6.40 (s, 2H), 4.02 (t, 1=6.4 Hz, 2H), 3.90 (t, 1=6.4 Hz, 4H), corresponding BODIPY dyes (Table 9). BODIPY dyes (3a, 
3.3 (s, 2H), 2.62 (s, 6H), 1.75 (q, 1=6.8 Hz, 6H), 1.61 (s, 6H), 3b, 3c, 5a, 5b, Sc, 6a, 6b and 6c) show fluorescence lifetimes 
1.49-1.42 (m, 6H), 1.40-1.24 (m, 48H), 0.88-0.84 (m, 9H); in several nanoseconds (Table 9). However, the diiodo-
13C NMR (100 MHz, CDC13) ll 159.0, 154.5, 145.7, 143.4, functionalized BODIPY dyes (4a, 4b and 4c) display much 
139.2, 131.1, 129.0, 115.2, 106.3, 84.5, 76.1, 73.9, 69.7, 35 shorter fluorescence lifetimes (ranging from 0.15 ns to 0.21 
32.1, 31.1, 30.5, 29.9, 29.8, 29.6, 29.5, 26.3, 26.2, 25.8, 22.9, ns), consistent with their decreased quantum yields because 
14.3, 13.7, 13.5. 11 B of efficient intersystem crossing induced by the heavy atom 
NMR (400 MHz, CDCl3): 3.82 (t, 1=97.6 MHz). IR(cm- effect of iodine (Table 9). 
) 3300 2922 2853 2108 1526 1469 1420 1387 1334 Arylationatthemesopositionhasnosignificanteffecton 1: ' ' ' ' ' ' ' ' ' 1310, 1183, 1112, 1066, l003, 830, 720_ ESI-MS. M+ the absorption and emission maxima ofBODIPY dyes since 40 the arylated moiety is not coplanar with the BODIPY core (C59H91 BF2N2 0 3) Calcd: m/z=925.2. Found: m/z=925.1. d · hi cir l h h h b · · · · · ue to stenc n ance a t oug t e su st1tut10n pos1t10n 1s 
Polymer C. structurally different (Table 9). As a result, three different 
Compound 4c (0.13 mmol, 0.15 g), compound 6c (0.146 BODIPY monomers (4a-4c and 6a-6c) each have only 1 or 
mmol, 0.135 g), Cul (0.01 mmol, 0.002 g) were added to 2 nm difference among their respective absorption or emis-
100-mL flask under a nitrogen atmosphere. In the glove box, 45 sion spectral maxima. However, the absorption and emission 
Pd(PPh3)4 (0.01 mmol, 0.012 g) was added to the flask. maxima of polymer Care somewhat more red-shifted rela-
When a degassed mixed solution of anhydrous THF (20 mL) tive to those of polymers A and B, which might arise from 
and anhydrous diisopropylamine (20 mL) were added to the amplification effect of conjugated polymers. Polymers A, B 
flask, the mixture was stirred under reflux for 24 hours. After and C displays a little shorter fluorescence lifetimes than 
removal of the solvent, the residue was dissolved in meth- 50 their starting BODIPY dyes (3a, 3b and 4c) (Table 9). 
ylene chloride (5 mL), and added dropwise to 400 mL of 
ethanol to precipitate the polymer. The precipitated solid 
was collected by filtration and washed with excess ethanol 
and hexane. The obtained solid dried under vacuum for 24 55 
hat room temperature to obtain dark-violet solid (0.196 g). 
1H NMR (400 MHz, CDC13) Ii 6.42 (s, 2H), 3.99 (br, 2H), 
3.89 (br, 4H), 2.63 (s, 6H), 1.75 (br, 6H), 1.61 (s, 6H), 1.42 
(br, 6H), 1.24 (br, 48H), 0.86-0.85 (br, 9H). 13C NMR (100 
MHz, CDC13) Ii 158.2, 154.5, 143.3, 141.1, 139.3, 131.4, 
129.0, 115.2, 106.3, 94.6, 74.0, 69.7, 32.1, 31.1, 30.5, 29.9, 
29.8, 29.6, 29.5, 26.3, 26.2, 25.8, 22.9, 14.3, 13.7, 13.5; 
IR(cm-1): 2921, 2852, 1521, 1466, 1421, 1389, 1363, 1313, 
1229, 1167, 1092, 1000, 758, 721. 
Polymers A, B and C are soluble in common organic 
solvents such as chloroform, methylene chloride and THF. 
However, the solubility order is polymer C>polymer 
60 
65 
TABLE 9 
Absorption and emission maxima, and quantum yields of BODIPY 
dyes and polymers in metbylene chloride solution. Quantum yields 
of BODIPY dyes and polymeric dyes were determined by use of 
fluorescein (quantum yield of 0.85 in O.lN NaOH) as a standard. 
BODIPY dyes or polymers 
Polymer Thin film of 
3a 4a 5a 6a A polymer A 
Absorption 501 533 554 539 650 680 
maxima (nm) 
Emission 509 548 569 551 680 723 
maxima (nm) 
Quantum 2.3 
yield(%) 
US 9,623,123 B2 
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TABLE 9-continued 
Absorption and emission maxima, and quantum yields of BODIPY 
dyes and polymers in metbylene chloride solution. Quantum yields 
of BODIPY dyes and polymeric dyes were determined by use of 
fluorescein (quantum yield of 0.85 in O.lN NaOH) as a standard. 
Fluorescence 3.9 0.21 4.4 3.6 1.4 
lifetime (ns) 
Stokes shift 8 15 15 12 30 43 
(nm) 
BODIPY dyes or polymers 
Polymer Thin film of 
3b 4b Sb 6b B polymer B 
Absorption 502 534 555 540 662 728 
maxima (nm) 
Emission 510 549 5.70 5.52 684. 741 
maxima (nm) 
Quantum 2.7 
yield(%) 
Fluorescence 4.1 0.15 4.6 3.9 1.1 
lifetime (ns) 
Stokes shift 8 15 15 12 22 12 
(nm) 
BODIPY dyes or polymers 
Polymer Thin film of 
3c 4c Sc 6c C polymer C 
Absorption 503 535 556 541 669 726 
maxima (nm) 
Emission 511 550 570 553 690 743 
maxima (nm) 
Quantum 2.3 
yield(%) 
Fluorescence 3.2 0.19 4.4 3.0 1.6 
lifetime (ns) 
Stokes shift 9 15 14 12 19 19 
(nm) 
Thermal Stabilities of the Polymers. 
5 
10 
15 
20 
25 
30 
35 
80 
were measured in methylene chloride and calculated by 
using fluorescein exCited at 490 nm in 0.1 N NaOH as the 
reference ( quantum efliCiency, cPn=85% ). Fluorescence 
lifetimes were measured on a 010-3300 Nitrogen Laser 
laserstrobe PTI instrument and analyzed using FeliX32 
software. Molecular weights of the polymers were deter-
mined by gel permeation chromatography (OPC) by using a 
Waters AssoCiates model 6000A liquid chromatograph. 
Three American Polymer Standards Corp. ultrastyragel col-
unms in series with porosity indices of 103, 104, and 105 A 
were used and housed in an oven thermostatted at 30° C. The 
mobile phase was HPLC grade THF which was filtered and 
degassed by vacuum filtration through a 0.5, um fluoropore 
filter prior to use. The polymers were detected by a Waters 
Model 440 ultraviolet absorbance detector at a wavelength 
of 254 nm and a Waters Model 2410 refractive index 
detector. Molecular weights were determined relative to 
polystyrene standards. 
Materials. 
Unless otherwise indicated, all reagents and solvents were 
obtained from commerCial suppliers (Aldrich, Sigma, 
Fluka, Acros Organics, Fisher SCientific, Lancaster) and 
were used without further purification. Air- and moisture-
sensitive reactions were conducted in oven-dried glassware 
using a standard Schlenk line or drybox techniques under an 
inert atmosphere of dry nitrogen. 9,9-Bis-(6'-bromohexyl)-
2, 7-diido-9H-fluorene, 1,4-diiodo-2,5didecyloxybenzene 
(7b ), and 2,5-diiodo-3-decylthiophene (7C) were prepared 
according to the reported procedures. 
Polymer A 
The synthetic route to Polymer A is shown in FIG. 44 and 
is detailed below. 
Ethyl 4-( 4-Formylphenoxy)butanoate (la) 
When 150 mL of degassed DMF was added to a 500 mL 
three-neck round-bottom flask containing 4-hydroxybezal-
dehyde (40.9 mmol, 5 g), ethyl 4-bromobuterate (49.1 
mmol, 9.57 g), and K2 C03 (122 mmol, 16.8 g) under a 
40 nitrogen atmosphere, the mixture was stirred for 4 h at 80° 
C. under a nitrogen atmosphere. After completion of the 
reaction (which was monitored by TLC), the reaction mix-
ture was concentrated under reduced pressure. The residue 
was dissolved in 50 mL of EtOAc and washed twice with 
Thermal stabilities of polymers A, B and C were deter-
mined by thermogravimetrc analysis (TGA) at the heating 
rate of 20° C./min under nitrogen atmosphere. From the 
graphs, the thermal decomposition temperatures (T d) of the 
polymers ranged from 270 to 360° C., which suggests their 
good thermal stability. (FIG. 41) The small amount of 45 
weight loss of polymer C before its Td is probably due to 
decomposition of the oliogmers. Differential scanning calo-
rimetry (DSC) of polymers did not give a clear phase 
transition, which may arise from that polymer chain move-
ments are limited by their rigid structures. 
water and saturated NaCl solution. The organic layer was 
collected, dried over anhydrous MgS04, and concentrated 
under reduced pressure. The resulting crude product was 
purified by silica gel colunm chromatography using hexane/ 
EtOAc (70/30, v/v) to obtain white solid (9.36 g, 97%). 1H 
so NMR (400 MHz, CDC13 ): o 9.85 (s, IH), 7.80 (d, 1=8.8 Hz, 
2H), 6.99 (d, 1=8.8 Hz, 2H), 4.12 (q, 1=7.2 Hz, 2H), 4.07 (t, 
1=6.0 Hz, 2H), 2.50 (t, 1=7.2 Hz, 2H), 2.12 (q, 1=6.4, 2H), 
1.26 (t, 1=7.2 Hz, 3H). 13C NMR (100 MHz, CDC13 ): o 
190.9, 173.2, 164.1, 132.2, 130.2, 114.9, 67.3, 60.7, 30.8, 
Example 14 
Synthesis of Fluorescent Conjugated 
Glycopolymers A-E 
The structures of Polymers A-E are shown in FIG. 42 
Instrumentation. 
1H NMR and 13cNMR spectra were taken on a 400 MHz 
Varian Unity Inova spectrophotometer instrument. 1H and 
13c NMR spectra were recorded in CDC13 , and chemical 
shifts (o) are given in ppm relative to solvent peaks (1H, o 
7.26; 13C, o 77.3) as internal standard. UV spectra were 
taken on a Hewlett-Packard 8452A Diode Array UV-visible 
spectrophotometer. Fluorescence spectra were recorded on a 
Spex Fluorolog 1681 0.22 m steady-state fluorometer. Fluo-
rescence quantum yields of BODIPY dyes and polymers 
55 24.6, 14.4. 
BODIPY Dye 3a. 
Ethyl 4-(4-formylphenoxy)butanoate (la) (8.72 mmol, 
2.07 g) and 2,4-dimethylpyrrole (17.44 mmol, 1.66 g) were 
dissolved in 1000 mL of dry CH2Cl2 in a 2000-mL three-
60 neck flask. Eight drops of trifluoroacetic acid (TFA) were 
added to the reaction mixture, and the resulting mixture was 
stirred in the dark for 12 h under nitrogen atmosphere at 
room temperature. After the complete consumption of alde-
hyde (la) (which was monitored by TLC), DDQ (2,3-
65 dichloro-5,6-dicyano-l,4-benzoquinone) (8.72 mmol 1.974 
g) in 10 mL of CH2 Cl2 was added to the reaction mixture. 
When the mixture was stirred for 30 min, 17 mL of diiso-
US 9,623,123 B2 
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propylethylamine (DIEA) and 17 mL of BF3 .0Et2 were 
added to the mixture. After the mixture was further stirred 
for 30 min, it was concentrated to 200 mL and filtered. The 
filtrate was washed twice with water and brine solution, 
dried over anhydrous MgS04 , and concentrated under 5 
reduced pressure. The crude product was purified by column 
chromatography using hexane! EtOAc (90/10 to 70/30, v/v) 
116.3, 115.4, 101.8, 97.4, 67.1, 60.7, 30.9, 24.8, 14.4, 13.8, 
0.28. IR: 2955, 2923, 2152, 1737, 1609, 1530, 1472, 1393, 
1366, 1318, 1290, 1247, 1198, 1174, 1086, 1048, 1001,946, 
930, 765, 703 em- 1 . ESI-MS [Mt (C35H45BF2 N20 3 Si2 ) 
calcd, m/z=646.3. found, m/z=647.4. It shows absorption 
maximum at 553 nm and emission maximum at 569 nm in 
CH2Cl2 solution. 
to obtain a dark brown crystalline solid (1.51 g, 38%). IH 
NMR (400 MHz, CDCl3): ll 7.13 (d, 1=8.4 Hz, 2H), 6.96 (d, 
1=8.4 Hz, 2H), 5.95 (s, 2H), 4.14 (q, 1=7.2 Hz, 2H), 4.04 (t, 10 
1=6.2 Hz, 2H), 2.54-2.51 (m, SH), 2.15-2.11 (m, 2H), 1.40 
BODIPY Dye 6a. 
When BODIPY dye 5a (0.77 mmol, 0.50 g) was dissolved 
in degassed THF (8 mL) in a 50-mL flask at - 70 DC, 
tetrabutylammonium fluoride (TBAF) (3.1 mmol, 3 mL of 1 
M solution) was added dropwise to the mixture via syringe 
under a nitrogen atmosphere. The reaction temperature was 
brought to the room temperature, and the mixture was 
further stirred for 4 h under nitrogen atmosphere. After 
(s, 6H), 1.25 (t, 1=7.2 Hz, 3H). 13C NMR (100 MHz, 
CDCl3 ): Ii 173.3, 159.6, 155.4, 143.3, 142.0, 132.0, 129.4, 
127.3, 121.2, 115.2, 67.0, 60.67, 30.9, 24.8, 14.8, 14.4. IR: 15 
2954, 2922, 2970, 1736, 1609, 1542, 1514, 1464, 1441, 
1408, 1375, 1365, 1309, 1281, 1261, 1239, 1191, 1179, 
1153, 1090, 1043, 937,828,802,763, 703 em- 1 . ESI-MS: completion of the reaction, the reaction mixture was acidi-
fied with acetic acid, diluted with water, and then extracted M+ (C25H29BF2N2 0 3 ) calcd, m/z=454.2. found, m/z=454.9. 
It shows absorption maximum at 501 nm and emission 20 
maximum at 510 nm in CH2Cl2 solution. 
with 50 mL of CH2 Cl2 . When the reaction mixture was 
concentrated under reduced pressure, the residue was dis-
solved in 50 mL of CH2 Cl2 and washed twice with water and 
saturated saline solution. The organic layer was collected, 
dried over anhydrous MgS04 , and concentrated under 
BODIPY Dye 4a. 
When iodic acid ( 6.13 mmol, 1.08 g) in 5 mL of water was 
added dropwise to the ethanol solution 50 mL) containing 
compound 3a (3.1 mmol 1.4 g) and iodine (6.7 mmol 0.85 25 
g) over 30 min, the mixture was stirred for 2 h. 14 After the 
reduced pressure. The crude product was purified by column 
chromatography using hexane/EtOAc (20/80, v/v) to give 
the desired product as orange-pink crystalline solid (0.29 g, 
76%). 1H NMR (400 MHz, CDCl3 ): Ii 7.11 (d, 1=8.4 Hz, 
2H), 6.99 (d, 1=8.4 Hz, 2H), 4.15 (q, 1=7.2 Hz, 2H), 4.06 (t, 
completion of the reaction, the mixture was concentrated 
under reduced pressure, dissolved in CH2Cl2 and washed 
twice with water and saturated saline solution. The organic 
layer was collected, dried over anhydrous MgS04 , and 
concentrated under reduced pressure. The crude product was 
purified by column chromatography to yield 4a as red 
crystals (2.1 g, 98%). 1H NMR (400 MHz, CDCl3 ): Ii 7.11 
(d, 1=8.4 Hz, 2H), 6.99 (d, 1=8.4 Hz, 2H), 4.15 (q, 1=7.2 Hz, 
2H), 4.06 (t, 1=6.0 Hz, 2H), 2.62 (s, 6H), 2.54 (t, 1=6.0, 2H), 
2.17-2.13 (m, 2H), 1.42 (s, 6H), 1.26 (t, 1=6.8 Hz, 3H). 
NMR (100 MHz, CDCl3 ): Ii 173.3, 160.0, 156.8, 145.5, 
141.7, 131.9, 129.3, 126.9, 115.5, 85.7, 67.2, 60.7, 30.9, 
24.8, 17.4, 16.2, 14.5. IR: 2961, 2899, 1720, 1605, 1538, 
1509, 1464, 1431, 1398, 1344, 1310, 1296, 1263, 1225, 
1177, 1073, 1042, 1000, 916,837,763,705 em- 1 . ESI-MS: 
M+ (C25H27BF2I2N2 0 3 ) calcd, m/z=706.0. found, 
m/z=705.6. It shows an absorption maximum at 533 nm and 
emission maximum at 548 nm in CH2 Cl2 solution. 
BODIPY Dye Sa. 
30 1=6.0 Hz, 2H), 3.29 (s, 2H), 2.62 (s, 6H), 2.54 (t, 1=6.0, 2H), 
2.17-2.13 (m, 2H), 1.50 (s, 6H), 1.26 (t, 1=6.8 Hz, 3H). 2c 
NMR (100 MHz, CDCl3 ): Ii 173.3, 159.9, 158.9, 145.7, 
143.5, 131.5, 129.2, 126.4, 115.5, 115.2, 84.2, 76.2, 67.1, 
60.7, 30.9, 29.9, 24.8, 14.4, 13.7. IR: 3293, 3257, 2936, 
35 1719, 1529, 1474, 1394, 1368, 1316, 1288, 1272, 1244, 
1196, 1178, 1004, 953, 806, 766, 707 em- 1 . ESI-MS [Mt 
(C29H29BF2 N20 3 ) calcd, m/z=502.2. found, m/z=503.1. It 
shows absorption maximum at 538 nm and emission maxi-
mum at 552 nm in CH2Cl2 solution. 40 
Polymer A. 
BODIPY dye 4a (0.133 mmol, 94 mg), BODIPY dye 6a 
(0.139 mmol, 70 mg), and Cul (2 mg) were added to a 
100-mL flask under a nitrogen atmosphere. In the glove box, 
45 Pd(PPh3 ) 4 5 mg) was added to the flask. When a degassed 
mixed solution of anhydrous THF (20 mL) and anhydrous 
diisopropylamine (20 mL) were added to the flask, the 
mixture was stirred under reflux for 24 h. After removal of BODIPY dye 4a (1.69 mmol, 1.2 g), Cul (0.02 mmol, 
0.004 g), and Pd(PPh3 ) 2 Cl2 (0.02 mmol, 0.015 g) were 
added to a 100-mL three-neck round-bottom flask under a 50 the solvent, the residue was dissolved in methylene chloride. The organic layer was washed with water, dried over anhy-
drous MgS04 , and filtered. Then the filtrate was concen-
trated under reduced pressure and added to 200 mL of 
ethanol to precipitate the polymer. The precipitated solid 
nitrogen atmosphere. When 20 mL of anhydrous degassed 
THF, 20 mL of anhydrous diisopropylamine, and trimeth-
ylsilylacetylene 5.0 mmol, 0.49 g) were added to the flask, 
the mixture was stirred under reflux for 4 h. After the 
completion of the reaction (which was monitored by TLC), 
the reaction mixture was concentrated and dissolved in 50 
mL of CH2 Cl2 and washed twice with water and saturated 
saline solution. The organic layer was collected, dried over 
anhydrous MgS04 , and concentrated under reduced pres-
sure. The product was purified by silica gel column chro-
matography using hexane!EtOAc (95/5 to 80120, v/v) to 
yield orange-red solid (0.91 g, 84%). 1H NMR (400 MHz, 
CDCl3 ): Ii 7.17 (d, 1=8.4 Hz, 2H), 6.98 (d, 1=8.4 Hz, 2H), 
4.15 (q, 1=7.2 Hz, 2H), 4.05 (t, 1=6.0 Hz, 2H), 2.60 (s, 6H), 
2.54 (t, 1=6.0, 2H), 2.16-2.13 (m, 2H), 1.48 (s, 6H), 1.26 (t, 
1=6.8 Hz, 3H) 0.19 (s, 18H). 2 C NMR (100 MHz, CDCl3 ): 
Ii 173.3, 159.9, 158.7, 145.1, 143.1, 131.6, 129.3, 126.7, 
55 was collected, washed with ethanol, and dried under vacuum 
for 24 h at room temperature to obtain dark-violet solid 
(0.102 g). 1H NMR (400 MHz, CDCh): ll 7.11 (d, 2H), 6.99 
(d, 2H), 4.15 (broad q, 2H), 4.06 (broad t, 2H), 2.62 (s, 6H), 
2.54 (broad t, 2H), 2.17-2.13 (broad m, 2H), 1.42 (s, 6H), 
60 1.27 (broad t, 3H). 13C NMR (100 MHz, CDCl3 ): Ii 173.3, 
159.9, 158.1, 143.3, 142.3, 131.5, 129.2, 126.9, 116.5, 
115.5, 89.0, 67.1, 60.7, 30.9, 29.9, 24.8, 14.4, 13.7. IR: 2925, 
1732, 1608, 1513, 1472, 1436, 1390, 1313, 1226, 1164, 
1088, 836, 765, 703 em- 1 . It shows absorption maximum at 
65 659 nm and emission maximum at 678 nm in CH2Cl2 
solution. OPC (THF, polystyrene standard), Mn=16500 
g/mol; polydispersity=l .8. 
US 9,623,123 B2 
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Polymer B 
The synthetic route to Polymer Bis shown in FIG. 43 and 
is detailed below. 
Compound lb. 
When 200 mL ofDMF was added to a 500-mL three-neck 
round-bottom flask containing 3,4-dihydroxybezaldehyde 
59.7 mmol, 8 g), ethyl 4-bromobuterate (143.3 mmol, 27.9 
g), and K2 C03 (238.8 mmol, 32.4 g) under a nitrogen 
atmosphere, the mixture was stirred for 4 h at 80° C. under 
a nitrogen atmosphere. After completion of the reaction 
(which was monitored by TLC), DMF was removed from 
the mixture under reduced pressure. The residue was dis-
solved in 150 mL of EtOAc and washed with water and 
saturated saline solution twice. The organic layer was col-
lected, dried over MgS04 , and concentrated under reduced 
pressure. The resulting crude product was purified by silica 
gel colunm chromatography using hexane/EtOAc (70/30, 
v/v) to obtain white solid (20.7 g, 95%). 1H NMR (400 
MHz, CDC13 ): Ii 9.80 (s, LH), 7.42-7.37 (m, 2H), 6.94 (d, 
1=8.0 Hz, LH), 4.15-4.06 (m, SH), 2.54-2.49 (m, 4H), 
2.17-2.12 (m, 4H), 1.23 (t, 1=7.2 Hz, 6H). 13C NMR (100 
MHz, CDC13): ll 191.0, 173.2, 154.4, 149.3, 130.3, 126.9, 
112.2, 111.5, 68.1, 68.0, 60.6, 30.8, 30.6, 24.6, 24.5, 14.4. 
BODIPY Dye 3b. 
Compound lb (8.72 mmol, 3.19 g) and 2,4-dimethylpyr-
role (17.44 mmol, 1.66 g) were added to degassed anhydrous 
1000 mL of CH2 Cl2 in a 2000-mL three-neck roundbottom 
flask. When eight drops ofTFA were added to the reaction 
mixture, the mixture was stirred in the dark for 12 hat room 
temperature under nitrogen atmosphere. After the comple-
tion of aldehyde (1 b) (which was conformed by TLC), DDQ 
(2,3-dichloro-5,6-dicyano-l ,4-benzoquinone) (8.72 mmol 
1.97 4 g) in CH2Cl2 was added. After the mixture was stirred 
for 30 min, DIEA (diisopropylethylamine) (17 mL) and 
BF3 .0Et2 (17 mL) were added. When the mixture was 
stirred for 1h h, it was concentrated to 200 mL and filtered. 
The filtrate was washed twice with water and brine solution, 
dried over MgS04 and concentrated under reduced pressure. 
The crude product was purified by colunm chromatography 
using hexane/EtOAc (90/10 to 70/30, v/v) to obtain a dark 
brown crystalline solid (1.8 g, 37%). 1H NMR (400 MHz, 
CDC13 ): Ii 6.95 (d, 1=8.4 Hz, LH), 6.78-6.76 (m, 2H), 5.95 
(s, LH), 4.17-4.05 (m, 6H), 3.98 (t, 1=6.0 Hz, 2H), 2.56-2.48 
(m, !OH), 2.18-2.08 (m, 4H), 1.44 (s, 6H), 1.26-1.20 (m, 
6H). 13C NMR (100 MHz, CDC13 ): Ii 173.3, 173.2, 155.5, 
149.7, 149.6, 143.3, 141.7, 131.8, 127.7, 121.3, 121.1, 
114.3, 113.9, 68.5, 68.2, 60.6, 30.8, 24.8, 14.7, 14.6, 14.4. 
IR: 2926, 1739, 1720, 1543, 1509, 1470, 1413, 1371, 1306, 
1265, 1160, 1134, 1060, 1037, 1007, 975, 954, 824, 802, 
760, 744, 726 em- 1 . ESI-MS [M+Nat 
(C31 H39BF2 N2 0 6Na) calcd, m/z=607.3. found, m/z=607.3. 
It shows absorption maximum at 502 nm and emission 
maximum at 511 nm in CH2 Cl2 solution. 
BODIPY Dye 4b. 
When iodic acid ( 6.13 mmol, 1.08 g) in 5 mL of water was 
added dropwise to the ethanol solution 50 mL) containing 
BODIPY dye 3b (3.1 mmol 1.8 g) and iodine (6.7 mmol 0.85 
g) over 30 min, the mixture was stirred for 2 h. After the 
completion of the reaction, the reaction mixture was con-
centrated under reduced pressure and dissolved in CH2 Cl2 . 
The organic layer was washed twice with water and with 
saturated saline solution, dried over MgS04 , and concen-
trated under reduced pressure. The crude product was puri-
fied by colunm chromatography using hexane/EtOAc (80/ 
20, v/v) to yield 4b as red crystals (2.5 g, 98%). 1H NMR 
(400 MHz, CDC13): ll 6.97 (d, 1=8.4 Hz, LH), 6.75-6.71 (m, 
84 
2H), 4.17-4.09 (m, 6H), 3.97 (t, 1=6.0 Hz, 2H), 2.61 (s, 6H), 
2.57-2.48 (m, 4H), 2.18-2.08 (m, 4H), 1.45 (s, 6H), 1.27-
1.20 (m, 6H). 13C NMR (100 MHz, CDC13 ): ll 173.3, 173.1, 
156.8, 150.0, 149.9, 145.5, 141.4, 131.8, 127.2, 120.9, 
5 114.3, 113.6, 85.7, 68.6, 68.2, 60.6, 30.8, 24.8, 17.3, 16.2, 
14.4. IR: 2977, 2957, 2772, 2931, 1730, 1539, 1508, 1463, 
1396, 1345, 1309, 1265, 1245, 1178, 1138, 1119, 1085, 
1048, 989, 956, 758, 724 em- 1 . ESI-MS [M+Nat 
(C31H37BF2 I2 N20 6Na) calcd, m/z=859.1. found, 
10 m/z=859.4. It shows absorption maximum at 534 nm and 
emission maximum at 549 nm in CH2 Cl2 solution. 
BODIPY Dye Sb. 
BODIPY dye 4b (1.7 mmol, 1.5 g), Cul (0.02 mmol, 4 
mg) and Pd(PPh3 ) 2Cl2 (0.02 mmol, 15 mg) were added to a 
15 100-mL three-neck round-bottom flask under nitrogen atmo-
sphere. When degassed anhydrous THF (20 mL), anhydrous 
diisopropylamine (20 mL), and trimethylsilylacetylene 5.3 
mmol, 0.52 g) were added to the flask, the mixture was 
stirred under reflux for 4 h. After the completion of the 
20 reaction (which was monitored by TLC), the reaction mix-
ture was concentrated under reduced pressure, dissolved in 
50 mL of CH2 Cl2 and washed twice with water and saturated 
saline solution. The organic layer was collected, dried over 
MgS04 , and concentrated under reduced pressure. The 
25 product was purified by silica gel colunm chromatography 
using hexane/EtOAc (95/5 to 70/30, v/v) to yield orange-red 
solid (1.07 g, 82% ). 1 H NMR ( 400 MHz, CDC13 ): Ii 6.96 ( d, 
1=8.4 Hz, LH), 6.74-6.71 (m, 2H), 4.15-4.07 (m, 6H), 3.97 
(t, 1=6.0 Hz, 2H), 2.60 (s, 6H), 2.57-2.48 (m, 4H), 2.18-2.09 
30 (m, 4H), 1.52 (s, 6H), 1.27-1.20 (m, 6H), 0.19 (s, 18H). 13C 
NMR (100 MHz, CDC13 ): Ii 173.3, 173.1, 158.8, 149.9, 
149.8, 145.0, 142.7, 131.4, 127.0, 120.9, 116.4, 114.3, 113.6, 
101.9, 97.3, 68.6, 68.2, 60.6, 30.8, 24.8, 14.4, 13.7, 13.6, 
0.28. IR: 2921, 2852, 2201, 1604, 1513, 1467, 1435, 1389, 
35 1363, 1310, 1263, 1227, 1162, 1083, 994, 814, 760, 724 
em- 1 . ESI-MS [M]+ (C41H55BF2 N20 6 Si2 ) calcd, 
m/z=776.4. found, m/z=776.9. It shows absorption maxi-
mum at 554 nm and emission maximum at 570 nm in 
CH2Cl2 solution. 
40 BODIPY Dye 6b. 
When BODIPY dye 5b (0.65 mmol, 0.50 g) was dissolved 
in degassed THF (8 mL) in a 50-mL flask at - 70 DC, 
tetrabutylammonium fluoride (TRAP) (2.6 mmol, 2.6 mL of 
1 M solution) was added dropwise to the mixture via syringe 
45 under nitrogen atmosphere. The reaction temperature was 
brought to room temperature, and the mixture was further 
stirred for 4 h under nitrogen atmosphere. After completion 
of the reaction, the reaction mixture was acidified with acetic 
acid, diluted with water, and then extracted with 50 mL of 
50 CH2Cl2 . The organic layer was washed twice with water and 
saturated saline solution. The organic layer was collected, 
dried over anhydrous MgS04 , and concentrated under 
reduced pressure. The crude product was purified by colunm 
chromatography using hexane/EtOAc (20/80, v/v) to give 
55 the product as orange-pink crystalline solid (0.29 g, 75%). 
1H NMR (400 MHz, CDC13 ): Ii 6.97 (d, 1=8.4 Hz, LH), 
6.76-6.71 (m, 2H), 4.15-4.07 (m, 6H), 3.96 (t, 1=6.0 Hz, 
2H), 3.30 (s, 2H), 2.60 (s, 6H), 2.57-2.48 (m, 4H), 2.18-2.09 
(m, 4H), 1.54 (s, 6H), 1.27-1.20 (m, 6H). 13C NMR (100 
60 MHz, CDC13): Ii 173.3, 173.1, 158.9, 150.0, 149.9, 145.7, 
143.2, 131.4, 126.8, 120.9, 115.2, 114.3, 113.6, 84.3, 76.1, 
68.6, 68.2, 60.6, 30.8, 24.8, 14.4, 13.7, 13.6. IR: 3296, 3255, 
2958, 2933, 1728, 1532, 1467, 1392, 1316, 1265, 1247, 
1184, 1084, 1013, 995, 761 em- 1 . ESI-MS [M+Nat 
65 (C31H37BF2 I2 N20 6Na) calcd, m/z=655.3. found, 
m/z=655.9. It shows absorption maximum at 539 nm and 
emission maximum at 553 nm in CH2 Cl2 solution. 
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Polymer B. 
BODIPY dye 4b (0.81 mmol, 0.677 g), BODIPY dye 6b 
(0.84 mmol, 0.531 g), and Cul (O.Ql mmol, 4 mg) were 
added to a 100-mL round-bottom flask. Pd(PPh3 ) 4 (10 mg) 
was added to the flask under a nitrogen atmosphere. When 5 
a degassed mixed solution of anhydrous THF (20 mL) and 
anhydrous diisopropylamine (20 mL) were added to the 
flask, the mixture was stirred under reflux for 24 h. After 
removal of the solvent, the residue was dissolved in meth-
ylene chloride and washed with water. The organic layer was 10 
collected, dried over anhydrous MgS04 , and filtered. 
Then the filtrate was concentrated under reduced pressure 
and added to 200 mL of ethanol to precipitate the polymer. 
The precipitated solid was collected, washed with ethanol, 15 
and dried under vacuum for 24 h at room temperature to 
obtain dark-violet solid (0.912 g). 1H NMR (400 MHz, 
CDC13 ): Ii 6.96 (br, LH), 6.73 (br, 2H), 4.15-4.09 (br, 6H), 
3.97 (br, 2H), 2.62 (s, 6H), 2.55-2.49 (br, 4H), 2.14-2.10 (br, 
4H), 1.54 (s, 6H), 1.25-1.20 (br, 6H). 13C NMR (100 MHz, 20 
CDC13 ): ll 173.3, 173.1, 158.2, 150.0, 149.8, 143.3, 142.3, 
131.7, 126.9, 120.9, 116.5, 114.2, 113.6, 89.0, 68.6, 68.2, 
60.6, 31.1, 30.8, 24.8, 14.4, 13.8, 13.7. IR: 2932, 1729, 
1513, 1471, 1436, 1390, 1311, 1264, 1228, 1161, 1087,992, 
882, 816, 760, 725, 694, 681 em- 1 . It displays absorption 25 
maximum at 665 nm and emission maximum at 683 nm in 
CH2 Cl2 solution. OPC (THF, polystyrene standard), Mn =23 
800 g/mol; polydispersity=l.9. 
86 
hexane. The obtained solid was dried under vacuum for 24 
hat room temperature to obtain dark-violet solid (0.147 g). 
1H NMR (400 MHz, CDC13 ): ll 7.65-7.60 (br, lH), 7.45-7.36 
(m, 2H), 7.03-6.99 (br, lH), 6.84-6.77 (br, 2H), 4.19-4.12 
(br, 6H), 4.12-4.00 (br, 2H), 2.76 (s, 6H), 2.59-2.13 (m, 
16H), 1.94 (br, 4H), 1.66 (s, 6H), 1.56-1.47 (br, 4H), 
1.36-1.09 (m, 34), 0.86-0.84 (br, 6H). 13C NMR (100 MHz, 
CDC13 ): ll 173.3, 173.2, 158.9, 151.1, 149.9, 144.1, 140.7, 
132.3, 131.8, 130.8, 125.5, 121.1, 120.2, 116.4, 114.4, 97.7, 
68.7, 68.3, 60.7, 40.5, 32.4, 32.2, 31.6, 30.8, 29.8, 28.8, 24.8, 
23.9, 22.7, 22.6, 14.5, 14.0, 13.9. IR: 2925.4, 1731.7, 
1521.2, 1391.2, 1313.7, 1269.7, 1245.4, 1078.6, 1002.5, 
820.6, 760.4 cm- 1 . It shows absorption maximum at 606 nm 
and emission maximum at 641 nm in CH2 Cl2 solution. OPC 
(THF, polystyrene standard), Mn =21 600 g/mol; polydisper-
sity=2.1. 
Polymer D. 
BODIPY dye 6b (0.08 mmol, 50 mg), 1,4-diiodo2,5-
didecyloxybenzene (7b) (0.072 mmol, 46 mg), and Cul (2 
mg) were added to a 100-mL flask under a nitrogen atmo-
sphere. In the glovebox, Pd(PPh3 ) 4 5 mg was added to the 
flask. When a degassed mixed solution of anhydrous THF 
(20 mL) and anhydrous diisopropylamine (20 mL) were 
added to the flask, the mixture was stirred under reflux for 
24 h. The polymer was purified in a way for polymer C to 
obtain dark-violet solid (0.073 g). 1H NMR (400 MHz, 
CDC13 ): Ii 6.99 (br, lH), 6.85-6.75 (br, 4H), 4.18-4.11 (br, 
6H), 3.99-3.92 (br, 6H), 2.72 (s, 6H), 2.58-2.49 (m, 4H), 
2.18-2.12 (br, 4H), 1.75 (br, 4H), 1.62 (s, 6H), 1.42 (br, 4H), 
1.28-1.20 (br, 30H), 0.86-0.84 (br, 6H). 13C NMR (100 
Polymers C, D and E 
The synthetic route to polymers C, D and E is shown in 
FIG. 44 and detailed below. 
9,9-Bis(6'-(hexylthio )hexyl)-2,7-diiodo-9H-fluorene (7a) 
When 150 mL of degassed DMF was added to a 250-mL 
three-neck round-bottom flask containing 9,9-bis-(6'-bromo-
hexyl)-2,7-diido9H-fluorene (2.69 mmol, 2 g), hexanethiol 
(8.07 mmol, 0.95 g), and K2 C03 (10.8 mmol, 1.48 g) under 
30 MHz, CDC13): Ii 173.3, 173.1, 158.8, 153.4, 152.0, 149.9, 
143.8, 142.3, 131.8, 127.1, 123.4, 121.0, 116.6, 116.0, 114.3, 
113.8, 93.5, 87.4, 70.4, 69.5, 68.6, 68.3, 60.7, 33.9, 32.0, 
30.9, 29.9, 29.8, 29.7, 29.54, 29.51, 29.4, 26.3, 26.2, 24.8, 
22.9, 14.4, 14.4, 14.3, 13.8, 13.7. IR: 2924.6, 1726.2, 
a nitrogen atmosphere, the mixture was stirred for 24 h at 
40° C. under a nitrogen atmosphere. After completion of the 
reaction (which was monitored by TLC), the reaction mix-
ture was concentrated under reduced pressure, added to 
water, and extracted with EtOAc. The organic layer was 
washed twice with water and saturated NaCl solution, dried 
over anhydrous MgS04 , and concentrated under reduced 
pressure. The resulting dried product was purified by silica 
gel column chromatography using hexane/EtOAc to obtain 
brown liquid (1.47 g, 67%). 1H NMR (400 MHz, CDC13 ): Ii 
7.65-7.61 (m, 4H), 7.38 (d, J=7.6, 2H), 2.44-2.35 (m, SH), 
1.89-1.85 (m, 4H), 1.53-1.47 (m, 4H), 1.4-1.22 (m, 20H), 
1.15-1.04 (m, SH), 1.03-0.84 (m, 6H). 13C NMR (100 MHz, 
CDC13 ): ll 152.5, 140, 136.3, 132.1, 121.7, 93.4, 55.5, 40.2, 
32.4, 32.3, 31.7, 31.6, 29.9, 29.8, 29.7, 28.8, 23.8, 22.8, 14.3, 
14.2. IR: 2924.9, 2853.4, 1593.4, 1567.8, 1448.0, 1409.4, 
1393.4, 1377.0, 1279.1, 1255.6, 1054.0, 1003.3, 879.2, 
808.1, 738.3 cm- 1 . ESI-MS M+ (C37H56I2 S2 ) calcd, 
m/z=818.8. found, m/z=818.7. 
Polymer C. 
35 1526.4, 1314.8, 1009.7, 762.0 em-
1
. It exhibits absorption 
maximum at 635 nm and emission maximum at 657 nm in 
CH2Cl2 solution. OPC (THF, polystyrene standard), 
Mn= 19200 g/mol; polydispersity= 1.9. 
Polymer E. 
BODIPY dye 6b (0.126 mmol, 80 mg), 2,5-diiodo3-
40 deeylthiophene (7c), (0.115 mmol, 54 mg), and Cul (2 mg) 
were added to a 100-mL flask under a nitrogen atmosphere. 
In the glovebox, Pd(PPh3 ) 4 5 mg was added to the flask. 
When a degassed mixed solution of anhydrous THF (20 mL) 
and anhydrous diisopropylamine (20 mL) were added to the 
45 flask, the mixture was stirred under reflux for 24 h. The 
polymer was purified in a way for polymer C to obtain 
dark-violet solid (0.106 g). 1H NMR (400 MHz, CDC13 ): Ii 
7.00-6.98 (m, 2H), 6.76 (br, 2H), 4.18-4.10 (br, 6H), 3.98 
(br, 2H), 2.66 (s, 6H), 2.58-2.49 (m, 6H), 2.18-2.12 (br, 4H), 
50 1.57 (br, SH), 1.27-1.22 (br, 20H), 0.86-0.84 (br, 3H). 13C 
NMR (100 MHz, CDC13 ): Ii 173.3, 173.1, 158.7, 150.2, 
149.9, 147.4, 144.3, 142.6, 132.7, 131.8, 126.8, 123.1, 121, 
116.2, 115.9, 114.3, 113.7, 89.1, 86.4, 76.9, 68.6, 68.2, 60.6, 
32.1, 30.8, 30.3, 29.9, 29.8, 29.7, 29.6, 29.5, 24.8, 22.9, 19.9, 
55 14.44, 14.41, 14.3, 13.9, 13.8. IR: 2921.1, 1731.0, 1516.5, 1391.3, 1312.0, 1246.0, 1170.0, 1000.0, 760.0, 724.7 em- 1 . 
It shows absorption maximum at 628 nm and emission 
maximum at 664 nm in CH2Cl2 solution. OPC (THF, poly-
styrene standard), Mn=15 700 g/mol; polydispersity=2.0. 
BODIPY dye 6b (0.126 mmol, 80 mg), 9,9-bis(6'(hexyl-
thio)hexyl)-2,7-diiodo-9H-fluorene (7a) (0.115 mmol, 94 
mg), and Cul (2 mg) were added to a 100-mL flask under a 
nitrogen atmosphere. In the glovebox, Pd(PPh3 ) 4 5 mg was 60 
added to the flask. When a degassed mixed solution of 
anhydrous THF (20 mL) and anhydrous diisopropylamine 
(20 mL) were added to the flask, the mixture was stirred 
under reflux for 24 h. After removal of the solvent, the 
residue was dissolved in methylene chloride 5 mL and added 
Optical Properties of the Monomers and Polymers. 
The absorption properties of green emissive BODIPY dye 
(3a) are characterized by a strong S0 ----;,S 1 (it-it*) transition at 
501 nm and a weaker broad band around 350 nm ascribed to 
the S0 ----;,S2 (it-it*) transition (FIG. 45). Introduction of 
2,6-diiodo substituents to the BODIPY core leads to large 
65 red shifts (33 and 38 nm) of both the UV absorption and 
fluorescence maxima, respectively, significantly depressing 
the fluorescence quantum yield because of efficient inter-
to 400 mL of ethanol to precipitate the polymer. The 
precipitated solid was filtered and washed with ethanol and 
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different BODIPY monomer pairs ( 4a-4b and 6a-6b) each 
have only 1 nm difference between their respective absorp-
tion or emission spectral maxima. However, the absorption 
system crossing induced by the heavy atom effect of iodine 
(FIG. 45, Table 10). 2,6-Diethynylation of2,6-diiodotetram-
ethyl BODIPY (4a) results in a little red shift due to the 
enhanced conjugation. However, polymer A emits in the 
deep red region at 678 nm and exhibits pronounced 5 
bathochromic shifts (158 and 168 nm) of both the absorption 
and the fluorescence maxima relative to the initial BODIPY 
dye (3a) because of its significant extension of it-conjuga-
tion (FIG. 46 and Table 10). Polymer B displays an absorp-
tion maximum at 665 nm and fluorescence maximum at 683 
nm, a slight red-shift relative to polymer A. The absorption 
peaks of conjugated polymers become broader than 
BODIPY monomers as a result of the extended it-conjuga-
tion (FIG. 46). BODIPY dyes (3a, 3b, 5a, 5b, 6a, and 6b) 
show fluorescence lifetimes of several nanoseconds (Table 
10). However, the diiodo-functionalized BODIPY dyes (4a 
and 4b) display much shorter fluorescence lifetimes (ranging 
from 0.08 to 0.13 ns), consistent with their decreased 
quantum yields because of efficient intersystem crossing 
induced by the heavy atom effect of iodine (Table 10). 
and emission maxima of polymer B are somewhat more 
redshifted relative to those of polymer A, which might arise 
from amplification effect of conjugated polymers. The quan-
tum yields of the mesa-phenyl BODIPY dyes (3b, 5b, and 
6b) are a little higher than those of the corresponding less 
substituted analogues (3a, 5a, and 6a) (Table 10). The 
10 difference might result from reduced free rotation of the 
phenyl group in the more substituted compounds and a 
subsequent decrease in loss of energy from the excited states 
through nonirradiative molecular motions. Polymers A and 
TABLE 10 
Absorption and Emission Maxima and Quantum Yields of BODIPY 
Dyes and Polymers in Metbylene Chloride Solution. 
15 B displays similar fluorescence lifetimes to their starting 
BODIPY dyes (3a and 3b) (Table 10). 
Incorporation of different band gap monomers such as 
fluorene, benzene, and thiophene units into the backbone of 
poly(2,6-BODIPY-ethynylene) results in the copolymers 
20 with different red emissions. Fluorescence maxima of the 
copolymers with fluorene, benzene, and thiophene units are 
641, 657, and 664 nm, respectively (Table 11), which is 
consistent with their band gap energy differences 
(fluorine>benzene>thiophene ). Introduction of the thio-
BODIPY dyes or polymers 25 phene unit to poly(2,6-BODIPY-ethynylene) significantly 
------~-~~----- reduces the fluorescence quantum yield of the copolymer 
3a 4a 5a 6a polymer A 
absorption maxima (nm) 501 533 553 538 659 
emission maxima (nm) 510 548 569 552 678 
quantum yield(%) 76 5.8 71 63 21 
fluorescence lifetime (ns) 3.8 0.13 4.5 4.2 3.8 
BODIPY dyes or polymers 
3b 4b Sb 6b polymer B 
absorption maxima (nm) 502 534 554 539 665 
emission maxima (nm) 511 549 570 553 683 
quantum yield(%) 81 5.8 79 67 23 
fluorescence lifetime (ns) 4.1 0.08 5.2 5.9 3.7 
aQuantum yields of BODIPY dyes and polymeric dyes were determined by use of 
fluorescein (quantum yield of 0.85 in O.lN NaOH) as a standard. 13 -16 
TABLE 10 
Absorption and Emission Maxima and Quantum Yields of BODIPY 
Dyes and Polymers in Metbylene Chloride Solutiona 
BODIPY dyes or polymers 
3a 4a 5a 6a polymer A 
absorption maxima (nm) 501 533 553 538 659 
emission maxima (nm) 510 548 569 552 678 
quantum yield(%) 76 5.8 71 63 21 
fluorescence lifetime (ns) 3.8 0.13 4.5 4.2 3.8 
BODIPY dyes or polymers 
3b 4b Sb 6b polymer B 
absorption maxima (nm) 502 534 554 539 665 
emission maxima (nm) 511 549 570 553 683 
quantum yield(%) 81 5.8 79 67 23 
fluorescence lifetime (ns) 4.1 0.08 5.2 5.9 3.7 
aQuantum yields of BODIPY dyes and polymeric dyes were determined by use of 
fluorescein (quantum yield of 0.85 in O.lN NaOH) as a standard. 13 -16 
Arylation at the mesa position has no significant effect on 
the absorption and emission maxima of BODIPY dyes since 
the arylated moiety is not coplanar with the BODIPY core 
because of steric hindrance, although the substitution posi-
tion is structurally different (Table 10). As a result, two 
30 
35 
40 
45 
50 
55 
60 
65 
and shortens fluorescence lifetime of the copolymer due to 
efficient intersystem crossing induced by the heavy atom 
effect of sulfur. 
TABLE 11 
Absorption and Emission Maxima and Quantum Yields of 
BODIPY-Based Copolymers in Metbylene Chloride Solutiona 
BODIPY-based copolymers 
polymer C polymer D polymer E 
absorption maxima (nm) 606 635 628 
emission maxima (nm) 641 657 664 
quantum yield(%) 25 24 6 
fluorescence lifetime (ns) 2.8 3.6 0.23 
aQuantum yields of BODIPY dyes and polymeric dyes were determined by use of 
fluorescein (quantum yield of 0.85 in O.lN NaOH) as a standard. 13 -16 
Example 15 
Prevention of Nonspecific Interactions of 
Conjugated Glycopolymers with Other Proteins 
Well-defined poly(ethylene glycol) as tethered spacers 
between carbohydrate and polymer backbones are used to 
enhance water-solubility of conjugated glycopolymers, and 
prevent the nonspecific interactions of BODIPY-based con-
jugated glycopolymers with other proteins. Histone (from 
calf thymus, Type II-A), hemoglobin (from bovine blood), 
myoglobin (from horse heart), lysozyme (from chicken egg 
white), cytochrome c (from bovine heart), albumin (from 
bovine serum), and sticking protein fibrinogen are used to 
test whether there are nonspecific interactions of the conju-
gated glycopolymers with these proteins by measuring UV-
Visible and fluorescent spectra of the conjugated glycopo-
lymers in 0.1 M phosphate buffer (pH 7.2) in the absence 
and presence of different concentrations of each protein 
above (from 1.0 µM to 1.0 mM). The non-specific interac-
tions of the conjugated glycopolymers with other proteins 
can result in changes of fluorescent intensity of the conju-
gated glycopolymers. 
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Example 16 
Detection of Escherichia coli 
90 
lymers for one half to two hours with gentle shaking, 
centrifuged at 10,000 g for 30 minutes, and washed six times 
with 0.1 M phosphate buffer. The final cell pellet is resus-
Fluorene-based a-mannose bearing conjugated glycopo- 5 
lymer (polymer XXIV) and a-mannose bearing conjugated 
poly(p-phenylene) (polymer XXX) have been used as 
bioimaging materials for detection of E. coli bacteria. 
pended in 0.1 M phosphate buffer (pH 7.2). Absorption and 
fluorescent spectra of BODIPY-based conjugated glycopo-
lymers are recorded in 0.1 M phosphate buffer (pH 7.2) with 
1.0 mM CaC12 and 1.0 mM MnC12 in the absence and 
presence of different amounts from (a few to 109 ) of 
bacterial cells. It is expected that strong interactions of E. 
coli bacteria with BODIPY-based conjugated glycopolymers 
bearing a-marmose residues will result in the formation of 
fluorescently-stained bacterial clusters or cells. A fluorescent 
confocal microscope is used to capture images of these 
fluorescently-stained bacterial clusters or cells, and deter-
mine detection limit (number of bacterial cells per mL) of 
the imaging materials. Cooperative multiple bindings of E. 
coli bacteria with a-mannose-bearing glycopolymers are 
tested by adding free a-mannose to the phosphate buffer 
containing fluorescently stained bacteria clusters. Measure-
20 ments can then be made of the sufficient level of concen-
Two E. coli strains, ORN! 78 and ORN208, were used for 
testing and control experiments to investigate the specific 10 
binding of a-marmose-bearing polymers XXIV and XXX to 
FimH protein of E. coli. The ORN! 78 strain expresses the 
wild-type type 1 pili that selectively bind to a-mannose, 
whereas the ORN208 strain is deficient of the fimH gene and 
expresses abnormal type 1 pili that fail to mediate specific 15 
binding to a-marmose. Incubation of polymer XXIV or 
XXX with the ORN! 78 strain resulted in formation of 
fluorescently stained bacteria clusters from which the poly-
mer was not removed by rinsing and separation. However, 
Polymers XXIV and XXX failed to bind to ORN208 strain 
and polymers XXIII and XXXI did not bind to the ORN! 78 
strain, 11 which indicates that a-mannose-bearing polymers 
XXIV and XXX selectively bind to ORN! 78 through mul-
tivalent interactions. Results show that fluorescently-stained 
bacterial cluster and individual cells by glycopolymer XXIV 25 
can easily be observed. Strong multivalent interactions 
between polymer XXIV and bacterial pili result in signifi-
cant red shifts in both absorption and emission spectral 
maxima because long, flexible poly(ethylene glycol) teth-
ered spacers, significantly reduce steric binding hindrance of 30 
the polymeric marmose residues to bacterial pili (FIG. 25). 
The red shift of the polymer fluorescence was also observed 
tration of free a-mannose needed (relative to the concen-
tration of the a-mannose-bearing glycopolymers) to make 
fluorescently stained bacteria clusters completely disappear. 
This will enable the study of the strength of the cooperative 
multiple bindings of E. coli with the glycopolymers bearing 
different densities and spacing of a-mannose ligands. 
Control experiments are conducted using the ORN208 
cells instead of the ORN! 78 cells to test the selectivity of 
BODIPY-based conjugated glycopolymers and investigate 
whether there are nonspecific interactions of the conjugated 
glycopolymers with the ORN208 cells as the ORN208 strain 
is unable to mediate a-mannose-specific binding. 
in fluorescent imaging of fluorescently-stained bacterial 
cluster where there is a big green spot in the center of the 
image. 
Example 17 
Use of BODIPY-Based Conjugated Glycopolymers 
to Sensitively Detect Escherichia coli 
BODIPY-based fluorescent conjugated glycopolymers as 
bioimaging materials are used to detect Escherichia coli (E. 
coli). Type 1 pili in E. coli are filamentous proteinaceous 
appendages composed of FimA, FimF, FimG, and FimH 
proteins. FimH protein is uniquely responsible for the bind-
ing to a-D-mannose. Two E. coli strains, ORN! 78 and 
ORN208, will be used for testing and control experiments 
since the ORN! 78 strain expresses wild-type 1 pili that 
selectively binds to a-D-mannose. In contrast, the ORN208 
strain is deficient of the fimH gene and expresses abnormal 
type 1 pili that fail to mediate a-D-marmose-specific bind-
ing. E. coli bacterial cells will be grown and prepared 
according to the published procedure. (Biomacromolecules 
2006, 7, (9), 2470-2474). Other bacterial samples such as 
Campylobacter Jejuni and Yersinia enterocolitica are 
obtained from American Type Culture Collection (ATCC) 
Global Bioresource Center. The cultures are grown in TYG 
medium (5% tryptone, 2.5% yeast extract, 1% glucose) at 
37° C. for 24 to 48 h with shaking at 200 rpm. Bacterial cells 
are collected by centrifugation at 20,000 g, washed and 
resuspended in phosphate-buffered saline (PBS) or appro-
priate buffer for further studies. 
A 1.0 mL aliquot of E. coli ORN! 78 cells (with different 
cell number) in 0.1 M phosphate buffer (pH 7.2) with 1.0 
mM CaC12 and 1.0 mM MnC12 are incubated with 5-20 µg 
aliquot of BODIPY-based fluorescent conjugated glycopo-
E. coli is detected in contaminated samples by incubating 
a-mannose-bearing conjugated glycopolymers with strain 
35 ORN! 78 which is placed as a contaminant into solutions 
that include sheep erythrocytes and serum. E. coli is detected 
in solution containing different bacteria of E. coli and 
Campylobacter Jejuni and Yersinia enterocolitica. The test-
ing is conducted in a manner similar to that of pure bacterial 
40 samples. 
Anticipated results: BODIPY-based conjugated glycopo-
lymers will circumvent the problem of residual blue fluo-
rescence, (blue haze) that tends to emanate from biological 
fluids because the deep-red and near-infrared emissive poly-
45 meric dyes with emission wavelengths ranging from 680 nm 
to 900 nm have low background absorption, low scattering 
and cheap illumination sources. Strong multivalent interac-
tions of a-mannose-bearing conjugated glycopolymers with 
E. coli strain ORN! 78 will result in fluorescently-stained 
50 bacterial clusters or fluorescently-stained bacterial cells, 
which will depend on number of bacterial cells. BODIPY-
based conjugated glycopolymers bearing oligomannose or 
hydrophobic aromatic a-mannose residues will have much 
higher sensitivity than those bearing a-marmose residues 
55 because the FimH adhesin of Type 1 fimbriae of E. coli 
possesses an extended combining site and a hydrophobic 
region next to the carbohydrate-binding site of FimH, and 
displays a considerably higher affinity to oligomarmose and 
hybrid type such as Mana3Man~4GlcNAc and Mana6 
60 (Mana3)Mana6(Mana3)Man, and to hydrophobic aromatic 
a-mannose. BODIPY-based conjugated glycopolymers 
bearing longer oligo(ethylene glycol) tethered spacers (with 
repeated unit (m)>lO, up to 43) will be highly soluble in 
aqueous solution and display much stronger multivalent 
65 interactions with bacterial pili due to less steric binding 
hindrance of carbohydrates to the bacterial pili, 10 which 
might allow for sensitive detection of a few bacterial cells. 
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BODIPY-based conjugated glycopolymers bearing galac-
tose or N-acetylgalactosamine residues will have strong 
interactions with Yersinia enterocolitica which is reported to 
selectively interact with galactose and N-acetylgalac-
tosamine of native small intestinal mucin through a plasmid- 5 
mediated process. BODIPY-based conjugated glycopoly-
mers bearing fucose residues will have strong interactions 
with Campylobacter jejuni whose binding to intestinal epi-
thelial cells is achieved through fucosylated carbohydrate 
10 
epitopes. 
Example 18 
Use of BODIPY-Based Conjugated Glycopolymers 
to Detect Influenza Virus 
15 
a-Sialic acid-bearing fluorescent conjugated glycopoly-
mers are used to detect influenza virus. Influenza virus is 20 
roughly globular in shape and approximately 1000 A in 
diameter. The outer surface of the virus contains the protein 
hemagglutinin (RA) and neuraminidase. The HA molecules 
aggregate into triangular clusters, distributing irregularly on 
the surface of the virus and the center-to-center distance 25 
between the clusters is 95-150 A. The binding of the HAs to 
sialic acid (N-acetylneuraminic acid) groups present on cell 
surface glycoproteins and glycolipids initiates infection of a 
red blood cell by influenza virus and drives the cells to 30 
aggregate into massive clusters. The subtypes found in avian 
influenza virus binds preferentially to a-Sia(2-3)-Gal 
which predominates in avian gastrointestinal tract where 
viruses replicate. Human influenza virus prefers a-Sia 
(2-6)-Gal. 35 
Influenza virus A/ AA/ 6/ 60 (H2N 2) strain passaged in mice 
and another passaged in chickens is obtained from Depart-
ment of Public Health, University of Michigan, Ann Arbor, 
Mich., and propagated in embryonated chicken eggs using 
standard methods. a-Sialic acid-bearing glycopolymer stock 40 
solution is diluted with 0.1 M phosphate buffer (pH 7.2). 
When 1.0 mL of this solution is transferred to a 2.0 mL 
Eppendorf tube, 5-20 µL of the stock solution of Influenza 
Virus A or Bis added to the tube, mixed and incubated at 4° 45 
C. for 0.5-2 hours. The UV-visible absorption and fluores-
cent spectra are recorded and compared with the same 
concentration of the mother solution. Fluorescent imaging of 
fluorescent clusters of the sialic acid-bearing glycopolymers 
with influenza virus is conducted a similar way to that of the 50 
fluorescently stained E. coli clusters. 
Anticipated results: BODIPY-based conjugated glycopo-
lymers bearing NeuAca2,6Gal~l,4GlcNAc~ or NeuAca2, 
6Gal~l,4GlcNAc~ residues (Table 3) will display strong 
interactions with human influenza virus while BODIPY- 55 
based conjugated glycopolymers bearing NeuAca2,3Gal~l, 
4GlcNAc~ or NeuAca2,3Gal~l,4GlcNAc~ residues (Table 
3) will not have any interactions with human influenza. 
The invention claimed is: 
1. A method of enhancing medical imaging comprising 
administering an effective amount of a polymer to a subject 
60 
in need of medical imaging and obtaining an image, wherein 
the amount of the polymer is sufficient to enhance an image 65 
compared to an image obtained in absence of the polymer; 
wherein the polymer is according to formula (I): 
or 
or 
92 
(I) 
~ 
A 
~N, /N 
B 
R1 /\ Rs Ro Ro 
wherein each -A- is independently selected from 
-AR-, 
--=-AR-=--, 
----====--AR--===--, or 
----====--==~-AR--===----====--
wherein each-AR- is independently selected from arylene 
or heteroarylene; 
wherein each R3 is independently selected from R, alkyl, 
aryl or heteroaryl 
wherein each R2 and R4 are independently selected from 
alkyl or H; 
wherein each R1 and R5 are independently selected from 
hydrogen, alkyl, 
or 
--=-AR; 
wherein each R0 is -F, --OR, -R, aryl, heteroaryl, 
-----===~-R, ----====--Ary!, 
-----====--Heteroaryl; 
wherein each R is independently selected from -H, 
-(CH2)mR10, -(CH2)mCOO(CH2)pCH3, -(CH2)m 
S03Na, -(CH2)mP03Na, -(CH2)mN(CH3)3 +Br-, 
-(CH2)mCOH(CH2)pCH3, -(CH2)mOR10, -(CH2) 
OR8 , ----CH2CHiOCH2CH2)mOR10, ----CH2CH2 
(OCH2CH2)mOR8 , -CH2CHiOCH2CH2)mSR8 , or 
/\/\/\ 
----c_O O O OCH3 
0 0 0 OC~; 
\__J \__J \__J 
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and 
wherein each R8 is independently selected from a carbo-
hydrate residue; 
and wherein each R10 is independently selected from 
hydrogen, alkyl, heteroalkyl, hydroxy, amino, 5 
ammonic acid, thiol, carboxylic acid, nitrile, azide, 
ethynylene, halo, and tosylate; 
wherein m is from O to 100; 
wherein n is from 2 to 300 and 
wherein p is from O to 20. 
2. The method of claim 1, wherein the image is deep-
tissue image. 
3. The method of claim 1, wherein the image is of a tumor 
or a cancer cell. 
4. The method of claim 3, wherein the polymer is further 
functionalized with a cancer-homing peptide. 
10 
15 
5. A method of detecting the presence of a target in a 
sample comprising contacting the sample with a polymer 
which binds to the target and detecting fluorescence of the 20 
polymer; wherein the polymer is according to formula (I): 
or 
(I) 
R2 R3 ~ 
f ,::::7 ~ j A 
~N, /N 
B 
/\ R1 Ro Ro Rs 
wherein each -A- is independently selected from 
-AR-, 
---<===~-AR--====--
----'=c==c~-AR---'=='c==c--, or 
--------AR--------
wherein each-AR- is independently selected from arylene 
or heteroarylene; 
wherein each R3 is independently selected from R, alkyl, 
aryl or heteroaryl 
wherein each R2 and R4 are independently selected from 
alkyl or H; 
25 
30 
35 
40 
45 
50 
wherein each R1 and R5 are independently selected from 55 
hydrogen, alkyl, 
or 
--=-AR; 
60 
or 
94 
--=--Heteroaryl; 
wherein each R is independently selected from -H, 
-(CH2)mR10, -(CH2)mCOO(CH2)pCH3, -(CH2)m 
S03Na, -(CH2)mP03Na, -(CH2)mN(CH3)3 +Br-, 
-(CH2)mCOH(CH2)pCH3, -(CH2)mOR10, -(CH2) 
OR8 , ----CH2CHiOCH2CH2)mOR10, ----CH2CH2 
(OCH2CH2)mOR8 , -CH2CHiOCH2CH2)mSR8 , or 
/\/\/\ 
---(__O O O OCH3 
0 0 0 OC~; 
\_J\_J\_J 
and 
wherein each R8 is independently selected from a carbo-
hydrate residue; 
and wherein each R10 is independently selected from 
hydrogen, alkyl, heteroalkyl, hydroxy, amino, 
ammonic acid, thiol, carboxylic acid, nitrile, azide, 
ethynylene, halo, and tosylate; 
wherein m is from O to 100; 
wherein n is from 2 to 300 and 
wherein p is from O to 20. 
6. The method of claim 5, wherein the sample is in a 
subject. 
7. The method of claim 5, wherein the target is selected 
from the group consisting of bacteria and viruses. 
8. The method of claim 7, wherein the target is influenza. 
9. The method of claim 8, wherein the target is human 
influenza. 
10. The method of claim 7, wherein the polymer is 
functionalized with a2,6-sialic acid. 
11. The method of claim 8, wherein the target is avian 
influenza. 
12. The method of claim 11, wherein the polymer is 
functionalized with a2,3-sialic acid. 
13. The method of claim 7, wherein the target is E. coli. 
14. The method of claim 13, wherein the polymer is 
functionalized with a-mannose. 
15. The method of claim 7, wherein the target is 
Clostridium spp. 
16. The method of claim 15, wherein the polymer is 
functionalized with ~-lactosamine. 
17. The method of claim 5, wherein the target is a tumor 
or a cancer cell. 
18. The method of claim 17, wherein the polymer is 
functionalized with a cancer-homing peptide. 
wherein each R0 is -F, -OR, -R, aryl, heteroaryl, 
-----R, -----Ary!, 
19. A method of monitoring drug delivery comprising 
administering a polymer to a subject and detecting fluores-
65 cence of the polymer in the subject, wherein the polymer is 
further functionalized with an active agent; wherein the 
polymer is according to formula (I): 
or 
or 
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and 
(I) wherein each R8 is independently selected from a carbo-
~ 
A 
~N, /N 
B 
R1 /\ Rs Ro Ro 
wherein each -A- is independently selected from 
-AR-, 
--=-AR-=--, 
--==-AR--===--, or 
wherein each-AR- is independently selected from arylene 
or heteroarylene; 
wherein each R3 is independently selected from R, alkyl, 
aryl or heteroaryl 
wherein each R2 and R4 are independently selected from 
alkyl or H; 
wherein each R1 and R5 are independently selected from 
hydrogen, alkyl, 
or 
--=-AR; 
wherein each R0 is -F, -OR, -R, aryl, heteroaryl, 
----R, -~=-Aryl, 
----Heteroaryl; 
hydrate residue; 
and wherein each R10 is independently selected from 
5 hydrogen, alkyl, heteroalkyl, hydroxy, amino, 
ammonic acid, thiol, carboxylic acid, nitrile, azide, 
ethynylene, halo, and tosylate; 
wherein m is from O to 100; 
wherein n is from 2 to 300 and 
10 wherein p is from O to 20. 
15 
20 
25 
40 
45 
50 
20. The method according to claim 1, wherein each AR is 
independently selected from 
~ ~' 
Rn Re 
R R 
wherein each R is independently selected from -H, 
-(CH2)mR10, -(CH2)mCOO(CH2)pCH3, -(CH2)m 
S03Na, -(CH2)mP03Na, -(CH2)mN(CH3)3 +Br-, 
-(CH2)mCOH(CH2)pCH3, -(CH2)mOR10, -(CH2) 55 
OR8 , ----CH2CHiOCH2CH2)mOR10, ----CH2CH2 
(OCH2CH2)mOR8 , -CH2CHiOCH2CH2)mSR8 , or 
/\/\/\ 60 
----c_O O O OCH3 
0 0 0 OC~; 
\__J \__J \__J 65 
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-continued 
OR 
~ 
10 
98 
ORs, ----CH2CHiOCH2CH2)mOR10, ----CH2CH2 
(OCH2CH2)mORs, -CH2CHiOCH2CH2)mSRs, or 
and 
wherein each Rs is independently selected from a carbo-
hydrate residue; 
15 and wherein each R10 is independently selected from 
hydrogen, alkyl, heteroalkyl, hydroxy, amino, 
ammonic acid, thiol, carboxylic acid nitrile azide 
ethynylene, halo, and tosylate. ' ' ' 
21. The method according to claim 1, wherein each R3 is 
20 independently selected from 
R R 
N......_ /N 
M2 
(bpy)i 
R 
25 
30 
35 
wherein each RA, RB, Re and RD is independently selected 
from R, OR, hydrogen, alkyl, heteroalkyl, hydroxy, 
amino, thiol, carboxylic acid, nitrile, azide, halo or RA 40 
and RB may together form an aromatic ring, or Re and 
RD may together form an aromatic ring or both RA and 
RB and Re and RD may together form an aromatic ring; 
wherein each RD RF and RG is independently selected 
from R, OR, hydrogen, alkyl, heteroalkyl, aryl, het- 45 
eroaryl, hydroxy, amino, thiol, carboxylic acid, nitrile, 
azide, halo, or RE and RF may together form a ring; 
wherein each RP and RQ is independently selected from 
hydrogen or together form an aromatic ring; 
wherein each X is independently a carbon atom or a 50 
heteroatom; 
wherein q is an integer from 1 to 3; 
wherein M is selected from Zn, Cu, Fe, or Pt; 
wherein M2 is selected from Ru or Ir; and 
wherein bpy is 55 
R R 
-{>--OR 
R 
p or 
wherein each RF is independently selected from R, OR, 
hydrogen, alkyl, heteroalkyl, aryl, heteroaryl, hydroxy, 
amino, thiol, carboxylic acid, nitrile, azide or halo; and 
wherein each R is independently selected from -H, 
and 
-(CH2)mR10, -(CH2)mCOO(CH2)pCH3, 
-(CH2)mS03Na, -(CH2)mP03Na, -(CH2)m 
N(CH3)3 +Br-, -(CH2)mCOH(CH2)PCH3, -(CH2)m 
OR10, -(CH2)0Rs, -CH2CHiOCH2CH2)mOR10, 
----CH2CHi OCH2CH2)m O Rs, ----CH2CH2 ( OCH2 
CH2)mSRs, or 
wherein each Rs is independently selected from a carbo-
hydrate residue; 
and wherein each R10 is independently selected from 0---0; N N 
wherein each R is independently selected from -H, 
-(CH2)mR10, -(CH2)mCOO(CH2)pCH3, -(CH2)m 
S03Na, -(CH2)mP03Na, -(CH2)mN(CH3)3 +Br-, 
-(CH2)mCOH(CH2)pCH3, -(CH2)mOR10, -(CH2) 
60 hydrogen, alkyl, heteroalkyl, hydroxy, amino, 
ammonic acid, thiol, carboxylic acid, nitrile, azide, 
ethynylene, halo, and tosylate. 
22. The method according to claim 1, wherein each R1 and 
R5 is independently -CH3 or -CH2CH3. 
* * * * * 
